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Abstract
The increasing use of electronic platforms in healthcare has resulted in the generation of
unprecedented amounts of data in recent years. The amount of data available to clinical
researchers, physicians, and healthcare administrators continues to grow, which creates an
untapped resource with the ability to improve the healthcare system drastically. Despite the
enthusiasm for adopting electronic health records (EHRs), some recent studies have shown
that EHR-based systems hardly improve the ability of healthcare providers to make better
decisions. One reason for this inefficacy is that these systems do not allow for human-data
interaction in a manner that fits and supports the needs of healthcare providers. Another
reason is the information overload, which makes healthcare providers often misunderstand,
misinterpret, ignore, or overlook vital data. The emergence of a type of computational system
known as visual analytics (VA), has the potential to reduce the complexity of EHR data by
combining advanced analytics techniques with interactive visualizations to analyze,
synthesize, and facilitate high-level activities while allowing users to get more involved in a
discourse with the data. The purpose of this research is to demonstrate the use of
sophisticated visual analytics systems to solve various EHR-related research problems. This
dissertation includes a framework by which we identify gaps in existing EHR-based systems
and conceptualize the data-driven activities and tasks of our proposed systems. Two novel
VA systems (VISA_M3R3 and VALENCIA) and two studies are designed to bridge the
gaps. VISA_M3R3 incorporates multiple regression, frequent itemset mining, and interactive
visualization to assist users in the identification of nephrotoxic medications. Another
proposed system, VALENCIA, brings a wide range of dimension reduction and cluster
analysis techniques to analyze high-dimensional EHRs, integrate them seamlessly, and make
them accessible through interactive visualizations. The studies are conducted to develop
prediction models to classify patients who are at risk of developing acute kidney injury (AKI)
and identify AKI-associated medication and medication combinations using EHRs. Through
healthcare administrative datasets stored at the ICES-KDT (Kidney Dialysis and
Transplantation program), London, Ontario, we have demonstrated how our proposed
systems and prediction models can be used to solve real-world problems.
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Summary for Lay Audience
Advances in healthcare technology have resulted in the generation of large amounts of
electronic data in the form of electronic health records (EHRs). Adoption of EHR makes it
easy to organize, access, and store medical records through computerized data management
tools. Despite the potential benefits, healthcare professionals continue to report difficulty in
adopting EHR-based systems. One of the main reasons for this problem is the complicated
and improperly designed user interfaces in these systems, which often makes healthcare
providers overlook vital information. The purpose of this research is to prove the use of
visual analytics (VA) to solve various EHR-related problems. VA combines automated
analysis with interactive visualizations for effective reasoning, understanding and decision
making based on complex data. Through a literature survey and proposed framework, we
first analyze the existing EHR-based systems and understand why they fail to fulfill the
computational demand of EHRs. Two novel VA systems (VISA_M3R3 and VALENCIA)
and two studies are designed to demonstrate how the VA approach can be used to overcome
the challenges of EHRs. VISA_M3R3 is designed to assist healthcare providers in the
identification of medications that may associate with a higher risk of developing acute kidney
injury (AKI). VALENCIA provides users with the ability to explore high-dimensional EHRs
using a number of dimension reduction and cluster analysis algorithms. The studies are
conducted to identify AKI-associated medication and medication combinations and predict
the risk of developing AKI using EHRs. Through healthcare administrative datasets stored at
the ICES-KDT (Kidney Dialysis and Transplantation program), we have shown how our
proposed approach can be used to solve real-world problems.
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Chapter 1

1

Introduction

1.1 Motivation
The increasing use of electronic platforms in healthcare has produced unprecedented
amounts of data in recent years. In the healthcare industry, as a part of modernizing their
operations, the medical organizations are adopting electronic health records (EHRs) and
deploying new information technology systems that generate, collect, digitize, and
analyze their data (Caban and Gotz, 2015). This data includes, but is not limited to,
medical and demographic records of patients, hospital and emergency room records, and
results of laboratory tests. The amount of information available to clinical researchers,
physicians, healthcare administrators, and policymakers continues to grow, which creates
an untapped resource with the ability to drastically improve the healthcare system
(Kamal, 2014; Murdoch and Detsky, 2013). While initially created for archiving patient
records and supporting healthcare administrative tasks such as billing, many researchers
have observed the secondary use of EHRs for clinical research purposes (Shickel et al.,
2018). Healthcare providers use modern systems to diagnose patients (Graber et al.,
2017), detect hidden patterns and trends, study the effects of medications (Feng et al.,
2019), determine the effectiveness of treatments (Cowie et al., 2017), monitor patient
improvement (Doupi, 2012), reduce medical errors (Agrawal, 2009), and ultimately
improve quality of care (Ali et al., 2007; Christensen and Grimsmo, 2008; Tang and
McDonald, 2006). Despite the growing interest in adopting EHRs, some studies have
shown that EHR-based systems hardly improve the ability of healthcare providers to
make better decisions (Heisey-Grove et al., 2014; Lau et al., 2012). One of the main
reasons for this inefficacy is that these systems do not allow for human-data interaction in
a manner that supports and fits the needs of healthcare providers (Himmelstein et al.,
2010; Rind, 2013). Another reason is the information overload that arises when the
number of data items exceeds the limit of human cognition (Halford et al., 2005). The
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users often misunderstand, misinterpret, ignore, or overlook vital data because of
information overload. In the healthcare domain, information overload often leads to an
incorrect diagnosis, wrong interpretation of patient conditions, and erroneous treatment
decisions (Caban and Gotz, 2015). For example, in a survey about the efficacy of
electronic health records (EHRs) in the U.S., of over 500 primary-care physicians, only
66% of physicians were somewhat satisfied with existing EHR systems. Many physicians
still continue to report problems. About 40% of physicians thought that there are more
challenges with existing EHR-based systems than benefits. These physicians suggested
that these systems’ user interfaces were not designed well. They found this more
important than the incorporation of analytics capabilities that support diagnosis,
management, and prevention. Of those surveyed, 72% wanted improved user interfaces in
these systems; whereas 43% believed that predictive analytics would improve the
efficacy of EHR-based systems (EHRIntelligence, 2018). Thus, it seems that there is a
growing demand for computational systems that integrates automated analysis techniques
with user interfaces that facilitate interaction with visualizations of data (i.e., interactive
visualizations).
Interactive visualizations can be defined as computational systems that store and process
data and use visual representations to amplify human cognition (Proctor and Vu, 2012;
Sedig and Parsons, 2016). They have the potential to boost the utilization of data in
healthcare by providing a means to access the EHR data at various levels of granularity
and abstraction. Interactive visualizations enable users to explore the underlying data,
modify the representation, and change different visual elements to achieve their goals.
For the last two decades, several EHR-based visualization systems have been developed
to support healthcare providers to perform various data-driven activities (Rind et al.,
2013). However, there are some gaps in support for certain types of higher-level activities
and tasks supported by these systems for a number of reasons. Firstly, some of the
visualizations are not capable of dealing with fast-paced data generated by different
healthcare organizations (Cybulski et al., 2015; Zhang et al., 2012). Secondly, some
improperly designed visualizations encode too much information at once, which often
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overwhelm the cognitive abilities of users and limit users’ ability to make time-sensitive
decisions (Pike et al., 2009; Tominski, 2015). Finally, most of these systems can only
represent a limited number of attributes and relationships within the data (Aimone et al.,
2013; Faisal et al., 2013; Kosara and Miksch, 2002; Lavado et al., 2018). When working
with high dimensional healthcare data, it is important to analyze hidden, non-explicit, and
unknown relationships among the attributes. Thus, even the complex visualization
systems are often inadequate to fulfill the computational demand of EHRs because they
do not incorporate analytical processes, which is essential for recognizing hidden patterns
and trends.
Data analytics is the process of investigating raw data to gain both deeper and novel
insights on associations within the data (Koh and Tan, 2005). Data analytics includes
algorithms, techniques, and methods from different fields, such as statistics, machine
learning, and data mining, to assist users in informed decision-making (Han and Kamber,
2011). There are several systems developed in recent years that employ different
analytics techniques to predict patient outcomes, enable disease diagnosis and prognosis,
make treatment-related decisions, and discover relationships between risk factors (Yoo et
al., 2012). Although these systems are designed to analyze large amounts of data, they
often fail to build trust with healthcare providers. One of the main reasons lies in their
lack of transparency and interpretability. The intermediary steps, adjustment of the
configuration parameters, and theoretical assumptions are kept hidden from end-users,
which limits their application in healthcare settings (Yoo et al., 2012). In addition, most
of the analytics systems are not capable of efficiently managing ill-defined problems
because they do not consider human judgment in the decision-making process (Ola and
Sedig, 2014). In order to address these issues, analytical processes need to be made
accessible through visualizations.
Despite the advantages, both interactive visualization systems, with compelling
interaction and representation techniques and data analytics systems, with their powerful
computational capabilities, fall short in fulfilling the computational and cognitive
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demands of EHRs. Thus, it seems that a combined approach may be needed—that is,
combining analytical processes with interactive visualizations. Visual analytics (VA) has
the potential to address the needs of EHRs by combining the strengths and alleviate the
limitations of both types of systems mentioned above (Ola and Sedig, 2014). VA
manages the complexity of EHRs and supports visuo-analytical reasoning in such a way
that the initially overwhelming scale of data becomes a treasured asset (Kamal, 2014). It
enables users to analyze, synthesize, and facilitate high-level cognitive activities while at
the same time get more involved in the discourse with the data (D. Keim et al., 2010a;
Thomas and Cook, 2006). Although the VA approach conceivably supports different
EHR-driven activities (e.g., exploration of patient history and identification of patients at
risk), to date, healthcare falls behind other sectors in the development of VA systems.
The design of such systems is not straightforward, which requires designers to take into
consideration users’ activities and tasks, human factors, and the structure of the data. A
number of complicated decisions need to be made by the designers. For instance, when
choosing an analysis technique, it is important to consider which algorithm to use, which
samples and features to incorporate, and what granularity to seek for a specific task.
Similarly, when developing visualizations, one needs to determine how to encode and
organize data elements and how to support users’ tasks. Consequently, integrating
analysis techniques with visualizations results in a more complicated challenge. Thus,
there is a lack of direction and confusion over how to design effective VA systems for
EHRs (Carroll et al., 2014; Folorunso and Shawn Ogunseye, 2008; Turner et al., 2008).
The goal of this dissertation is to demonstrate how VA systems can be designed for
EHRs. To begin with, we conducted a systematic literature survey to examine the design
of existing EHR-based systems. Since there were not too many VA systems that are
designed for EHRs, we included the EHR-based interactive visualization systems as well
in the survey. We then presented a framework to analyze and evaluate EHR-data-driven
tasks and activities of these systems. The framework helped us to identify gaps in the
existing systems and conceptualize the data-driven activities and tasks of EHR-based VA
systems. In light of this, we designed and developed two novel VA systems
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(VISA_M3R3 and VALENCIA) and conducted two independent studies. The systems
and studies in this dissertation were mainly focused on acute kidney injury (AKI) because
they were designed to assist the clinicians, epidemiologists, and analysts at the ICESKDT program. ICES is an independent, non-profit, world-leading research organization
that uses population-based health and social data to produce knowledge on a broad range
of healthcare issues. KDT refers to the Kidney Dialysis and Transplantation
program located in London, Ontario, Canada. We demonstrated the usefulness of these
systems by investigating the process of analyzing the health administrative datasets
housed at ICES to gain novel insights into the data and fulfill the tasks at hand. The
tasks included, but are not limited to, predicting AKI, identifying AKI-associated
medication, examining the synergistic effects of AKI-associated medication
combinations, and identifying risk-factors for AKI.
One of the main contributions of this dissertation is the conceptualization and design of
human- and activity-centered computational systems for healthcare. There are several
challenges that designers might face when developing a computational system for
healthcare providers. These challenges include, but are not limited to, providing busy
physicians timely information in the precise format, visualizing comparativeeffectiveness and casual relationships, facilitating data-driven decision-making, and
characterizing and understanding similarity among information items. This dissertation
describes how these challenges can be addressed using a combination of statistical
methods, data mining algorithms, machine learning techniques, and information
visualization. This dissertation also demonstrates how VA systems can be designed in a
systematic way. It describes different components of VA in a structured manner and
explains the design decisions that need to be made while developing a VA system. This
dissertation then illustrates how different design choices can lead to the development of
an optimized VA system for healthcare. Finally, this dissertation demonstrates how
healthcare providers' abilities to interact with data mining and machine learning processes
can be improved by using well-designed VA systems. Through the development of two
novel VA systems, this dissertation offers the healthcare domain with evidence of the

6

efficacy of VA for analyzing EHRs. This research has implications for other domains
that require their data to be made accessible and analyzable through VA.

1.2 Structure of this dissertation
The rest of this dissertation is divided into six chapters, as follows:
In Chapter 2, we present a framework to identify and analyze EHR-data-driven tasks and
activities in the context of interactive visualization systems—that is, all the activities,
sub-activities, tasks, and sub-tasks that are and can be supported by EHR-based systems.
We conducted a systematic literature survey to analyze the researches that describe the
design, implementation, and/or evaluation of these systems. The survey includes an
overview of their goals, a short description of their visualizations, and an analysis of how
sub-activities, tasks, and sub-tasks combine and blend to accomplish their higher-level
activities. Our proposed framework reveals gaps in support of some higher-level
activities supported by these systems. This chapter provides background for the
dissertation.
In Chapter 3, we describe how VA systems can be designed to utilize the prescription
data stored in EHRs. To achieve this, we propose and describe VISA_M3R3, a novel VA
system designed to assist healthcare providers in identifying medications and medication
combinations that associate with a higher risk of AKI. By integrating multiple logistic
regression models, data visualization, frequent itemset mining, and human-data
interaction mechanisms, VISA_M3R3 allows users to explore complex relationships
between medications, medication combinations, and AKI in such a way that would be
difficult without the aid of a VA system.
In Chapter 4, we present a population-based retrospective cohort study to test the
hypotheses generated from the VISA_M3R3 and understand the synergistic effect of
AKI-inducing medication combinations. By integrating multivariable logistic regression,
frequent itemset mining, and stratified analysis, this study is designed to explore complex
relationships between medications and AKI. We demonstrate that our results are

7

consistent with previous studies through an electronic literature search and a consultation
with a nephrologist in this chapter.
In Chapter 5, we present another novel VA system, called VALENCIA, to address the
challenges of high-dimensional EHRs in a systematic way. VALENCIA brings together a
wide range of cluster analysis and dimension reduction techniques, integrate them
seamlessly, and make them accessible to users through interactive visualizations. It offers
a balanced distribution of processing load between users and the system to facilitate the
performance of high-level cognitive activities. Through a case study, we demonstrate
how VALENCIA can be used to analyze the healthcare administrative dataset stored at
ICES. During the cluster analysis of ICES datasets using VALENCIA, we identify
several risk factors that may associate with AKI by investigating the characteristics of
clusters where AKI is common. This motivated us to conduct a separate study on
predicting AKI, which is described in chapter 6.
In Chapter 6, we employ a number of machine learning techniques to identify older
patients who are at risk of developing AKI within 90 days after they are discharged from
the hospital or emergency department. The records of one million patients are included in
this study who visited the hospital or emergency department in Southwestern Ontario
between 2014 and 2016. We developed sixteen prediction models based on combinations
of four machine learning techniques and four ensemble-based methods along with a costsensitive logistic regression model. These models are evaluated through 10-fold crossvalidation and compared based on the AUROC metric. We also validate features that are
most relevant in predicting AKI with a healthcare expert through a participatory design
process to improve the performance and reliability of the models.
In Chapter 7, we outline the conclusions drawn from the research presented in the
preceding chapters, explain the contributions of this work to the broader scientific
community, and discuss some areas of future research.
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It is important to note that the chapters of this dissertation are self-sufficient and can be
read individually or sequentially. Chapters 2,3, 4, and 5 have been published; Chapters 6
has been accepted for publication. This dissertation is written in an integrated article
format, so Chapters 2 through 6 are self-contained.
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Chapter 2

2

Data-Driven Activities Involving Electronic Health
Records: An Activity and Task Analysis Framework for
Interactive Visualization Tools

This chapter has been published as N. Rostamzadeh, S.S. Abdullah, and K. Sedig, “DataDriven Activities Involving Electronic Health Records: An Activity and Task Analysis
Framework for Interactive Visualization Tools” in the Multimodal Technologies Interact.
Journal, 4(1), 7; February 2020. We changed the format to match the general format of
the dissertation. Figure, Table and Section numbers specified herein are relative to the
chapter number. For example, “Table 1” corresponds to Table 2-1; “Figure 1”
corresponds to Figure 2-1; and “Section 1.1” corresponds to Section 2.1.1. Moreover,
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter.

2.1 Introduction
An electronic health record (EHR) contains patient data, such as demographics,
prescriptions, medical history, diagnosis, surgical notes, and discharge summaries.
Healthcare providers use EHRs to make critical decisions, study the effects of treatments,
determine the effectiveness of treatments, and monitor patient improvement after a
particular treatment. In addition to these benefits, EHRs can potentially aid clinical
researchers in detecting hidden trends and missing events, revealing unexpected
sequences, reducing the incidence of medical errors, and establishing quality control
(Christensen and Grimsmo, 2008; Tang and McDonald, 2006). Recently, several
healthcare organizations have used systems that incorporate EHR data to improve the
quality of care; these systems are intended to replace traditional paper-based medical
records (Boonstra et al., 2014). However, a few studies reveal that these EHR-based
systems hardly improve the quality of care. One of the reasons for this is that they do not
allow for human–data interaction in a manner that fits and supports the needs of
healthcare providers (Himmelstein et al., 2010; Rind et al., 2013). A set of technologies
and techniques that can improve the efficacy and utility of these EHR-based systems can
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be found in information visualization (Rind et al., 2013), or broadly speaking interactive
visualization tools (IVTs).
IVTs can be defined as computational technologies that use visual representations (i.e.,
visualizations) to amplify human cognition when working with data (Sears and Jacko,
2007; Sedig and Parsons, 2016). IVTs can help people who use them gain better insight
by providing the means to explore the data at various levels of granularity and
abstraction. An important feature of IVTs that makes them suitable for the exploration of
EHRs is the ability to show relevant data quickly by mapping it to visualizations (Rind et
al., 2013). Another feature is interaction. Making the visualization interactive allows
healthcare providers to perform various data-driven tasks and activities. Interaction helps
users accomplish their overall goals by dynamically changing the mapping, view, and
scope of EHR data. In recent years, a number of EHR-based IVTs have been developed
and deployed to support healthcare providers in performing data-driven activities.
To provide a clear and systematic approach in examining EHR-based IVTs for clinical
decision support, this paper provides a framework for analyzing tasks and activities
supported by these tools. To do so, we will first provide a brief survey of some of the
existing IVTs that support the exploration and querying of EHR data and examine overall
patterns in these tools. This survey does not include EHR-based IVTs that are designed
for clinical documentation, administration, and billing processes.
There are a few studies that review EHR-based IVTs and their applications. Rind et al.
(Rind et al., 2013) reviewed and compared state-of-the-art information visualization tools
that involve EHR data using four criteria: (1) data types that they cover, (2) support for
multiple variables, (3) support for one versus multiple patient records, and (4) support for
user intents. Lesselroth and Pieczkiewicz (Lesselroth and Pieczkiewicz, 2011) surveyed
different visualization techniques for EHRs. They cover a large number of visualization
tools (e.g., Lifelines, MIVA, WBIVS, and VISITORS). Their survey is organized into
five sections: (1) multimedia, (2) smart dashboards to improve situational awareness, (3)
longitudinal and problem-oriented views to tell clinical narratives, (4) iconography and
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context links to support just-in-time information, and (5) probability analysis and
decision heuristics to support decision analysis and bias identification. Combi et al.
(Combi et al., 2010) reviewed a few visualization tools (e.g., IPBC, KHOSPAD, KNAVE
II, Paint Strips, and VISITORS) and described them based on the following features:
subject cardinality (single/multiple patients), concept cardinality (single/multiple
variables), abstraction level (raw data, abstract concepts, knowledge), and temporal
granularity (single, single but variable, multiple). Finally, in a book chapter, Aigner et al.
(Aigner et al., 2008) described strategies to visualize (1) clinical guidelines seen as plans
(e.g., GEM Cutter, DELT/A), (2) patients’ data seen as multidimensional information
space (e.g., Midgaard, VIE-VISU, Gravi++), and (3) patients’ data related to clinical
guidelines (e.g., Tallis Tester, CareVis).
A careful examination of the above surveys shows that a systematic analysis of IVTs with
a focus on how they support EHR-data-driven tasks and activities is lacking. The purpose
of the current paper is to fill this gap. Here, we present a framework for analyzing how
IVTs can support different EHR-based tasks and activities. The framework can help
designers and researchers to conceptualize the functionalities of EHR-based IVTs in an
organized manner. In addition, this paper is suggestive of how this framework can be
used to evaluate existing EHR-based IVTs and design new ones systematically. This
paper also leads to the development of best practices for designing similar frameworks in
similar areas.
The rest of this paper is organized as follows. Section 2 discusses how the proposed
framework is formed and examines the relationships among the three concepts of
activities, tasks, and low-level interactions in the context of the framework. Section 3
presents our strategy for searching relevant literature and explains our selection criteria.
Section 4 provides a brief survey of a set of IVTs and outlines their main goal(s). In this
section, using the proposed analytical framework, we identify the tasks and activities that
IVTs support. Finally, Section 5 discusses how the framework can be used to evaluate the
surveyed EHR-based IVTs.
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2.2 A Proposed Activity and Task Analysis Framework
In the context of IVTs, user-tool interaction can be conceptualized as actions that are
performed by users and consequent reactions that occur via the tool’s interface. This bidirectional relationship between the user and the tool supports the flow of information
between the two. Interaction allows for human–information discourse (Ola and Sedig,
2018). Furthermore, it allows users to adjust different features of the IVT to suit their
analytical needs. Interaction can be characterized at different levels of granularity (Sedig
and Parsons, 2016, 2013). As displayed in Figure 1, an activity can be conceptualized at
the highest level, where it is composed of multiple lower-level tasks (e.g., ranking,
categorizing, and identifying) that work together to accomplish the activity's overall goal.
An activity and a task can consist of multiple sub-activities and sub-tasks, respectively.
At the lower level, tasks can be considered to have visual and interactive aspects; tasks
that are supported by visual processing are called visual tasks. For instance, consider a
scenario in which a user is working with a stacked bar chart that aggregates laboratory
test results. The user needs to understand the distribution of a specific test of a collection
of patients after surgery over time. Some of the visual tasks that the user may need to
perform can include detecting the time when the test is at its peak and observing the
average test result at different times. Interactive tasks require users to act upon
visualizations. For instance, in the example above, the user may want to cluster the test
results based on different time granularities (e.g., over an hour, over a day, or over a
month). Each interactive task is made up of a number of lower-level actions (i.e.,
interactions) that are carried out to complete the task.
In most complex situations, activities, sub-activities, tasks, and sub-tasks are combined to
support users in accomplishing their overall goal. It is important to note two perspectives
from which we can view human–data discourse. From a top-down perspective, users’
goals flow from higher-level activities that need to be accomplished. From here, we go
down to a number of tasks and sub-tasks (visual and interactive), and then to a set of lowlevel interactions. From a bottom-up perspective, the performance of a series of low-level
interactions that users perform with visual representations gives emergence to tasks.
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Similarly, the performance of a sequence of tasks gives emergence to activities all the
way up until an overall goal is accomplished.
In this paper, we present an activity and task analysis framework for examining EHRbased IVTs (i.e., ones that involve EHRs as their main source of data with which users
perform data-driven tasks and activities). To identify what activities, sub-activities, tasks,
and sub-tasks are supported in EHR-based IVTs, we have examined a number of such
tools that have been developed by different researchers and have been reported in the
literature (see Wang et al. (Wang et al., 2008); Wongsuphasawat et al. (Wongsuphasawat
et al., 2011); Wongsuphasawat and Gotz (Wongsuphasawat and Gotz, 2012); Malik et al.
(Malik et al., 2014); Fails (Fails et al., 2006); Klimov et al. (Klimov et al., 2010);
Wongsuphasawat (Wongsuphasawat, 2009); Monroe et al. (Monroe et al., 2013);
Brodbeck et al. (Brodbeck et al., 2005); Chittaro et al. (Chittaro et al., 2003); Rind et al.
(Rind et al., 2011a); Plaisant et al. (Plaisant et al., 1998); Faiola and Newlon (Faiola and
Newlon, 2011); Pieczkiewicz et al. (Pieczkiewicz et al., 2007); Bade et al. (Bade et al.,
2004); Hinum et al. (Hinum et al., 2005); Rind et al. (Rind et al., 2011b); and Ordonez et
al. (Ordonez et al., 2012); Gresh et al. (Gresh et al., 2002); Horn et al. (Horn et al.,
2001)). To conceptualize and develop the elements of the framework, our focus is the
identification of activities and tasks that are independent of any specific technology or
platform. To be consistent, we re-interpret how activities and tasks are named by the
authors of the afore-listed sources in light of the unified language of our proposed
framework. The activity and task terms we use might differ from the language of the
existing literature since the authors have described their tools using their own vocabulary.
Unfortunately, the language that different authors use is not consistent. Such
inconsistency makes it difficult to analyze how well and comprehensively such tools
support EHR-based tasks and how they can be improved. In the next section, we define
and categorize the higher-level activities that result from interaction and combination of
different sub-activities, tasks, and sub-tasks.

14

2.2.1

Higher-Level Activities: Interpreting, Predicting, and
Monitoring

After reviewing numerous papers, we have concluded that, broadly speaking, all EHRdata-driven healthcare activities can be organized under three main categories:
interpreting (Auffray et al., 2016; Groves et al., 2003; Komaroff, 1979; Kumar et al.,
2007; Låg et al., 2014), predicting (Amarasingham et al., 2014; Cohen et al., 2014;
Kankanhalli et al., 2016; Raghupathi and Raghupathi, 2014; Allan F. Simpao et al., 2014;
Wang et al., 2018), and monitoring (Anderson et al., 2015; Hauskrecht et al., 2013; Kho
et al., 2007; Li and Wang, 2016; Saeed et al., 2002; Tia Gao et al., 2005). Interpreting
refers to the activity of detecting patterns from patients’ medical records and making
sense of the relationships among different features. Predicting refers to the activity of
anticipating patient outcomes and creating new hypotheses by analyzing patient history
and status (Siegel, 2013). Lastly, monitoring refers to the activity of repetitive testing
with the aim of adjusting and guiding the management of recurrent or chronic diseases
(Glasziou et al., 2005).
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Figure 2-1: Relationships among activities, tasks, and interactions. Top-down view:
activity is made up of sub-activities, tasks, sub-tasks, and interactions. Bottom-up
view: activity emerges over time, through performance of tasks and interactions.
Visualizations are depicted as Vis and reactions as 𝐑 𝐱 . Source: adapted from (Sedig
and Parsons, 2016).

2.2.2

Hierarchical Structure of Activities, Sub-Activities, Tasks,
and Sub-Tasks

In this section, we identify sub-activities, tasks, and sub-tasks that blend and combine
together to give rise to the three activities of interpreting, predicting, and monitoring.
Interpreting, as a higher-level activity, can be comprised of four sub-activities: (i)
understanding (e.g., gaining insight into patient medical records), (ii) discovering (e.g.,
finding patients with interesting medical event patterns), (iii) exploring (e.g., observing
patient data in different temporal granularities), and (iv) overviewing (e.g., providing
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compact visual summaries of all event sequences found in the data). Likewise, predicting
can be comprised of two sub-activities: (i) learning (e.g., generating new hypotheses
from the data), and (ii) discovering (e.g., recognizing the deterioration of the disease).
Finally, monitoring is composed of (i) investigating (e.g., examining the development of
a patient after treatment), (ii) analyzing (e.g., studying the aggregated event sequences for
quality assurance), and (iii) evaluating (e.g., assessing the quality of care based on
clinical parameters).

Figure 2-2: Overview of the proposed activity and task analysis framework. The
visual tasks are represented as blue and interactive tasks are represented as yellow.
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At the next level of the hierarchy, as shown in Figure 2, each sub-activity can be
composed of a number of visual (e.g., specifying, recognizing, and detecting) as well as
interactive tasks (e.g., locating, ordering, querying, and clustering). Moreover, as shown
in Table 1, each task consists of different sub-tasks; for instance, ordering can be carried
out by a combination of sub-tasks such as ranking, aggregating, identifying, and
classifying.

Visual

Interactive

Table 2-1: Shows the breakdown of the interactive and visual tasks.
Task

Sub-tasks

Ordering

Aggregating, Classifying, Identifying, Ranking

Locating

Aggregating, Aligning, Classifying, Identifying, Ranking

Querying

Classifying, Identifying, Ranking,

Organizing

Aggregating, Classifying, Identifying, Highlighting

Summarizing

Aggregating, Classifying, Identifying

Clustering

Classifying, Identifying, Ranking

Observing

Aggregating, Aligning, Identifying, Ranking

Recognizing

Aggregating, Aligning, Classifying, Identifying, Ranking

Specifying

Aggregating, Aligning, Classifying, Identifying, Highlighting, Ranking

Detecting

Classifying, Identifying, Ranking

2.3 Methods
2.3.1

Search Strategy

We conducted an electronic literature search in order to collect the research papers that
describe the design, implementation, or evaluation of EHR-based IVTs. In order to assure
a comprehensive document search, we included all the keywords that are relevant to the
goal of the research and also covered all the synonyms and related terms, both for EHRs
and visualization tools. We further broadened our search by adding an * to the end of a
term to make sure the search engines picked out different variations of the term. We also
added quotation marks around phrases to ensure that the exact sequence of words is
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found. To ensure that relevant papers were not missed in our search, we used a relatively
large set of keywords. We used two categories of keywords. The first category concerned
visualization tools and included the following terms: “visualization*”, “visualization
tool*”, “information visualization*”, “interactive visualization*”, “interactive
visualization tool*”, “visualization system*”, and “information visualization system*”.
For the second category, EHR, we used the following terms: “Health Record*”,
“Electronic Health Record*”, “EHR*”, “Electronic Patient Record*”, “Electronic
Medical Record*”, “Patients Record*”, and “Patient Record*”. As we were looking for
papers about EHR-based visualization tools, we used the keywords shown in Table 2.
We used the following search engines based on their relevance to the field: PubMed, the
ACM Digital Library, the IEEE Library, and Google Scholar. We also looked for relevant
papers in two medical informatics journals (International Journal of Medical Informatics
and Journal of the American Medical Informatics Association). Furthermore, additional
papers were collected in conference proceedings (e.g., IEEE Conference on Visual
Analytics Science and Technology (VAST), HCIL Workshop 2015, and IEEE VisWeek
Workshop on Visual Analytics in Health Care) that were published in 2007 and later. We
then manually reviewed the reference lists of the papers that met the selection criteria to
find other relevant studies that had not been identified in the database search. All the
studies included in this survey were published from 1998 until 2015. We reviewed all of
the abstracts, removed the duplicates, and shortlisted abstracts for a more detailed
assessment.
Table 2-2: Overview of the search terms used.
Terms Used
“Visualization*” +“Health Record*”
“Visualization*” + “Electronic Health Record*”
“Visualization*” + “EHR*”
“Visualization*” + “Electronic Patient Record*”
“Visualization*” + “Electronic Medical Record*”
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“Visualization*” + “Patients Record*”
“Visualization*” + “Patient Record*”
“Visualization tool*” +“Health Record*”
“Visualization tool*” + “Electronic Health Record*”
“Visualization tool*” + “EHR*”
“Visualization tool*” + “Electronic Patient Record*”
“Visualization tool*” + “Electronic Medical Record*”
“Visualization tool*” + “Patients Record*”
“Visualization tool*” + “Patient Record*”
“Information visualization*” +“Health Record*”
“Information visualization*” + “Electronic Health Record*”
“Information visualization*” + “EHR*”
“Information visualization*” + “Electronic Patient Record*”
“Information visualization*” + “Electronic Medical Record*”
“Information visualization*” + “Patients Record*”
“Information visualization*” + “Patient Record*”
“Interactive visualization*” +“Health Record*”
“Interactive visualization*” + “Electronic Health Record*”
“Interactive visualization*” + “EHR*”
“Interactive visualization*” + “Electronic Patient Record*”
“Interactive visualization*” + “Electronic Medical Record*”
“Interactive visualization*” + “Patients Record*”
“Interactive visualization*” + “Patient Record*”
“Interactive visualization tool*” +“Health Record*”
“Interactive visualization tool*” + “Electronic Health Record*”
“Interactive visualization tool*” + “EHR*”
“Interactive visualization tool*” + “Electronic Patient Record*”
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“Interactive visualization tool*” + “Electronic Medical Record*”
“Interactive visualization tool*” + “Patients Record*”
“Interactive visualization tool*” + “Patient Record*”
“Visualization system*” + “Health Record*”
“Visualization system*” + “Electronic Health Record*”
“Visualization system*” + “EHR*”
“Visualization system*” + “Electronic Patient Record*”
“Visualization system*” + “Electronic Medical Record*”
“Visualization system*” + “Patients Record*”
“Visualization system*” + “Patient Record*”
“Information visualization system*” + “Health Record*”
“Information visualization system*” + “Electronic Health Record*”
“Information visualization system*” + “EHR*”
“Information visualization system*” + “Electronic Patient Record*”
“Information visualization system*” + “Electronic Medical Record*”
“Information visualization system*” + “Patients Record*”
“Information visualization system*” + “Patient Record*”

2.3.2

Selection Criteria

Out of all the studies that survived the initial filtering, we only included those that
described an interactive visualization tool and provided a detailed description of the
tool’s visualization and its interaction design in order to analyze how the tool can support
different EHR-data-driven tasks and activities. All the papers related to the visualization
of any administrative tasks with patient data, medical guidelines, genetics data, and
syndromic surveillance were excluded from our survey as we only focused on clinical
EHR data. We also excluded the studies that were solely focused on the visualization of
free text (e.g., the patient’s progress notes) and medical images (e.g., magnetic resonance
imaging, and X-ray images).
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2.3.3

Results

A total of 912 articles were identified from our initial search of electronic databases. A
search of the gray literature and manually searching references from articles resulted in
an additional 34 papers. We removed a total number of 205 duplicates that were included
in the 946 articles, both within and between search engines. We then reviewed all the
abstracts and excluded 685 further articles. Next, we read the full text of 56 remaining
articles and excluded the ones that did not meet the selection criteria. Finally, 24 studies
remained for the analysis. The results of the selection procedure are displayed in the flow
diagram in Figure 3.

2.4 Survey of the Interactive Visualization Tools
In this section, we provide a survey of 19 IVTs that are described in the chosen articles
and use our proposed activity and task framework to analyze them. The survey includes
an overview of the goal of the IVT, a brief description of its visualization, and an analysis
of how sub-activities, tasks, and sub-tasks blend and combine to accomplish the tool's
main higher-level activities of interpreting, predicting and, monitoring. A very
important criterion to differentiate IVTs is whether they support activities that involve
multiple patient records or exploration of an individual patient. We divide our survey into
two different types of IVTs based on this criterion: population-based tools and singlepatient tools. Initially, studies were focused on single-patient tools, but since 2010, most
of the IVTs are developed to support large numbers of patient records. Our survey
includes more population-based tools, as it seems that these are more prevalent than
single-patient tools. For the first type, we survey 14 tools, and, for the second type, we
survey five tools.
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Figure 2-3: Search results and how we selected the 24 articles that described 19
IVTs.

2.4.1

Population-Based Tools

Population-based IVTs support data-driven activities that involve multiplicity of patient
records in aggregate form and simultaneously. Although these types of tools display
fewer details about a particular patient, they provide users with the ability to recognize
patterns, detect anomalies, find desired records, and cluster and aggregate records into
different groups. In this section, we survey fourteen population-based IVTs.

23

2.4.1.1

Lifelines2

Lifelines2 (Wang et al., 2009, 2008) enables users to explore and analyze a set of
temporal categorical patient records interactively. As shown in Figure 4, each record is
represented by a horizontal strip containing patient ID and multiple events in patient
history that occur at various times. Each event shows up as a color-coded triangle icon on
a horizontal timeline. Lifelines2 allows the detection of temporal patterns and trends
across EHRs to facilitate hypothesis generation and identify cause-and-effect
relationships between patient records.
This tool supports the activity of interpreting by allowing users to get a better
understanding of clinical problems and discovering patients with interesting medical
event patterns. It also supports monitoring by investigating the impact of hospital
protocol changes in patient care. It allows for temporal ordering of event sequences,
observing the distribution of temporal events, and locating records with particular event
sequences. These tasks (ordering, observing, locating) are supported by sub-tasks such as
ranking, aggregating, and identifying.
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Figure 2-4: Lifelines2: Interactive visualization tool for temporal categorical data.
Source: Image courtesy of the University of Maryland Human–Computer
Interaction Lab, http://hcil.umd.edu.

2.4.1.2

Lifeflow

Lifeflow (Guerra Gómez et al., 2011; Wongsuphasawat et al., 2011) provides a visual
summary of the exploration and analysis of event sequences in EHR data. While in
Lifelines2, due to limited screen space, it is not possible to see all records simultaneously;
Lifeflow gives users the ability to answer questions that require an overview of all the
records. To convert from Lifelines2 view to Lifeflow, a data structure called “tree of
sequences” is created by aggregating all the records. This structure is then converted into
a Lifeflow view with each node representing an event bar. Figure 5 shows Lifeflow
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visualization where all the records are vertically stacked on the horizontal timeline and all
the events are represented using color-coded triangles.
In this IVT, the sub-activities of exploring and overviewing medical events support the
activity of interpreting, while analyzing aggregated event sequences for quality
assurance supports the activity of monitoring. Recognizing patterns and temporal
ordering of aggregated event sequences are two tasks that enable Lifeflow to support
exploring, overviewing, and analyzing sub-activities. Finally, sub-tasks such as
aggregating, identifying, and classifying work together to accomplish higher-level tasks.

Figure 2-5: Lifeflow: Interactive visualization tool that provides an overview of
event sequences. Source: Image courtesy of the University of Maryland Human–
Computer Interaction Lab, http://hcil.umd.edu.
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2.4.1.3

Eventflow

Eventflow (Monroe et al., 2013) provides users with the ability to query, explore, and
visualize interval data interactively. It allows pattern recognition by visualizing events in
both a timeline that displays all individual records and an aggregated overview that
shows common and rare patterns. As displayed in Figure 6, all the records are shown on a
scrollable timeline browser. On the horizontal timeline, point-based events are displayed
as triangles, while interval events are represented by the connected rectangles. In the
center, an aggregated display gives users an overview of all event sequences in EHR data.
The aggregation method works exactly like the one in Lifeflow, but it has been extended
to work for interval events in the Eventflow. All the records with the same event
sequence are aggregated into a single bar and the average time between two events
among the records in the group is represented by the horizontal gap between two bars.
This tool supports interpreting by providing an overview of all event sequences found in
the data and exploring medical events (point-based events as well as interval events). The
overviewing and exploring sub-activities can be accomplished by recognizing temporal
patterns and simplifying temporal event sequences. Monitoring can be accomplished by
investigating aggregated event sequences. The investigating sub-activity is supported by
detecting anomalies in the data. Eventflow supports predicting by learning new
hypotheses where this sub-activity can be carried out by tasks such as specifying temporal
patterns and simplifying temporal event sequences. Aggregating, identifying, classifying
are the lowest-level sub-tasks for Eventflow.

2.4.1.4

Caregiver

Caregiver (Brodbeck et al., 2005) is an IVT that supports therapeutic decision making,
intervention, and monitoring. As displayed in Figure 7, the tool has three different views
where the upper view displays the duration and size of the patient groups that are chosen
by physicians to receive interventions. A common timeline for each patient is shown in
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the lower view of the chosen attributes. Caregiver allows users to create new cohorts
from the search results based on a combination of values of any number of variables.
In this tool, the activity of interpreting can be accomplished by discovering trends,
critical incidents, and cause–effect relationships. Caregiver also supports predicting by
allowing users to learn about the deterioration in the status of a disease. It supports these
sub-activities (discovering and learning) by specifying temporal relationships and
clustering. Specifying and clustering can be carried out by sub-tasks such as identifying,
classifying, and ranking.

Figure 2-6: Eventflow: Interactive visualization tool for analysis of event sequences
for both point-based and interval events. Source: image courtesy of the University of
Maryland Human–Computer Interaction Lab, http://hcil.umd.edu.

2.4.1.5

CoCo

CoCo (Malik et al., 2015, 2014) is an IVT for comparing cohorts of sequences of events
recorded in EHRs. It provides users with overview and event-level statistics of the chosen
dataset along with a list of available metrics to generate new hypotheses. It consists of a
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file manager pane, a dataset statistics pane, an event legend, a list of available metrics,
the main window, and options for filtering and sorting the results (as shown in Figure 8).
The summary panel includes high-level statistics containing the total number of records
and events in each record.
CoCo supports the activity of interpreting by allowing users to explore and investigate
two groups of temporal event sequences simultaneously. The activity of predicting can
be accomplished by learning new hypotheses from the statistical analysis while
comparing the event sequences (i.e., detecting differences among groups of patients).
Ranking, classifying, and identifying are the lowest-level sub-tasks in CoCo.

Figure 2-7: Caregiver: Interactive visualization tool for visualization of categorical
and numerical data. Source: Image courtesy of Dominique Brodbeck.
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2.4.1.6

Similan

Similan (Wongsuphasawat, 2009) is a tool that provides users with the ability to discover
and explore similar records in the temporal categorical dataset. Records are ranked by
their similarity to a target record that can be either a reference record or a user's specified
sequence of events. The similarity measure considers the transposition of events,
addition, removal, and temporal differences of matching to estimate the similarity of
temporal sequences. Simian lets users to visually compare the selected target with a set of
records and rank those records based on the matching score, as shown in the left side
middle panel in Figure 9.
In this IVT, interpreting can be carried out by exploring and discovering similar records
in temporal categorical data where these sub-activities themselves are supported by
detecting (calculating similarity measure among records) and recognizing similarity
among records. Predicting is accomplished by discovering patients with similar
symptoms to a certain target patient. The sub-activity discovering can be carried out by
tasks such as temporal ordering and dynamic query. Finally, sub-tasks such as ranking,
identifying, and classifying work together to accomplish higher-level tasks.
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Figure 2-8: CoCo: Interactive visualization tool for comparing cohorts of event
sequences. Source: image courtesy of the University of Maryland Human–Computer
Interaction Lab, http://hcil.umd.edu.

2.4.1.7

Outflow

Outflow (Wongsuphasawat and Gotz, 2012, 2011) is a graph-based visualization that
shows the eventual outcome across the event sequences in patient records. It aggregates
and displays event progression pathways and their corresponding properties, such as
cardinality, outcomes, and timing. The tool allows users to interactively analyze the event
sequences and detect their correlation with external factors (e.g., beyond the collection of
event types that specify an event sequence). The tool is a state transition diagram, which
is represented by a directed acyclic graph. The states (nodes) are unique combinations of
patient symptoms that are mapped to rectangles, where the height of each rectangle is
proportional to the number of patients. The graph is divided into different layers
vertically, where layer i consists of all states in the graph with i symptoms. These layers
are arranged from left to right, displaying patient history from past to future. Edges
display transitions among symptoms where each edge encodes the number of patents that
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are involved in the transition and the average time interval between different states. The
end state that is represented by a trapezoid followed by a circle is used to mark points
where the patient paths have ended. Finally, the color of the edges and end states
represents the average outcome for the corresponding group of patients.

Figure 2-9: Similan: interactive visualization tool for the exploration of similar
records in the temporal categorical data. Source: image courtesy of the University of
Maryland Human–Computer Interaction Lab, http://hcil.umd.edu.
In this tool, sub-activities of exploring and overviewing event sequences work together to
accomplish the activity of interpreting. Outflow also supports predicting by allowing
users to discover the progression of temporal event sequences. The sub-activities of
exploring, overviewing, and discovering can be accomplished by summarizing temporal
event sequences, specifying temporal relationships, and detecting patterns from statistical
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summaries. Finally, aggregating, identifying, and classifying are the lowest-level subtasks.

2.4.1.8

IPBC

IPBC (Chittaro et al., 2003) (interactive parallel bar charts) is an interactive 3D
visualization of temporal data. IPBC applies visual data mining to a real medical problem
such as the management of multiple hemodialysis sessions. It provides users with the
ability to make various decisions regarding such things as therapy, management, and
medical research. Each time series is displayed as a 3D bar chart where one of the
horizontal axes shows time and the vertical axis represents the value, as displayed in
Figure 10. Lined up bar charts on the second horizontal axis enable users to view all the
series simultaneously.
IPBC supports interpreting by allowing users to explore patient data interactively.
Monitoring can be carried out by evaluating the quality of care based on certain clinical
parameters. The sub-activities of exploring and evaluating are supported by specifying
temporal relationships and recognizing similar patterns where these tasks themselves can
be accomplished by sub-tasks such as identifying, classifying, and ranking.

2.4.1.9

Gravi++

Gravi++ (Hinum et al., 2005) allows users to explore and analyze multiple categorical
variables using interactive visual clustering. This tool uses a spring-based layout to place
both patient and variable icons across the visualization, where the value of a variable for
a patient identifies the distance between that patient's icon and the variable’s icon.
Gravi++ provides users with the ability to detect clusters since patients with similar
values are placed together on screen. In order to visualize the exact values of each
variable for each patient, the tool shows each patient’s value as a circle around variables.
The patient icons are represented by spheres while the variable icons are encoded by
squares. Moreover, the tool can encode different patient attributes using patient icons; for
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instance, the size of the sphere can be mapped to the body mass index of the patient and
its color can encode the patient’s gender or therapeutic outcome.

Figure 2-10: IPBC: 3D visualization tool for analysis of numerical data from
multiple hemodialysis sessions. Source: reprinted from Journal of Visual Languages
& Computing, 14, Chittaro L, Combi C, Trapasso G, Data mining on temporal
data: a visual approach and its clinical application to hemodialysis, 591-620,
Copyright (2003), with permission from Elsevier.
This tool supports the activity of interpreting by allowing users to explore patient data
and discover clusters of similar patients. Monitoring can be accomplished by
investigating the development of a patient after a certain treatment. The sub-activities of
exploring, discovering, and investigating are supported by tasks such as recognizing
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patterns and specifying temporal relationships. Finally, identifying and classifying are the
lowest-level sub-tasks that are supported by the tool.

2.4.1.10 PatternFinder
PatternFinder (Fails et al., 2006) is a query-based tool for data visualization and visual
query that can help users search and discover temporal patterns within multivariate
categorical data. PatternFinder allows users to specify queries for temporal events with
time span and value constraints and enables them to look for temporally ordered
events/values/trends as well as the existence of events. Also, users can set a range of
possible time spans among the events to specify how far apart the events are from each
other. The tool has two main panels: the pattern design and query specification panel and
the result visualization panel. The leftmost part of the pattern design panel is the
Person/People panel that enables users to limit the types of patients by name, by choosing
from a list of patients, or by typing a text string. Any modifications that are done in this
panel are dynamic queries that lead to an immediate update of the results in the result
visualization panel. The temporal panel that is placed to the right of the Person/People
panel enables users to form temporal pattern queries by chaining the events together.
Users are able to search for the presence of events, the temporal sequence of events (e.g.,
an emergency doctor's visit followed by a hospitalization), the temporal sequence of
values (e.g., 200 or below cholesterol followed by 240 or higher), and the temporal value
patterns (e.g., monotonically decreasing). The result visualization panel displays a
graphical table of all the matches where each row shows a single pattern match for one
patient. Pattern matches are represented as a timeline in a "ball-and-chain" visualization
fashion where the event points are shown as circles and time spans are displayed by blue
bars between the events. The color of the event point in the result visualization panel
matches the color of the associated event in the query specification panel. All the events
that match the query pattern specified by users are linked together by horizontal lines.
In this tool, the activity of interpreting is supported by discovering patterns and exploring
patient data dynamically, where these sub-activities themselves can be carried out by
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tasks such as specifying temporal relationships and issuing dynamic queries. Identifying
and ranking are the two low-level sub-tasks that work together to support the
aforementioned tasks.

2.4.1.11 TimeRider
TimeRider (Rind et al., 2011a) offers an animated scatter plot to help users discover
patterns in irregularly sampled patient data covering several time spans. As shown in
Figure 11, time is represented by either traces or animation in TimeRider. Color, shape,
and size of marks are used to encode up to three additional variables. Users can compare
patient records of different time spans by synchronizing patients' age, calendar date, and
the start and end of the treatment.

Figure 2-11: TimeRider: Interactive visualization tool for pattern recognition in
patient cohort data. Source: reprinted by permission from Springer Nature:
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Springer, Ergonomics and Health Aspects of Work with Computers, Visually
Exploring Multivariate Trends in Patient Cohorts Using Animated Scatter Plots,
Rind A, Aigner W, Miksch S, et al., copyright (2011).
This tool supports interpreting by allowing users to detect trends, clusters, and
correlations and providing them with an overview to visually compare patient data in
parallel. The sub-activities of detecting and overviewing can be carried out by tasks such
as specifying temporal relationships, clustering, and recognizing patterns. Identifying and
aligning are the sub-tasks that work together to support the aforementioned tasks.

2.4.1.12 VISITORS
VISITORS (Klimov et al., 2010) is an IVT that allows for exploration, analysis, and
retrieval of raw temporal data. The tool uses raw numerical data (e.g., white blood cell
counts) across time to derive temporal abstractions (e.g., durations of low, normal, or
high blood-cell-count levels for patients). It then uses lower-level temporal abstractions
in conjunction with raw data to generate higher-level abstractions. Finally, patient
groups’ values are aggregated and displayed. Figure 12 shows this tool’s visualization
environment, where raw numerical data is represented by line charts, whereas categorical
data is displayed as tick marks or bars on a horizontal zoomable timeline.
In this tool, the activity of interpreting is supported by exploring patient data in different
temporal granularities. The sub-activity of exploring can be carried out by tasks such as
specifying relationships, observing the distribution of aggregated values of a group of
patients, and locating records based on specific time and value constraints. VISITORS
supports the activity of monitoring by sub-activities, such as investigating treatment
effects, clinical trial results, and quality of clinical management processes. The latter subactivity, investigating, can be carried out by the task of recognizing patterns as well as all
the other tasks needed to support the activity of interpreting. Finally, aggregating,
classifying, aligning, and identifying are the lowest-level sub-tasks that are supported by
this tool.
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Figure 2-12: VISITORS: Interactive visualization tool for the exploration of
multiple patient records. (A) displays lists of patients. (B) displays a list of time
intervals. (C) displays the data for a group of 58 patients over the current time
interval. Panel 1 shows the white blood cell raw counts for the patients, while Panels
2 and 3 display the states of monthly distribution of platelet and haemoglobin in
higher abstraction, respectively. Abstractions are encoded in medical ontologies
displayed in panels (D). Source: reprinted from Journal of Artificial Intelligence in
Medicine, 49, Klimov D, Shahar Y, Taieb-Maimon M, Intelligent visualization and
exploration of time-oriented data of multiple patients, 11-31., copyright (2010), with
permission from Elsevier.

2.4.1.13 Prima
Prima (Gresh et al., 2002) is a population-based IVT that allows users to explore the
categorical and numerical data by constructing different linked views. This helps users to
not only understand the large set of patient records but also discover patterns and trends
in the dataset. The aggregated window provides an overview of the categorical variables
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by showing the proportions of patients in each category for those variables using stacked
bar charts. This window enables users to filter patients by applying a color “brush”. It
also displays correlations among different categorical variables through interactive
coloring. Another view displays a histogram of numerical variables. The data can also be
explored with a 2D scatter plot. Another view of the data is called multiple category
tables. It shows the values of either a single variable or multiple categories. Finally, the
tool incorporates the Kaplan–Meier curve to estimate the survival function from the
patient data.
Prima supports the activity of interpreting by allowing users to explore patient data
interactively, where this sub-activity itself can be accomplished by recognizing patterns
and specifying temporal relationships. Finally, aggregating and ranking are the lowestlevel sub-tasks that are supported by the tool.

2.4.1.14 WBIVS
WBIVS (Pieczkiewicz et al., 2007) is a web-based interactive tool that visualizes
numerical and categorical variables for lung transplant home monitoring data. Numerical
variables are displayed in line plots, while categorical variables are visualized in matrix
plots. The tool visualizes ten variables in total. When a data point gets selected, all the
other data points that belong to the same time period will get highlighted in the other
charts. Moreover, users can find details about the last two chosen data points on the right
part of the graph.
This tool supports the interpreting activity by allowing users to explore patient data
interactively and discover patterns. Monitoring is supported by investigating treatment
effects. The exploring and discovering sub-activities can be accomplished by tasks such
as specifying temporal relationships among data points and organizing data for pattern
recognition. These tasks can be composed of lowest-level sub-tasks, such as identifying,
classifying, and highlighting.
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2.4.2

Single-Patient Tools

Single-patient IVTs provide visualizations of one single-patient record at a time. These
tools enable users to overview a given patient’s historical data, detect important events in
the patient’s history, and recognize trends. In this section, we survey five single-patient
IVTs.

2.4.2.1

Midgaard

Midgaard (Bade et al., 2004) allows for exploration of the intensive care units’ data at
different levels of abstraction from overview to details. It uses visualizations to display
numerical variables of treatment plans. It incorporates a complex semantic zoom method
for numerical variables by calculating their categorical abstractions based on the
available screen area and zoom level. Midgaard provides users with the ability to switch
between different views such as a colored background, colored bars, area charts, or
augmented line charts based on the level of details. The tool can progressively switches
to a more detailed view to display all the individual data points when users zoom in or
switch back to more compact graphical elements when they zoom out.
Midgaard can also visualize medical treatment plans using colored bars where each bar
can contain further bars displaying sub-plans. It allows users to navigate and zoom by
interacting with two time axes that are placed below the visualization area. The bottom
axis displays a temporal overview of the patient record while the middle axis allows users
to see specific time intervals in more detail.
The activity of interpreting is supported by exploring patient data at different levels of
abstraction, where this sub-activity itself can be accomplished by tasks such as
recognizing fluctuations in data. Identifying and classifying are the two sub-tasks that are
supported by this tool.
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2.4.2.2

MIVA

MIVA (Faiola and Newlon, 2011) (Medical information visualization assistant) is a tool
that transforms and organizes biometric data into temporal resolutions to provide
healthcare providers with contextual knowledge. It allows users to prioritize and
customize visualizations based on specific clinical problems. It visualizes the data using
point plots to display temporal changes in numerical values, where each variable is
represented by a separate plot, as shown in Figure 13. MIVA enables users to detect
changes in multiple physiological data points over time for faster and more accurate
diagnosis. Users can control the data source, time resolutions, and time periods to narrow
down the assessment of a patient’s condition.

Figure 2-13: MIVA: Interactive visualization tool to show the temporal change of
numerical values where each variable is represented by an individual point plot.
Source: image courtesy of Antony Faiola.
This tool supports the activity of interpreting by enabling users to carry out sub-activities
such as exploring longitudinal relationships in patient data where this sub-activity can be
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accomplished by tasks such as specifying temporal relationships and recognizing patterns.
At the level of sub-tasks, this tool supports identifying as well as classifying.

2.4.2.3

VIE–VISU

VIE–VISU (Horn et al., 2001) uses a set of glyphs to display changes in a patient's status
over time in intensive care. Each glyph’s geometrical shape and color encodes categorical
variables, while the numerical variables are represented by size of the glyph's elements.
Every glyph can encode 15 variables that are classified by physiological systems. For
instance, the respiratory parameters are mapped to a rectangle in the middle of the glyph;
circulatory parameters are mapped to a triangle on top of the glyph, and the fluid balance
parameters are shown by two smaller rectangles at the bottom of the glyph. By default,
the tool displays 24 glyphs, one per hour.
The activity of interpreting can be accomplished by overviewing a patient’s status, where
this sub-activity is supported by tasks such as recognizing patterns. This tool supports
monitoring by evaluating changes in patient’s status over time. The task of identifying
temporal relationships supports the sub-activity of evaluating. Finally, aggregating and
classifying are two sub-tasks that can be carried out by the tool.

2.4.2.4

Lifelines

Lifelines (Plaisant et al., 1998) offers a visualization environment to show patient history
on a zoomable timeline, where a patient's medical record is displayed by a set of events
and lines. Episodes and events in a patient record are represented by a set of multiple line
segments as shown in Figure 14. Color can be used to encode the states of categorical
variables. This IVT provides an overview of a patient history to recognize trends, specify
important events, and detect omissions in data.
The activity of interpreting is supported by understanding patient’s status where this subactivity itself can be carried out by tasks such as recognizing patterns and specifying
temporal relationships. The tool supports monitoring by allowing users to carry out subactivities such as investigating trends and anomalies in patient data. The investigating
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sub-activity is supported by outlining and summarizing the patient data. Finally,
aggregating, classifying, and identifying are the sub-tasks that are supported by the tool.

Figure 2-14: Lifelines: interactive visualization tool that displays patient’s medical
histories on a timeline. Source: image courtesy of the University of Maryland
Human–Computer Interaction Lab, http://hcil.umd.edu.

2.4.2.5

VisuExplore

VisuExplore (Pohl et al., 2011; Rind et al., 2011b) displays patient data in different views
aligned with a horizontal timeline, where each view shows multiple variables. This IVT
uses common visualization techniques that make it easy to use and learn. In this tool,
numerical data are displayed using bar charts and line plots, whereas categorical data are
represented using event charts and timeline charts, as shown in Figure 15.
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Figure 2-15: VisuExplore: interactive visualization tool that displays patient data in
various views on a timeline. Source: reprinted by permission from Springer Nature:
Springer, Human–Computer Interaction, Patient Development at a Glance: An
Evaluation of a Medical Data Visualization, Pohl M, Wiltner S, Rind A, et al.,
copyright (2011).
In this tool, the activity of interpreting is supported by exploring temporal data of
patients with chronic diseases, where this sub-activity can be carried out by tasks such as
specifying temporal relationships. Finally, aligning and identifying are two sub-tasks that
can be carried out by the tool.

2.5 Discussion and Limitations
In this paper, we have presented and proposed a framework to identify and analyze EHRdata-driven tasks and activities in the context of IVTs—that is, all the activities, subactivities, tasks, and sub-tasks that are supported by EHR-based IVTs. Using a survey of
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19 EHR-based IVTs, we demonstrate how these IVTs support activities by identifying
the combination of sub-activities, tasks, and sub-tasks that work together to help users
carry out the three higher-level activities as displayed in Table 3. Interpreting is
supported by all IVTs surveyed in this paper. Eventflow, Similan, CoCo, Outflow, and
Caregiver are the only IVTs that support predicting, whereas Lifelines2, Lifeflow,
Eventflow, Gravi++, IPBC, TimeRider, VISITORS, WBIVS, VIE-VISU, Lifelines,
CoCo, and Visu-Explore are the tools that facilitate monitoring. Going down from highlevel activities, recognizing patterns and specifying temporal relationships are the most
common sub-activities that help users with the activity of interpreting in most of the
IVTs. The existing EHR-based IVTs support predicting by giving users the ability to
perform sub-activities such as learning new hypotheses, discovering patients with similar
symptoms to a target patient, and detecting early deterioration of a disease. Finally, the
most common sub-activities that facilitate monitoring are evaluating the quality of care
and investigating the development of a patient's status after treatment.
Our proposed framework can offer a number of benefits for designers, researchers, and
evaluators of EHR-based IVTs. Firstly, the framework can help the designer to
conceptualize activities, tasks, and sub-tasks of EHR-based IVTs systematically.
Secondly, it can assist researchers in making sense of IVTs by providing them with all
the activities that can be accomplished by carrying out different sets of sub-activities,
tasks, and sub-tasks. Thirdly, this framework can be used by evaluators to identify the
gaps in support of higher-level activities supported by existing IVTs. It appears that
almost all existing IVTs focus on the activity of interpreting, while only a few of them
support predicting despite the importance of this activity in supporting users to find the
patients that are at high risk and identify the risk factors of various diseases. Also, some
of the EHR-based IVTs do not pay enough attention to monitoring, even though this
activity is beneficial in investigating the quality of clinical management processes. All
these higher-level activities should be an integral part of a properly designed EHR-based
IVT since healthcare providers use such tools to (1) better understand patients' condition,
(2) anticipate the course of a specific disease, and (3) track patients' condition after
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treatment. Most of the tools surveyed in this paper can only satisfy a certain aspect of
users' needs. According to a recent survey in the US, 40% of the clinicians are not
satisfied with the existing EHR-based system (EHRIntelligence, 2018). Therefore, a
framework is needed to guide the designer of an IVT in choosing which activities, tasks,
and sub-tasks the tool should support. Using questions such as, "What activities can users
accomplish by executing a set of tasks?" or "What tasks should be supported to provide
users with the ability to perform their activities?", we demonstrate how the proposed
framework can be used by designers of EHR-based IVTs to systematically conceptualize
and design the tasks and activities of such tools. Given the framework, all designers need
to know is, which low-level sub-tasks, tasks, and sub-activities to select and how to blend
and combine them to support higher-level activities and allow users to accomplish their
overall goal. For instance, if a designer wants to design an IVT to monitor an infant's
condition in the neonatal intensive care unit, they can choose different sets of subactivities, such as investigating the effect of a specific treatment or evaluating changes in
infant's status over time. Then, the designer selects a combination of tasks such as the
temporal ordering of event sequences or displaying the distribution of temporal events to
support the chosen sub-activities. Finally, a set of sub-tasks, such as ranking,
aggregating, and identifying, are chosen to support the selected tasks.
We believe a successful EHR-based tool should be capable of doing more than just
storing, retrieving, and exchanging patient data. It should support more complex
activities, tasks, and sub-tasks to allow healthcare providers to accomplish their goals.
Our proposed framework promises a new means for designers of EHR-based IVTs to
understand the effectiveness of incorporating such activities, tasks, and sub-tasks in their
tool. The use of our framework in EHR-based IVTs will also help physicians to make
better treatment decisions and track changes in a patient's condition over time.
This paper has three key limitations. First, we do not investigate the completeness and
accuracy of the data sources that IVTs are using as our survey relies on the descriptions
of the IVTs found in publications and video tutorials. Second, as the main goal of this
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paper is the analysis of EHR-based IVTs, we exclude tools that are mainly dependent on
statistical and machine learning methods. Finally, we do not consider commercial tools in
this paper. This is because online descriptions of such tools do not systematically and
thoroughly cover the features of these tools, i.e., their visualizations, interactions, and
results.
The findings of this paper will lead to the development of best practices for creating
similar frameworks in other domains. A possible area of future research involves
developing frameworks for visual analytics tools that incorporate automated analysis
techniques along with interactive visualizations to support the increasingly large and
complex datasets in EHRs.
Table 2-3: Evaluation summary of the 19 existing tools based on the proposed
framework.
IVTs
Sub-activity

Interpreting

Predicting

Monitoring

discovering,
understanding,

no

investigating

locating, observing,
Tasks

Population-based tools

Lifelines 2

n/a
ordering

ordering

aggregating, identifying,
Sub-tasks

n/a
ranking

aggregating,
identifying,
ranking

Sub-activity

exploring, overviewing

no

analyzing

Tasks

ordering, recognizing

n/a

ordering,
recognizing

Sub-tasks

aggregating, classifying,
identifying

n/a

aggregating,
classifying,
identifying

Sub-activity

exploring, overviewing

learning

investigating

Lifeflow

Eventflow

locating,
observing,
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Similan

Tasks

recognizing,
summarizing

specifying,
summarizing

detecting

Sub-tasks

aggregating, classifying,
identifying

aggregating,
classifying,
identifying

aggregating,
classifying,
identifying

Sub-activity

discovering, exploring

discovering

no

Tasks

detecting, recognizing

ordering, querying

n/a

Sub-tasks

identifying, classifying,
ranking

identifying,
classifying, ranking

n/a

Sub-activity

exploring

learning

investigating

Tasks

detecting

detecting

detecting

Sub-tasks

classifying, identifying,
ranking

identifying,
classifying, ranking

identifying,
classifying,
ranking

Sub-activity

exploring, overviewing

discovering

no

detecting, specifying,

detecting,
specifying,

CoCo

Tasks
summarizing

Outflow

summarizing

Sub-tasks

aggregating, classifying,
identifying

aggregating,
classifying,
identifying

n/a

Sub-activity

discovering

learning

n/a

Tasks

specifying

clustering,
specifying

n/a

Sub-tasks

classifying, identifying,
ranking

classifying,
identifying,
ranking

n/a

Sub-activity

discovering, exploring

no

investigating

Caregiver

Gravi++

n/a
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Tasks

recognizing, specifying

n/a

recognizing,
specifying

Sub-tasks

classifying, identifying

n/a

classifying,
identifying

Sub-activity

exploring

no

evaluating

Tasks

recognizing, specifying

n/a

recognizing,
specifying

Sub-tasks

classifying, identifying,
ranking

n/a

classifying,
identifying,
ranking

Sub-activity

discovering, exploring

no

no

Tasks

specifying, querying

n/a

n/a

Sub-tasks

identifying, ranking

n/a

n/a

Sub-activity

exploring

no

no

Tasks

recognizing, specifying

n/a

n/a

Sub-tasks

aggregating, ranking

n/a

n/a

Sub-activity

detecting, overviewing

no

investigating

Tasks

clustering, recognizing,
specifying

n/a

recognizing

Sub-tasks

aligning, identifying

n/a

n/a

Sub-activity

exploring

no

investigating

n/a

locating,
observing,
recognizing,
specifying

n/a

aggregating,
aligning,
classifying,
identifying

IPBC

Pattern
Finder

Prima

Timerider

Tasks

locating, observing,
specifying

Sub-tasks

aggregating, aligning,
classifying

VISITORS
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Sub-activity

discovering, exploring

no

investigating

Tasks

organizing, specifying

n/a

organizing,
specifying

Sub-tasks

classifying, highlighting,
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Chapter 3

3

Multiple regression analysis and frequent itemset
mining of electronic medical records: A visual analytics
approach using VISA_M3R3

This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, A.X. Garg,
and E. McArthur, “Multiple regression analysis and frequent itemset mining of electronic
medical records: A visual analytics approach using VISA_M3R3” in the Data
Journal, 5(2), 33; March 2020. We changed the format to match the general format of the
dissertation. Figure, Table and Section numbers specified herein are relative to the
chapter number. For example, “Table 1” corresponds to Table 3-1; “Figure 1”
corresponds to Figure 3-1; and “Section 1.1” corresponds to Section 3.1.1. Moreover,
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter.

3.1 Introduction
As part of modernizing their operations, healthcare and medical organizations are
adopting electronic medical records (EMRs) and deploying new information technology
systems that generate, collect, digitize, and analyze their data (Caban and Gotz, 2015).
With the development of EMRs and the extensive use of computerized provider order
entry tools, patients’ medication profile data is now accessible and processable for
secondary reuses (Abramson et al., 2011; Delamarre et al., 2015). The amount of
prescription data available to clinical researchers, pharmaceutical scientists, and
clinician-scientists continues to grow, creating an analyzable resource for generating
insights that can help improve the healthcare system (Kamal, 2014; Murdoch and Detsky,
2013). Healthcare providers use modern EMR-based systems to identify adverse drug
events (Hannan, 1999; Honigman et al., 2001), study medication-medication interactions
(Rinner et al., 2015), investigate medication effects on particular medical conditions
(Gruchalla, 2000; Tandon et al., 2015), and ultimately prevent medication errors
(Agrawal, 2009; Gildon et al., 2019; Singer and Duarte Fernandez, 2015).
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A common problem in clinical medicine which may lead to development of acute kidney
injury (AKI) is medication-induced nephrotoxicity (Assadi and Ghane Shahrbaf, 2015;
Fusco et al., 2016; Khan et al., 2017). AKI can be defined as a sudden loss of kidney
function over a short period of time (Porter et al., 2014; Nicholas M. Selby et al., 2012).
The rate of medication-induced AKI can be as high as 60 percent (Gandhi et al., 2000;
Kaufman et al., 1991; Nash et al., 2002; Schetz et al., 2005). Many prior studies have
assessed the impact of individual nephrotoxic medications on AKI (Alexander et al.,
2017; Moffett and Goldstei, 2011; Ryan M. Rivosecchi et al., 2016). The combination of
multiple medications can further increase the risk of AKI through synergistic or
accumulative nephrotoxicity (Schetz et al., 2005). For each additional nephrotoxic
medication, the chance of developing AKI may increase by 53 percent (Cartin-Ceba et
al., 2012). Rivosecchi et al., through an exhaustive literature search, further emphasize
the need for a comprehensive understanding of how medication combinations alter the
risk of AKI (Ryan M. Rivosecchi et al., 2016). According to a Center for Disease Control
report, as of 2017, there were more than 5,000 medications in the market and 1,000
adverse medication effects known in the literature. So, for drug-drug interactions there
may be 125 billion possible adverse medication effects between all possible pairs of
medications (Collins, 2018; Zitnik et al., 2018). An individual clinical study is often
required to test the nephrotoxicity of each medication or medication combination.
Therefore, it is impossible to comprehensively assess medication-induced AKI through
this number of clinical studies.
Data analytics can offer a solution to this problem by employing algorithms, methods,
and techniques from different fields, such as data mining, statistics, and machine learning
(Han and Kamber, 2011). Data analytics is the investigation of raw data to gain both
novel and deeper insights on associations within the data (Koh and Tan, 2005). There are
several tools designed and developed in recent years that employ advanced machine
learning techniques to improve drug-safety science, predict adverse drug reactions, and
identify drug-drug interactions (Basile et al., 2019; Dey et al., 2018; Lysenko et al., 2018;
Munsaka, 2017; Schmider et al., 2019; Vamathevan et al., 2019). While most clinical
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machine learning tools are designed to incorporate large amounts of data, they are not
capable of efficiently managing ill-defined problems that need human judgment. The
main challenge of using machine learning techniques lies with their lack of
interpretability and transparency, hence limiting their application in healthcare settings
(Vamathevan et al., 2019).
Interactive visualizations have the potential to address this challenge by providing a
means to access the data at various levels of granularity and abstraction (Rind et al.,
2011b). They can be defined as computational systems that store and process data and
use visual representations to amplify human cognition (Sedig and Parsons, 2016; Wilson,
2014). Interactive visualizations allow users to explore the underlying data, modify
representations, and change different visual elements to achieve their goals. In recent
years, several EMR-based systems have been developed to interactively visualize patient
prescription history (Ozturk et al., 2014), potential adverse medication events (Duke et
al., 2010), and prescription behaviors (Van der Corput et al., 2014). Most of these
systems only represent a limited number of attributes and relationships within the data
(Faisal et al., 2013; Kosara and Miksch, 2002; Lavado et al., 2018; A Rind et al., 2011).
When working with high-dimensional EMR data, it can be useful to analyze hidden, nonexplicit, and unknown relationships among all the data attributes (Lee and Yoon, 2017;
Perer et al., 2015). One of the main issues with traditional data visualization systems is
that they do not incorporate analytical processes, which are essential for recognizing
hidden patterns and trends in the data. Therefore, interactive data visualization systems,
alone and without data analytics components, fall short of satisfying the computational
needs and requirements of users.
While beneficial, both data analytics systems, with their advanced computational
capabilities and interactive visualization systems, with powerful interaction and
representation mechanisms, when used individually, prove inadequate in certain
situations. The emergence of a type of computational system known as visual analytics
(VA) has the potential to reduce the complexity of EMR data by combining the strengths
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and alleviate the limitations of both aforementioned systems (Parsons et al., 2015; Saffer
et al., 2004; A. F. Simpao et al., 2014). VA can improve the capabilities of users to
perform complex data-driven tasks by analyzing EMRs in such a way that would be
difficult or sometimes even impossible to do otherwise. Even though VA is suitable for
different healthcare activities (e.g., prediction of diseases, exploration of patient history,
and identification of adverse medication events), to date, healthcare environments lag
behind other sectors in the development of such systems (Amarasingham et al., 2014;
Caban and Gotz, 2015; Feng et al., 2019).
The purpose of this study is to demonstrate how VA systems can be designed in a
systematic way: 1) to examine the association between medications and AKI, in
particular, and 2) to support other clinical investigations involving EMRs, in general. To
this end, we present a novel system that we have developed, called VISA_M3R3—
VISual Analytics, VISA for Multiple Regression analyses and fRequent itemset Mining
of electronic Medical Records, M3R3. VISA_M3R3 is intended to assist clinicians and
healthcare researchers at the ICES-KDT (Kidney Dialysis and Transplantation), located
in London, Ontario, Canada. We demonstrate VISA_M3R3 by investigating the process
of identifying medications and medication combinations that associate with a higher risk
of AKI using ICES health administrative data. To our knowledge, no prior VA system
has been designed to examine how different medications affect kidney function and
increase the risk of developing AKI. While few VA systems have been developed for
other areas in healthcare (Basole et al., 2015; Bernard et al., 2015; Gotz et al., 2012;
Huang et al., 2015; Klimov et al., 2015; Mittelstädt et al., 2014; Ninkov and Sedig, 2019;
Perer et al., 2015; A. F. Simpao et al., 2014), VISA_M3R3 is novel in that it integrates
multiple regression models (i.e., multivariable logistic regression), frequent itemset
mining (i.e., Eclat algorithm), data visualization, and human-data interaction mechanisms
in an integrated fashion. As such, the design concept of VISA_M3R3 can be generalized
for the development of other EMR-based VA systems that apply multivariable regression
and frequent itemset mining to gain novel and deep insights into massive clinical data
that exist for different health conditions (e.g., diabetes and heart failure, to name a few).

54

The rest of this paper is organized as follows. Section 2 provides an overview of the
terminological and conceptual background to understand the design of VISA_M3R3.
Section 3 describes the methodology employed for the design of the proposed VA
system. Section 4 presents VISA_M3R3 by providing a description of its structure,
components, and results. Finally, Section 5 discusses the usefulness and limitations of the
proposed system and some future areas of application.

3.2 Background
This section presents the necessary background concepts and terminology for
understanding the design of VISA_M3R3. VA systems fuse the strengths of automated
analysis and interactive visualizations to allow users to explore data interactively, identify
patterns, apply filters, and manipulate data to achieve their goals. This process is more
complicated than an automated internal analysis coupled with an external visualization to
show the results. It is both data-driven and user-driven and requires re-computation when
users manipulate data through visual representations. VA not only relies on
computational techniques and analytics but also supports human-in-the-loop mechanisms
that allow users to employ human judgment to reach evidence-based conclusions. To
understand the concepts of VA, we discuss the spatial structure and different modules of
VA systems in this section.

3.2.1

Spatial Structure of Visual Analytics

To conceptualize the spatial structure of VA, Sedig et al. (Sedig et al., 2012; Sedig and
Parsons, 2016) proposed its processing load to be divided into at least 5 spaces:
information space, computing space, representation space, interaction space, and mental
space. The information space represents bodies of data that come from different sources.
Data may come from abstract spaces (e.g., treatment plans) or concrete spaces (e.g.,
prescriptions). Data is then processed in the computing space, which may include (1) preprocessing techniques such as data cleaning, filtering, fusion, integration, and
normalization and (2) data processing and transformation techniques such as data mining,
mathematical procedures, and statistical methods. Since the underlying processing is
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carried out in the computing space, users of the VA system ideally do not need to be
concerned with any computational work of this space. Resulting data items are then
encoded into perceptible visual forms in the representation space. In order to achieve
their goals through a visually perceptible interface, users can choose actions from a set of
available options (i.e., the interaction space) to act upon existing visualizations in the
representation space. Finally, the mental space refers to users perceiving and processing
changes in the interface through carrying out mental operations such as apprehension,
induction, deduction, judgment, and memory encoding.
In healthcare settings, it is important for the designer to find a balanced distribution of the
processing load among the above five spaces. VA systems can offer such a balanced
distribution of processing load through a proper integration of advanced analytics
techniques (i.e., data mining, statistics, and machine learning) with visual representations
to facilitate high-level cognitive activities and tasks while at the same time allowing users
to get more involved in interactive conversation with the data through its manipulation,
analysis, and synthesis (D. Keim et al., 2010b; Ola and Sedig, 2018; Thomas and Cook,
2006).

3.2.2

Modules of Visual Analytics Systems

The information processing load in a VA system is distributed between the user and the
main components of the VA system—namely, the analytics and the interactive
visualization modules (Cui, 2019; Jeong et al., 2015; D. Keim et al., 2010b; Ola and
Sedig, 2014; Parsons and Sedig, 2014; Sedig and Parsons, 2013). The data analytics
module encompasses the computing space and deals with the analysis of data from the
information space. The interactive visualization module encompasses representation and
interaction spaces.

3.2.2.1

Data Analytics Module

Human cognition has limitations when engaged in data-intensive mental tasks, especially
when the data is large and complex (Green and Maciejewski, 2013; Ola and Sedig, 2014).
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The analytics module of the VA system supports user cognition by carrying out most of
the computational load. It provides users with the ability to make time-critical decisions
by placing the majority of the processing load in the computing space. In a VA system,
data analytics should not be solely controlled by the system. Instead, users should be
involved in controlling the parameters, settings, and intermediary steps of the processing
stage. The primary responsibility of the analytics module is to store, prepare, analyze,
transform, and perform computerized analysis of the raw data. In the context of VA, the
analytics process can be divided into three main stages: data pre-processing, data
transformation, and data analysis (Ola and Sedig, 2014).
The raw data from the information space gets processed in the pre-processing stage. Data
often contains errors, exceptions, noise, and/or uncertainty. There are several possible
reasons for having inaccurate data in EMRs. For instance, problems might arise from
confusing data collection manual, faulty instruments, or incorrect data entry. The data
analytics module might derive incorrect patterns if the data is noisy or erroneous.
Therefore, it is very important to pre-process raw EMR data retrieved from a variety of
sources. Data pre-processing includes cleaning, integration, and reduction (Han et al.,
2011).
The pre-processed data is then transformed into forms appropriate for data analytics
algorithms. The quality of information, knowledge, and insight extracted from a dataset
can be improved by its transformation (Kusiak, 2001). Strategies for data transformation
may include smoothing, attribute construction (i.e., feature generation), aggregation,
normalization, and discretization (Han and Kamber, 2011).
Finally, data analysis is the stage to uncover previously undetected relationships among
data items and extract the implicit, previously unknown, and possibly useful information
from data (Agrawal et al., 1993; Sahu et al., 2008). The data analysis process includes,
but is not limited to, frequent itemset mining, regression, classification, and clustering.
Usually, these techniques allow analysis of limited types of variables and do not support
heterogeneous data (D. Keim et al., 2010b). VA systems overcome this limitation by
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incorporating interactive visualizations and human reasoning in the decision-making
loop.

3.2.2.2

Interactive Visualization Module

Interactive visualization is an integral part of VA for organizing data items in the
information space and mapping them to visual structures. Interactive visual
representations provide users with the ability to change and modify the displayed data
and to guide the analysis process. This, in turn, will set off a chain of internal reactions
that lead to the execution of additional data analysis processes. Interactive visualizations
can potentially bridge the gap between the internal mental representation of the user and
the external representations of the system by allowing the information processing load to
be distributed between the user and the system.
Design of visualizations is straightforward when dealing with simple tasks. As tasks
require completion of one or more subtasks, they become more complex. As tasks
become more complex, design becomes less apparent, particularly when dealing with
massive amounts of heterogeneous data (Heer and Kandel, 2012; Sedig and Parsons,
2013). To support complex, EMR-driven tasks, visualizations require some initial
analysis (D. Keim et al., 2010b). For instance, the task of identifying high-risk
medications for a certain medical condition includes sub-tasks such as finding association
between the medical condition and medications (through data analysis), observing their
relationships (through visual representations), and filtering medications that are
associated with the medical condition (through analysis and visualization). Furthermore,
because external structures of data affect how users perform tasks, another challenge
involves determining how to organize a large number of data items in the visual
representations. To support the performance of complex tasks, VA combines advanced,
behind-the-scene analytics techniques with interactive external visualizations that
organize data items (Kehrer and Hauser, 2013; Keim et al., 2008).
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3.2.3

Visual Analytics and Analytical Reasoning

User-triggered actions, consequent reactions, and discourse with information are essential
in a VA system whose function is to facilitate users' analytical reasoning activities—
activities that refer to both rational and logical analysis of data as well as evaluation of
results. Such activities also involve analogical, deductive, and inductive reasoning to
reach conclusions (Sedig and Parsons, 2013), and emerge from a series of lower-level
tasks (e.g., developing hypotheses or identifying relationships among data elements)
(Heuer, 1999; Thomas and Cook, 2006). In order to reach a conclusion, some of these
lower-level tasks take place in an iterative and non-linear manner depending on cognitive
needs and overall goals of the user (Sedig and Parsons, 2013). Generally speaking,
analytical reasoning can be viewed as transforming given data into information,
knowledge, and insight (Gilhooly, 2004; Sedig and Parsons, 2013). This derived
knowledge and insight serves as a foundation for other cognitive activities such as
decision-making or problem-solving (Han et al., 2011; Leighton, 2004).
EMRs contain large bodies of complex data, and, oftentimes, EMR-driven tasks are illdefined. Thus, users have to rely on their experience, knowledge, and judgement to
perform complex activities (i.e., decision-making and problem-solving) in a healthcare
setting (Varga and Varga, 2016). Human-in-the-loop mechanisms involving interaction
with the visual and analytical modules of VA systems can thus help healthcare activities
(Green and Maciejewski, 2013).

3.3 Materials and Methods
This section describes the methodology we have employed to design the proposed VA
system, namely VISA_M3R3. For our EMR-based data, we use Ontario’s healthcare
databases housed in the ICES facility to illustrate how VISA_M3R3 can be used to
identify AKI-associated medications and medication combinations among older patients.
In Section 3.1, we provide an overview of the design process and participants. We then
describe data sources and cohort entry criteria in Sections 3.2 and 3.3, respectively.
Section 3.4 explains the implementation details of our VA system. Finally, in Section 3.5,
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we introduce the components of VISA_M3R3 and briefly describe how the overall
system works, which is also discussed more extensively in Section 4.

3.3.1

Design Process and Participants

Healthcare tasks usually include both well- and ill-defined problems. The well-defined
tasks have specific goals, clear expected solutions, and, oftentimes, a single solution path.
On the contrary, ill-defined tasks do not have clear goals, expected solutions, or solution
paths (Arifin et al., 2017).
To help us understand how healthcare practitioners perform real-world tasks, and to help
us conceptualize and design VISA_M3R3, we adopted a participatory design approach.
Participatory design is a co-operative approach that involves all stakeholders (e.g.,
partners, end-users, or customers) in the design process to ensure the end product meets
their needs (Muller, 2007). A clinician-scientist, a statistician, an epidemiologist, data
scientists, and computer scientists were involved in the design and evaluation process of
VISA_M3R3. During the initial stage in the participatory design process, we realized that
healthcare experts solve ill-defined problems in many different ways. It is difficult and
sometimes impossible to determine a single correct problem-solving strategy (i.e.,
analytics and/or visualization techniques) for ill-defined tasks. Different techniques have
their strengths and weaknesses, and there are different criteria to find out which technique
is more appropriate for a specific problem. As such, we asked experts to provide us with
1) a list of varying real-world, EMR-driven tasks that they perform, 2) analytics
techniques they usually rely on to accomplish those tasks, 3) visualization techniques
with which they are familiar, and 4) formative feedback on design decisions. In our
collaboration with experts, we recognized two high-level tasks to consider in designing
VISA_M3R3 system. 1) They would like to study the relationships between prescribed
medications and AKI; 2) They would like to identify commonly prescribed medication
combinations and understand the impact of different combinations on AKI. We were told
that healthcare experts usually use different regression techniques to accomplish these
types of tasks. Since the system has been designed to assist clinicians and healthcare
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researchers at the ICES-KDT program, we decided to incorporate the analytical and
visualization techniques with which they are more familiar. This was essential to build
trust between the proposed system and its end-users.

3.3.2

Data Sources

For the particular version of VISA_M3R3, we are primarily interested in analyzing
medications prescribed to older hospitalized patients in Ontario. Accordingly, we
obtained patient characteristics, prescriptions, and hospital admission data from 5 health
administrative databases. We used the Ontario Drug Benefit Program database to get
medication use data. We acquired patient characteristics data from the Registered Persons
Database, which contains demographic data on all Ontario residents who have ever been
issued a health card. We obtained hospital admissions and emergency department (ED)
visit data from the Canadian Institute for Health Information Discharge Abstract
Database and National Ambulatory Care Reporting System, respectively. International
Classification of Diseases, ninth (pre-2002), and tenth revision (post-2002) codes was
used to identify the baseline comorbidities and incidence of AKI from ED visit and
hospital admission data.

3.3.3

Cohort Entry Criteria

We developed a cohort of individuals aged 65 years or older who were admitted to
hospital or who visited the ED between April 1, 2014 and March 31, 2016. The ED visit
date or hospital admission date served as the index (cohort entry date). If an individual
had multiple ED visits or hospital admissions, we selected the first incident. Individuals
with an invalid healthcare number, age, and/or sex were excluded from the cohort. A
120-day look-back window from the index date was used to capture the associated
medication use data. We used a 5-year look-back window to identify relevant baseline
comorbidities.
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3.3.4

Implementation Details

The current VISA_M3R3 system is implemented in HTML, JavaScript library D3,
standard PHP programming language, and R packages. R was used to develop the
Analytics module. Html and D3 were used to create various external representations in
the Visualization module. The communication between these two modules is
implemented using PHP and JavaScript.
Most of the data analytics components were developed in R (version-3) because it 1)
provides extensive support for carrying out data mining operations such as regression and
frequent itemset mining, 2) is available in ICES workstations, 3) has a vast array of
libraries, 4) is a platform-independent tool, 5) is an open-source tool, and 6) is constantly
growing and providing updates whenever new features are available.
We used D3 to implement external representations of the Visualization module because
of the following reasons. 1) D3 offers a data-driven approach to help users attach their
data to the DOM (Document Object Model) element. 2) It allows users to get access to
full capabilities of modern web-browsers. 3) D3 uses a functional style that enables users
to reuse JavaScript code and add functionalities. 4) It is compatible with other
programming languages and platforms that have been used in this system. And 5) D3 is
free and open-source software.

3.3.5

Workflow

As shown in Figure 1, VISA_M3R3 has three modules: Analytics, Visualization, and
Interaction. The Analytics module is composed of two components: 1) single-medication
analyzer and 2) multiple-medications analyzer. The Visualization module is composed of
five views: 1) single-medication view, 2) multiple-medications view, 3) frequent-itemsets
view, 4) covariates view, and 5) medication-hierarchy view. The Interaction module
provides users with six main actions: 1) arranging, 2) drilling, 3) filtering, 4) searching,
5) selecting, and 7) transforming. The basic workflow of the system is as follows.
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First, an integrated dataset is created from different EMR databases stored at ICES. Next,
the inclusion and exclusion criteria are applied to build the final cohort. The variables in
the comorbidity and prescription data are then encoded and transformed into forms
appropriate for analysis. After applying pre-processing techniques, we split the dataset
into two groups. One contains the single medication data, and the other contains
medication combination data; the latter is generated from the frequent itemset mining
algorithm. We develop a number of multivariable regression models on both groups of
data. The models are then validated through Bonferroni correction and mapped into
respective visual representations. We developed five views to represent data items
created from different analysis techniques. The output of the single-medication and
multiple-medications analyzers are encoded into two scatter plots in the singlemedication and multiple-medications views, respectively. The frequent-itemsets view
represents the result of the frequent itemset mining algorithm using a chord diagram. The
covariates view allows users to control the information presented in other views though
sliders. The medication-hierarchy view includes a data table to display additional
information about data elements from the original dataset. Users are allowed to perform a
number of actions on the visual representations to manipulate data items. For instance,
users can highlight and/or filter out certain items and drill down into the details of the
selected data elements in different views.
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Figure 3-16: Workflow diagram of VISA_M3R3. Different colors are used to show
the separation of the three main modules.
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3.4 Design of VISA_M3R3 and Results
In this section, we describe the three main components of VISA_M3R3 as well as some
results. Section 4.1 (Analytics module) explains how the data is processed and offers a
summary of its results. Section 4.2 (Visualization module) describes VISA_M3R3's
interfaces and discusses how the system helps users in interpreting results. Finally,
Section 4.3 (Interaction module) illustrates how users can interact with the displayed
data.

3.4.1

Analytics Module

We use VISA_M3R3 to analyze ICES' EMRs to identify individual medications and
medication combinations that are associated with AKI. Our system aims to facilitate
understanding of relationships among medications, medication combinations, and AKI.
The Analytics module of VISA_M3R3 performs an individual and group analysis using
logistic regression and frequent itemset mining to achieve this goal.

3.4.1.1

Single-Medication Analyzer

Single-medication analyzer includes the regression models created to identify the
association between each medication and AKI. In order to capture an accurate
association, we include the demographic and comorbidity variables as potential
covariates in the models. For demographics (i.e., the study of a population based on
certain non-medical factors), we include the following variables in the models: age, sex,
income quintile, rural location, and long-term care. For comorbidity (commonly defined
as any distinct additional disease or condition that has existed during the clinical course
of a patient who has the first disease or condition under observation), we include the
following variables in the models: diabetes mellitus, hypertension, heart failure, coronary
artery disease, cerebrovascular disease, peripheral vascular disease, chronic liver disease,
chronic kidney disease, major cancers, and kidney stones. We obtain the medication
prescription data from the Ontario Drug Benefit Program database. This database
includes medication name, medication dose, date filled, and route-of-administration of
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the prescriptions. We identify 595 different medications by analyzing prescriptions that
have been filled 120 days before the index date. Thus, we create 595 binary variables to
record the medication use data for each medication and each patient. We also gather the
class and subclass information of these medications from the literature.
We combine data from different sources into a single dataset. The combined dataset
contains 5 demographic, 10 comorbidity, and 595 medication variables for each patient
included in the cohort. In total, there are 926,005 unique patients in the dataset. Next, we
apply the necessary pre-processing and transformation techniques on the combined
dataset to make it ready for the regression analysis. We use the “glm” function in R
packages to develop separate multivariable logistic regression models (Williams et al.,
1984) for each medication in the dataset. Thus, the regression formula includes AKI as
the response variable and medication, demographics, and comorbidities as predictor
variables. The “family” argument in the “glm” formula is set to “binomial”. We use the
“summary” function to obtain the estimate, p-value, standard error, and z-score for each
coefficient. In addition, the “confit” function is used to compute 95 percent confidence
intervals and odds ratio.
VISA_M3R3 provides users with the ability to compare regression models based on their
odds ratios, confidence intervals, p-values, and standard errors. Odds ratio measures the
association between medication and AKI. A high odds ratio for a specific medication
indicates a stronger positive association between that medication and AKI. A list of
statistically significant medications is created by filtering models based on the p-value of
the medication variable’s coefficient. A small p-value indicates that it is unlikely that an
observed relationship between the predictor (i.e., medication) and response variable (i.e.,
AKI) is due to chance. Out of 595, we find 55 medications that are strongly associated
with AKI. In order to avoid false positives when comparing multiple independent models,
we make the alpha value lower based on the Bonferroni correction to account for the
number of comparisons being done. A p-value less than 8.4e-5 (divide 0.05 by 595) is
considered to be statistically significant in this context. Next, we calculate the frequency
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of each medication in the list. Data items produced through the single-medication
analyzer include odds ratios, confidence intervals, p-values, standard errors, and usage
frequencies of 55 medications. Users of VISA_M3R3 can explore and manipulate these
data items to make sense of how an individual medication can affect AKI. Users’
sensemaking tasks include, but are not limited to, identifying medications with high odds
ratio and lower p-value, understanding the comparative risk of medications, assessing the
behavior of medication class or subclass, and exploring data items at various levels of
abstraction.

3.4.1.2

Multiple-Medications Analyzer

In order to identify the medication combinations that are associated with AKI, we first
prepare a dataset of frequently prescribed medications. Since we have 595 individual
medications, the total number of combinations is a large number. Therefore, we use the
Eclat algorithm (Agrawal et al., 1993) to obtain frequent combinations with a support of
0.07%. Eclat is a frequent itemset mining algorithm that employs a depth-first search to
discover groups of items that frequently occur in a transaction database. An itemset that
appears in at least a pre-defined number of transactions is called a frequent itemset. At
this stage, a total of 24,212 frequent itemsets (i.e., medication groups) are produced from
595 individual medications.
A number of binary variables are created to record the usage of the mediation groups. We
set the value of a particular medication group for a patient when that patient has been
dispensed all medications within the group within 120 days before the index date (at least
once per medication). Next, we apply a multivariable logistic regression model on each
medication group to identify potential accumulative nephrotoxicity. The formula includes
group variables, individual medication variables that belong to the group, demographic
variables, and comorbidities as predictors. Statistically significant medication groups are
identified by filtering the models based on a Bonferroni-corrected alpha value (divide
0.05 by the number of medication groups). We also calculate the usage frequency of 78
medication groups that are found to be statistically significant.
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In the multiple-medications analyzer, we employ a combination of frequent itemset
mining and logistic regression to generate data items such as frequent medication
combinations, statistically significant medication groups, p-values, odds ratios,
confidence intervals, and standard errors. These data items allow users to understand the
synergistic effect of a combination of different medications on AKI. Users’ sensemaking
tasks include, but are not limited to, identifying medication groups with high impact on
AKI, understanding the comparative risk of medications within a group, and exploring
data items at various levels of abstraction. VISA_M3R3 organizes data items in different
visual representations to allow users to perform these tasks.

3.4.2

Visualization Module

VISA_M3R3 (Figure 2) is composed of five main views: single-medication view,
multiple-medications view, covariates view, medication-hierarchy view, and frequentitemsets view. These views are supported by a number of selection controls, such as
search bar and collapsible tree structure. Each of these visualizations represents an
important aspect of the Analytics module. In this section, we discuss how data items
generated in the Analytics module are encoded as visual representations to allow users
perform the activities and tasks mentioned in the previous section.

3.4.2.1

Single-Medication View

Single-medication view uses a scatter plot to represent the results of individual regression
models for all the medications, as displayed in Figure 3. The generated scatter plot
displays each model in proximity to each other based on their p-value and odds ratio. A
linear scale is used for the vertical axis (odds ratio), whereas a log scale is used for the
horizontal axis (p-value) since the p-value is exponential. Medications that are plotted
closer together affect the risk of developing AKI in a similar manner. The regression
model for each medication is encoded as a glyph where horizontal lines on both sides of
each circle represent the confidence interval, and the vertical line shows the standard
error of the model. The single-medication view enables users to identify high-risk
medications that are associated with AKI and understand the comparative risk of these
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medications. For instance, the glyph in the top-right corner with a p-value of 1e-45 and
an odds ratio of 2.4 represents Metolazone. These values suggest that the odds of
developing AKI for a patient using this medication are more than two times higher than a
patient with similar conditions who is not using it.

Figure 3-17: The Visualization module of VISA_M3R3 is composed of five views:
(A) single-medication view, (B) multiple-medications view, (C) covariates view, (D)
medication-hierarchy view, and (E) frequent-itemsets view.
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Figure 3-18: Scatter plot of single-medication view.

3.4.2.2

Multiple-Medications View

The multiple-medications view, displayed in Figure 4, uses another scatter plot to
represent the results of the regression analysis of groups that are created by the frequent
itemset mining algorithm. Each glyph in this scatter plot encodes a medication group
model. Similar to the single-medication view, horizontal lines on both sides of each circle
in the glyph represent the confidence interval, and the vertical line shows the standard
error of the model. We map the p-value and odds ratio to the x- and y-axis, respectively.
The multiple-medications view provides users with the ability to detect medication
groups that are associated with AKI. For instance, through frequent itemset mining
analysis, we find that the pair of Gabapentin and Furosemide medications are frequently
prescribed together. As shown in Figure 4, this pair appears to be associated with AKI
with a p-value of 1e-26.
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Figure 3-19: Scatterplot of multiple-medications view.

3.4.2.3

Frequent-Itemsets View

Frequent-itemsets view represents the result of the frequent itemset mining analysis by
showing all possible combinations of the most frequent items using a chord diagram. As
shown in Figure 5, medications are mapped to nodes along the circumference of the
circle. Each node consists of an individual circle and a text field showing the name of the
medication. Each chord (link) connects two nodes (medications) if they co-occur in the
dataset within a certain timeframe. For instance, as shown in Figure 5, there are links
between Moxifloxacin Hcl and three other medications (Furosemide, Allopurinol, and
Amlodipine besylate) because these three medications have been prescribed with
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Moxifloxacin Hcl more than a certain number of times (0.07 percent of the total
population) within 120 days prior to the index date.
The size of the circle of each node displays the frequency of the medication in the
dataset. Higher usage frequency of a certain medication results in a larger radius for the
circle representing that medication. This allows users to visually compare medications
based on their use frequency. For instance, a relatively large radius of the circle
representing Ramipril indicates that it is one of the frequently prescribed medications in
Figure 5-B.
The nodes that belong to the same subclass are placed close to each other separated by
spaces. This enables users to visually identify the nodes that share common
characteristics (i.e., belong to the same subclass). For instance, users can detect that
Furosemide, Hydrochlorothiazide, Metolazone, Indapamide, and Chlorthalidone are all
Diuretics; therefore, they are placed in the same group (Figure 5-A). The frequentitemsets view also reveals subclasses that are composed of a higher number of AKIassociated medications. It can be observed from Figure 5 (C-1 and C-2) that there are two
subclasses (Angiotensin and Beta-blockers) that contain six medications that are
associated with AKI.
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Figure 3-20: Chord diagram showing the results of the frequent itemset mining
analysis in the frequent-itemsets view.

3.4.2.4

Covariates View

The covariates view is composed of several sliders that filter data items with respect to
different covariates involved in the regression model. The number of sliders depends on
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the number of covariates that are found to be statistically significant based on the result
of the regression analysis. As displayed in Figure 6, six sliders are generated to create
control for cancer, diabetes, hypertension, heart failure, coronary artery disease, and
coronary liver disease.
Each slider included in the covariates view has three components (a rectangle, vertical
lines, and two arc-shaped handles). The rectangle contains the other two components in
it. The length of the rectangle represents a linear or log scale, depending on the type of
variable it is representing. A linear scale is used when the slider represents the odds ratio
of a covariate. We use a log scale to represent the p-value of a covariate. All sliders are
generated based on the p-value of the covariates. The vertical lines in the rectangles
represent the regression models of both single-medication and multiple-medications
analyzers. The placement of the line on the horizontal axis depends on the p-value or
odds ratio of the covariate in the corresponding model. For instance, in the slider
representing diabetes (second from the top in Figure 6), most of the models are densely
clustered in the right corner. This indicates that diabetes has a high impact on the
association between medications and AKI. Two arc-shaped handles are placed on both
ends of the rectangle to allow users to choose a range of values on the horizontal axis.

3.4.2.5

Medication-Hierarchy View

The medication-hierarchy view contains a data table to provide a list of medications that
have been selected through other views, as displayed in Figure 7. The table has three
sortable columns for medications, subclasses, and higher-level classes. Each subclass
contains a set of medications that share common chemical structures and mechanisms of
action, and/or are used to treat similar diseases. A class contains medication subclasses
that can be grouped together because of their similarity.
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Figure 3-21: Six sliders representing different covariates in the covariates view.

Figure 3-22: The medication-hierarchy view shows the list of medications and their
classes and subclasses.
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3.4.3

Interaction Module

The Interaction module of VISA_M3R3 is intended to support human-in-the-loop
processes of VA. Using the many interactions provided by this module, users can gain
insight into the data and manipulate the incorporated data analysis techniques. In this
section, we will explore these interactions and discuss how they assist users in identifying
high-risk medications and understanding the association between medication groups and
AKI. We describe interactions that can be performed in each of the views discussed in the
previous section. These interactions not only affect displayed data at the selected view
but also change the representation of the data in other views.

3.4.3.1

Single-Medication View Interactions

As shown in Figure 8, the glyphs representing regression models of individual
medications are placed very close to each other in the scatter plot. It is sometimes
difficult for users to distinguish between models when the glyphs are densely clustered.
In order to address this issue, we use the Cartesian fisheye distortion technique on both
axes of the scatter plot. Fisheye distortion enables users to zoom in on small areas of the
plot without losing sense of its overall structure. Users can apply fisheye distortion by
moving their mouse pointer over the grey rectangular areas on both axes of the scatter
plot. Fisheye distortion magnifies the local region around the mouse continuously. Users
have the ability to enable and disable the fisheye distortion action by clicking on the grey
rectangular areas. The color of the rectangular area gets lighter when the fisheye
distortion action is disabled. As shown in Figure 8, fisheye on the top-left scatter plot is
disabled (light grey rectangles) and bottom-left scatter plot is enabled (relatively dark
grey rectangles).
The model selection interaction of the single-medication view affects all the other views.
Using this interaction (Figure 8), users can highlight a single medication model
throughout VISA_M3R3 in order to 1) determine positions of group models that include
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the selected medication in the multiple-medications view, 2) detect the position of the
selected medication in the covariates view, 3) observe the class and subclass of the
selected medication in the medication-hierarchy view, and 4) identify other medications
that are frequently prescribed with the selected medication in the frequent-itemsets view.
The selected medication is highlighted using the red color in the top-left scatter plot in
Figure 8. The glyphs representing corresponding groups in the bottom-left scatter plot,
vertical lines representing the medication in the covariates view, and links between
selected medication and other frequently used medications in the frequent-itemsets view
are all highlighted using the amber color. The utility of this interaction is when users are
interested in learning more about a medication that is strongly associated with AKI. They
would select a glyph at the top-right corner of the scatter plot, whereupon VISA_M3R3
would highlight and display the relevant information associated with that glyph. Another
interaction supported by this view is hovered drilling. This interaction enables users to
drill into scatter plot glyphs and get additional information about their corresponding
model (Figure 3).

Figure 3-23: Overview of interactions in the single-medication view.

77

3.4.3.2

Multiple-Medications View Interactions

We designed the interactions of the multiple-medications view in a similar manner to the
interactions of the single-medication view. The only difference is how we have designed
the selection interaction. The group model selection interaction affects all the other
views. Using this interaction (Figure 9), users can highlight a group model throughout the
system in order to 1) identify the position of single models included in the selected group
in the single-medication view, 2) determine the position of the selected group in the
covariates view, 3) observe the class and subclass of medications included in the selected
group in the medication-hierarchy view, and 4) highlight the nodes and links representing
the group in the frequent-itemsets view. To maintain consistency across all views, the
color scheme of the multiple-medications view is similar to the single-medication view.
This interaction can be used when users want additional information about a specific
group model; they can select the corresponding glyph and observe whether medications
included in the selected group are associated with AKI individually in the singlemedication view.

Figure 3-24: Overview of interactions in the multiple-medications view.
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3.4.3.3

Covariates View Interactions

The single-medication and multiple-medications analyzers produce a set of regression
models. These models can be described by a certain number of common attributes (e.g.,
p-value and odds ratio of each covariate) because all of them include the same set of
demographic and comorbidity variables as their covariates. The value of an attribute
changes based on how each covariate affects the model. It is essential to understand the
impact of covariates on both single and group models.
Users can create complex queries composed of several simpler queries related to
attributes of different covariates. In each simple query, users apply a filter to the models
by selecting a specific range in each slider. Figure 10 shows an example of a complex
query involving p-value of six covariates. Users can drag both ends of the given sliders to
choose a certain range. The color of the range selector changes from green to red when a
slider is active. The color of the vertical line representing the model changes from grey to
amber when the corresponding model satisfies the criteria of the complex query. Also,
the medication-hierarchy view displays the list of models that meet the criteria of the
complex query.

Figure 3-25: Overview of interactions in the covariates view.
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In many situations, users struggle to choose appropriate ranges for the sliders. As a result,
the query might produce an empty or a limited result set. In order to address this issue,
we implemented a sensitivity encoding mechanism in VISA_M3R3 (Spence, 2002). The
sliders are set to their maximum and minimum ranges by default. In this case, the color of
the glyphs in both scatter plots is set to green because all models satisfy the query. The
color of the glyph in the scatter plots encodes the number of simple queries its
corresponding model satisfies in the covariates view, as shown in Table 1 and Figure 10.
Table 3-4: Sensitivity encoding using color coding of glyphs.
Number of
satisfied
filters
6
5
4
3
2
1
0

3.4.3.4

Color of the
glyphs
Green
Black
Blue
Cyan
Purple
Grey
Yellow

Frequent-Itemsets View Interactions

The selection interaction of the frequent-itemsets view affects the single-medication
view, covariates view, and medication-hierarchy view. Using this action (Figure 11),
users can select a single medication from the chord diagram by clicking on its
corresponding node in order to 1) identify other medications that are frequently
prescribed with the selected medication in the frequent-itemsets view, 2) understand the
association between the selected medication and AKI in the single-medication view, 3)
determine the position of the selected medication in the covariates view, and 4) observe
the class and subclass of the selected medication in the medication-hierarchy view.
Figure 11 shows an example of this interaction. Selecting Moxifloxacin Hcl would
highlight the links and the names of the other medications (i.e., Furosemide, Allopurinol,
and Amlodipine besylate) that are frequently consumed with Moxifloxacin Hcl.
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3.4.3.5

Medication-Hierarchy View Interactions

Medication-hierarchy view supports two interactions as shown in Figure 12. Users can
sort the table based on medication name, subclass, or class by clicking on the
corresponding column header. For instance, if they click on “Medication”, medication
names in the table get sorted alphabetically. They can also sort in the opposite order by
clicking on the same header again. In addition, users can click on any row in the table to
select the corresponding medication or medication groups. Selected medications get
highlighted in all other views.

Figure 3-26: Overview of interactions in the frequent-itemsets view.

3.4.3.6

Selection Controls

Selection controls include a search bar, a collapsible tree structure, and several buttons to
control the information displayed in different views (top-right corner of Figure 12). If
users are interested in learning about a specific medication, they can enter the name of
that medication (or part of the name) in the search bar and the information related to that
medication gets displayed in the medication-hierarchy view. Users can expand the tree

81

structure by clicking on the “+” icon at the top-right corner to get a menu of medication
subclasses. Each item in the menu is linked to a checkbox. It is possible to limit data
items displayed in other views by selecting these checkboxes. For instance, as shown in
Figure 12, users have selected a number of subclasses such as Iron preparations,
Vasodilator antihypertensive, and Antiemetics & Antinauseants in the collapsible tree
structure to limit the number of data items shown in the scatter plots, data table, and
chord diagram.

Figure 3-27: Overview of interactions in the medication-hierarchy view and
selection controls.

3.5 Discussion
In this paper, we have shown how VA systems can be designed to address the challenges
of prescription data stored in EMRs in a systematic way. To achieve this, we have
reported the development of VISA_M3R3, a VA system designed to assist medical
researchers at ICES’ KDT program. VISA_M3R3 incorporates three main components:
an Analytics module, made up of single-medication analyzer and multiple-medications
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analyzer; a Visualization module, made up of five views: single-medication view,
multiple-medications view, covariates view, frequent-itemsets view, and medicationhierarchy view; and an Interaction module, made up of a set of different human-data
interactions. VISA_M3R3 is unique in the manner in which it combines multivariable
regression with Eclat to support underlying processing in the computing space and
implements fisheye and sensitivity encoding to provide support for the representation and
interaction spaces. It offers a balanced distribution of processing load through a proper
integration of analytics techniques (i.e., regression and frequent itemset mining in the
Analytics module) with visual representations (i.e., different interactive views in the
Visualization module) to facilitate high-level cognitive tasks. Some of the main tasks
commonly performed by researchers, and which VISA_M3R3 is designed to support,
include: 1) compare multiple regression models, 2) understand the relationship between
different predictors and a response variable, 3) identify the frequent itemsets from items
of interest, and 4) interpret multivariable regression models. VISA_M3R3 is primarily
designed as a research tool for the medical researchers at ICES’ KDT program, and it is
up to them to decide how this system will be applied within the healthcare system. A
number of training materials have been prepared to assist new users who are not familiar
with the analytics and visualization techniques incorporated in VISA_M3R3 to use the
system effectively.
We have demonstrated how VISA_M3R3 can be used to detect AKI-associated
medications among older patients who visited the hospital or emergency department in
Ontario between 2014 to 2016 using ICES health administrative data. We have seen that
VISA_M3R3 allows healthcare researchers to generate hypotheses, understand the
relationships among data elements (e.g., medications and diseases), and recognize
patterns and trends that would be otherwise difficult to identify. About 9% of all the
medications that are prescribed to the older patients have been found to be associated
with AKI. Using VISA_M3R3, we detect 55 medications (Furosemide, Allopurinol,
Hydrochlorothiazide, Atorvastatin, Spironolactone, Olmesartan Medoxomil, to name a
few) and 78 medication combinations (Furosemide & Oseltamivir Phosphate, Allopurinol
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& Metolazone, Celecoxib & Quetiapine, and so on) that are associated with an increased
risk of AKI. In general, medications belong to Angiotensin Receptor Blockers, Diuretics,
Nonsteroidal Anti-inflammatory, and Xanthine Oxidase Inhibitors classes are found to be
strongly associated with AKI. Moreover, some combinations of medication classes such
as Anti-inflammatory & Antidepressants and Diuretics & Antiviral Agents have been
identified with the evidence for increased risk of developing AKI. The lists of
medications and medication combinations have been reviewed by a nephrologist to
validate the results. Most of these medications are already known to be nephrotoxic in the
existing literature, which confirms the accuracy of our findings through VISA_M3R3
(Chao et al., 2015; Kwok M. Ho and Power, 2010; Perez-Ruiz, 2017; PiersonMarchandise et al., 2017; Verdoodt et al., 2018; Wu et al., 2014).
In terms of the extensibility and scalability of VISA_M3R3, we have designed it in a
modular way so that it can easily accept new data sources, data types, and analysis
techniques. VISA_M3R3 can be used to investigate many other clinical problems, such
as identifying risk factors associated with hypertension, and understanding the
relationship between dietary habits and diabetes. To test the applicability of the system in
different healthcare areas, we have used VISA_M3R3 to detect hospital admission codes
(i.e., reasons for hospitalization) that are associated with AKI using healthcare utilization
database housed at ICES. We detected 8,543 itemsets by analyzing the hospital admission
codes that co-occur frequently. Using VISA_M3R3 to analyze this data, 185 individual
codes and 215 group codes are found to be statistically significant. The top few reasons
for hospitalization (representing admission codes associated with AKI) include 1)
Essential hypertension, 2) Malignant neoplasm of bladder, 3) Non-follicular (diffuse)
lymphoma, 4) Mycosis fungoides, 5) Iron deficiency anemia, and 6) Chronic obstructive
pulmonary disease. This result also aligns with what has already been known from the
literature, which more generally and comprehensively proves the efficacy of
VISA_M3R3's design (Anderson et al., 2010; Da’as et al., 2001; Kandler et al., 2014;
Malbrain et al., 1994; Martines et al., 2013).
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There are four key limitations to the development of VISA_M3R3. The first one is that it
reports the regression analysis result of the group models but does not consider how
individual items within the group are affecting the outcome. For instance, in the study
with medications, VISA_M3R3 reveals that the combination of Furosemide and
Metoprolol increases the risk of AKI. However, it does not explain the additive risk of
using Metoprolol with or without Furosemide and vice versa. This issue can be resolved
by incorporating a stratified analysis on each item available in at least one group. The
second limitation is that, even though we have had a participatory design and medical
experts have evaluated VISA_M3R3 and have found it very useful and usable, we have
not conducted any formal experimental usability studies to evaluate its performance, nor
the efficacy of its human-data discourse mechanisms. The third one is that VISA_M3R3
incorporates a limited number of analytics techniques. Although there are more advanced
machine learning algorithms in the literature, we decided to design the system based on
techniques that are more interpretable to our end-users (i.e., clinicians and healthcare
researchers). Fourth, the preparation of the dataset for VISA_M3R3 could be laborintensive in some situations, depending on the data source and problem at hand.
However, there are a number of readily available libraries and packages available to
assist users with the data cut and preparative work.

3.6 Conclusion
The purpose of this study is to demonstrate how VA systems can be designed in a
systematic way to support EMR-driven tasks and investigation of different clinical
problems. We report the development of a VA system (called VISA_M3R3) and
demonstrate how it can be used to help medical practitioners and researchers identify
medications and medication combinations that associate with a higher risk of AKI.
VISA_M3R3's novelty stems from its design: it incorporates multivariable regression,
frequent itemset mining, data visualization, and human-data interaction mechanisms in an
integrated fashion to support ill-defined, complex EMR-driven tasks. Using
VISA_M3R3, we analyzed ICES health administrative data. Through this analysis, 55
medications and 78 medication groups, strongly associated with AKI, were identified.
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Although, through clinical studies, a number of these AKI-associated medications and
medication groups are known by medical researchers, some of them have never been
studied before. VISA_M3R3 can alert and raise physicians' awareness of such potentially
AKI-associated medications. This, in turn, can prompt healthcare providers to conduct
further clinical investigations to improve healthcare research outcomes. Finally,
VISA_M3R3's design concepts are generalizable. They can be used to systematically
develop any VA system whose goal is to support medical tasks involving analysis of
EMR data using multiple regression models and frequent itemset mining. Applications of
such VA systems can lead to the emergence of best practices for developing similar VA
systems in other medical domains.
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Chapter 4

4

Machine Learning for Identifying Medication-Associated
Acute Kidney Injury

This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, D. J.
Lizotte, A.X. Garg, and E. McArthur, “Machine Learning for Identifying MedicationAssociated Acute Kidney Injury” in the Health Section of the Informatics
Journal, Volume 7; May 2020. We changed the format to match the general format of the
dissertation. Figure, Table, and Section numbers specified herein are relative to the
chapter number. For example, “Table 1” corresponds to Table 4-1; “Figure 1”
corresponds to Figure 4-1; and “Section 1.1” corresponds to Section 4.1.1. Moreover,
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter.

4.1 Introduction
Acute kidney injury (AKI), defined as a sudden loss of kidney function over a short
period of time, affects approximately 10% of patients admitted to hospitals worldwide
(Porter et al., 2014; Selby et al., 2012). It is associated with increased mortality,
morbidity, and estimated incremental health care costs of more than $200 million in
Canada annually (Collister et al., 2017). Medication-induced nephrotoxicity is very
common in clinical practice. It accounts for 19% of cases of AKI in a hospital setting
(Collister et al., 2017; Gandhi et al., 2000; Kaufman et al., 1991; Miyahara, 1978; Nash et
al., 2002; Uchino et al., 2005) and is associated with increased healthcare expenditure
(Choudhury and Ahmed, 2006; Collister et al., 2017). For instance, using the medication
utilization data in Canada for 2013, Morgan et al. (2016) have reported an estimated
healthcare cost of $419 million due to inappropriate prescriptions (Morgan et al., 2016).
Over the last two decades, the incidence rate of AKI has increased in Canada (Liu et al.,
2010; Mehrabadi et al., 2014), the United States (Nadkarni et al., 2016; Xue et al., 2006),
and the United Kingdom (Kolhe et al., 2016). The increasing occurrence of AKI is
related to the changing spectrum of diseases. There is a growing body of evidence
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showing that patients with multiple comorbidities and extrarenal complications are at a
higher risk of developing AKI (Mehta et al., 2004; Siddiqui et al., 2012). For instance,
Aikar et al. (Waikar et al., 2006) have shown that the high comorbidity rate, measured by
the Deyo-Charlson comorbidity index, is associated with AKI. In a study of 681 AKI
patients who are admitted to the intensive care unit, the occurrence of comorbid
conditions is high: 37% have coronary artery disease, 30% have chronic kidney disease,
29% have diabetes mellitus, and 21% have chronic liver disease (Mehta et al., 2004). As
a patient's number of comorbid conditions grow, there is a rise in associated
hospitalizations, physician visits, prescriptions, and expenses (Zulman et al., 2014),
ultimately leading to an increase in medication intake. Patients admitted to hospitals,
particularly critically ill patients with multiple comorbidities, often take several
medications, with up to 25% of these medications having nephrotoxic potential
(Choudhury and Ahmed, 2006). A study in 2005 has revealed that out of 7 million
adverse medication event reports, 2.7% include an incidence of AKI, of which 16% are
known nephrotoxins, 18% are possible nephrotoxins, and the rest are new potential
nephrotoxins (Uchino et al., 2005).
The use of nephrotoxic medications is associated with 16-25% of all AKI cases in the
adult population (Pannu and Nadim, 2008; Uchino et al., 2005). Few studies have been
conducted to identify medications that are commonly associated with AKI. Most of these
studies have been limited in assessing the impact of known nephrotoxic medications
(Alexander et al., 2017; Moffett and Goldstei, 2011; Rivosecchi et al., 2016). In addition,
information on medication combinations that can cause AKI lacks in the literature. It is
important to identify those combinations because a combination of multiple nephrotoxins
may result in synergistic or accumulative nephrotoxicity, thus increasing the chance of
renal failure (Schetz et al., 2005). For example, the risk of developing AKI increases by
53% for each additional nephrotoxic medication used by a patient (Cartin-Ceba et al.,
2012). Hence, it is important to identify not only nephrotoxic medications but also
medication combinations that affect the risk of AKI. Rivosecchi et al., through an
exhaustive literature search, further emphasize the need for a comprehensive
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understanding of how medication combinations alter the risk of AKI (Rivosecchi et al.,
2016). According to a CDC report in 2017, there are about 1,000 known adverse
medication effects and 5,000 medications available in the pharmacies (FastStats Therapeutic Drug Use), making for approximately 125 billion possible adverse
medication effects between all possible pairs of medications (Zitnik et al., 2018). Thus, it
is impossible to assess medication-induced AKI through this number of clinical trials
comprehensively. Moreover, conducting a trial to determine whether to prescribe or not
prescribe a potentially harmful combination would likely never receive research ethics
board approval.
Data analysis has the potential to address this challenge by employing methods and
techniques from different fields, such as data mining, statistics, and machine learning to
accomplish various data-driven tasks (Han and Kamber, 2011). It can be used to
investigate clinical data to gain both novel and deep insights to help healthcare providers
examine medication-induced nephrotoxicity. Recently, several studies have been
conducted to identify drug-drug interactions, improve drug-safety science, and predict
adverse drug reactions using machine learning techniques (Vamathevan et al., 2019). For
instance, Kandasamy et al. (2015) have developed a prediction model to identify druginduced nephrotoxicity using human induced pluripotent stem cells and random forest
(Kandasamy et al., 2015). In addition, Dey et al. (2018) have presented a deep learning
framework to predict adverse drug reactions and detect molecular substructures
associated with them (Dey et al., 2018). An automatic method of processing adverse
event reports using artificial intelligence and robotics is presented in (Schmider et al.,
2019). Lysenko et al. (2018) have incorporated Mashup (Cho et al., 2016) and a gradientboosted tree to predict drug toxicity using biological network data (Lysenko et al., 2018).
Although these studies are designed to deal with large bodies of data to solve different
medication-related problems, the relationship between medications and AKI has not been
studied before through automated data analysis. Automated data analysis techniques
allow an incorporation of large quantities of data that creates an opportunity to include
additional information to more comprehensively study individual medications and their
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combinations. It is essential to consider comorbidities while studying the effect of
medications since it is not clear whether the underlying comorbidities or medications
increase the risk of developing AKI. In addition to comorbidity data, demographics data
such as age, sex, and region, are also considered as risk factors for AKI (K. D. Liu et al.,
2019; Siew et al., 2016). Therefore, any complete study that investigates nephrotoxic
medications or combinations should include demographic and comorbidity data in the
analysis. Up until now, there is a lack of well-designed studies that consider demographic
and comorbidity data while assessing the risk of developing AKI with the use of single or
multiple medications. Even though the identification of nephrotoxic medications is
crucial for improved patient care, it has not been studied thoroughly through machine
learning techniques.
The purpose of this study is to identify individual medications associated with AKI in
hospitalized patients using an automated machine learning approach. We also identify
AKI-associated medication combinations and investigate whether the use of multiple
medications results in multiplicative effects on the risk of developing AKI. Finally, we
investigate how our findings are consistent with data in the existing literature. Our study
differs from other studies in three ways: (1) we consider all the frequently used
medications in the study, whether they have been known to be nephrotoxic or not; (2) we
use a frequent itemset mining algorithm to identify frequent medication combinations and
multivariable logistic regression to investigate the association between medication
combinations and AKI; and (3) we incorporate the patient's demographic and
comorbidity features as potential covariates in the regression models.

4.2 Materials and Methods
This section describes the methodology we have employed to conduct the study. We
describe the design process, study setting, workflow, data sources, cohort entry criteria,
input features, outcome, analysis processes, and tools.
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4.2.1

Design Process and Participants

To help us understand how healthcare providers perform automated analysis, and to help
us conceptualize and design our study, we adopted a participatory design method. It is a
co-operative method that involves all stakeholders (e.g., designers, intermediary-users,
and end-users) in the design process to ensure the output of the analysis meets their needs
(Muller, 2007). A statistician, a clinician, an epidemiologist, and several computer
scientists were involved in the design and evaluation process of this study. During the
initial stage in the designing process, we realized that healthcare providers usually
perform medication-safety related studies in many ways. It is difficult to determine a
single correct analytics technique for these tasks because different techniques have their
strengths and weaknesses. As such, we interviewed healthcare experts to identify the
data-driven tasks and analytics techniques with which they are familiar. We identified
four data-driven tasks to consider in designing this study through our collaboration with
healthcare experts at the ICES-KDT (ICES - an independent, non-profit, world-leading
research organization that uses population-based health and social data to produce
knowledge on a broad range of healthcare issues; KDT - Kidney Dialysis and
Transplantation program), located in London, Ontario, Canada. 1) Studying the
relationships between prescribed medications and AKI. 2) Identifying commonly
prescribed medication combinations to older patients. 3) Examining the effect of a
medication combination on AKI. 4) Investigating if a certain medication is associated
with an increased risk of developing AKI when used with another medication. We came
to know that healthcare experts usually rely on different regression techniques to
accomplish such tasks. Thus, we decided to employ multivariable regression in this
study. We also invited healthcare experts to provide us with formative feedback on
design decisions and results.

4.2.2

Design and Setting

We performed a population-based retrospective cohort study in older adults from April
2014 to March 2016 in Ontario, Canada, using administrative health databases located at
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ICES. These datasets were linked using unique encoded identifiers and analyzed at ICES.
The use of data in this project was authorized under section 45 of Ontario’s Personal
Health Information Protection Act, which does not require review by a Research Ethics
Board.
Ontario has a population of approximately 13 million residents with universal access to
hospital care and physician services, including 1.9 million people aged 65 years or older
who have universal prescription drug coverage (14% of the population). We suppressed
our results in cells with five or fewer patients to comply with privacy regulations and
minimize the chance of re-identification of patients.

4.2.3

Workflow

Figure 1 illustrates the basic workflow of the study presented in this paper. In the first
stage, we created an integrated dataset from different health administrative databases
stored at ICES. The data sources are explained in Section 2.4. Next, we applied the
inclusion and exclusion criteria presented in Section 2.5 to build the final cohort. The
demographic and comorbidity features were then encoded and transformed into
appropriate forms for analysis in Section 2.6. Section 2.7 describes the outcome (i.e.,
AKI) and how we identified the incidence of AKI. A brief description of the cohort is
presented in Section 2.8. After that, we performed individual and combination analysis,
which are discussed in Section 2.9 and 2.10, respectively. The results from both analyses
were then validated and presented in Tables 2 and 3.

4.2.4

Data Sources

We ascertained patient characteristics, drug prescriptions, and outcome data from 5
health administrative databases (Appendix A). The datasets were linked using unique,
encoded identifiers derived from health card numbers, and patient-level data were
analyzed at ICES. We obtained vital statistics from the Ontario Registered Persons
Database, which contains demographic data on all Ontario residents who have ever been
issued a health card. We used the Ontario Drug Benefit Program database to identify
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prescription drug use. This database contains highly accurate records of all outpatient
prescriptions dispensed to older patients, with an error rate of less than 1% (Levy et al.,
2003). We identified hospital admissions, baseline comorbidity data, and emergency
department visits from the National Ambulatory Care Reporting System (ED visits) and
the Canadian Institute for Health Information Discharge Abstract Database
(hospitalizations). We used the International Classification of Diseases, tenth revision
(post-2002) codes to assess baseline comorbidities. Baseline comorbidity data were also
obtained from the Ontario Health Insurance Plan database, which includes claims for
physician services. Coding definitions for comorbidity data are represented in Appendix
B.

Figure 4-28: Workflow diagram of the study presented in this paper. Different
colours are used to show the separation of three main parts (pre-processing,
individual analysis and combination analysis).
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4.2.5

Cohort Entry Criteria

We identified a cohort of individuals aged 65 years or older who were admitted to
hospital or visited the emergency department (ED) between 1st April 2014 and 31st
March 2016. The ED visit date or hospital admission date served as the index or cohort
entry date. If an individual had multiple ED visits or hospital admissions, we selected the
first incident. Individuals with invalid data regarding the health card number, age, and sex
were excluded. We also exclude: (1) patients who previously received dialysis or a
kidney transplant as AKI is often no longer relevant once a patient develops end-stage
kidney disease (diagnosis codes for exclusion criteria are shown in Appendix C); and (2)
patients who left the hospital against medical advice or without being seen by a
physician.

4.2.6

Baseline Covariates

There were a total of 5 demographic, 10 comorbidity, and 595 medication features in the
cohort, which serve as input for the analysis. Demographic information included age, sex,
residency status (urban and rural), long term care, and socioeconomic status (income
quintile according to Statistics Canada). We used a 5-year look-back window to identify
relevant baseline comorbidities, including diabetes mellitus, hypertension, heart failure,
coronary artery disease, cerebrovascular disease, peripheral vascular disease, chronic
liver disease, chronic kidney disease, major cancers, and kidney stones.
All of the features in the cohort were categorical. We converted the comorbidity features
into binary forms. For instance, if a patient had a particular comorbid condition, its
corresponding value was taken as "1." We set the value for sex and residency status
features if a patient was male and resided in urban areas. The income feature took an
integer value ranged between 1 to 5 to represent the income quintile of a particular
patient. All these features from different data sources were integrated using the encoded
identifiers derived by ICES. Finally, the features in the cohort were transformed into a
format and scale that were suitable for the analysis. For each feature in the cohort, we
recorded the last value before the index date. Thus, we aggregated multiple values (rows)
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of a single feature into one by considering the latest values of that feature for each
patient.

4.2.7

Outcome: Identification of AKI

AKI was the outcome variable for all the regression models in this study. We identified
the incidence of AKI in the first visit to the ED or hospital admission between 1st April
2014 and 31st March 2016. The incidence of AKI was captured using the National
Ambulatory Care Reporting System and the Canadian Institute for Health Information
Discharge Abstract Database based on the International Classification of Diseases (ICD),
Tenth Revision (ICD-10-CA) "N17" diagnostic codes. We considered the first incidence
in case of multiple episodes of AKI for a patient. We set the value of the outcome
variable if a patient was diagnosed with AKI. We recorded the first incidence of AKI in
case there were multiple episodes.

4.2.8

Cohort Characteristics

A total of 924,533 participants were included in the derivation cohort, of which 25,084
(2.7%) had AKI during their hospital or ED encounter. Selected characteristics of this
cohort are shown in Table 1. The mean age was 70 years, and 56% were women. Sixteen
percent of the patients resided in rural areas, and 6% of them were in long term care. The
pre-existing comorbidities were hypertension (88%), diabetes (38%), coronary artery
disease (25%), major cancer (16%), heart failure (14%), cerebrovascular disease (3%),
peripheral vascular disease (2%), chronic liver disease (4%), chronic kidney disease
(9%), and kidney stones (1%).
Table 4-5: Baseline characteristics of patients admitted to the hospital or who visited
the emergency department (ED).
Characteristics
Cohort size
Age, yr, mean (SD)
65 to <70
70 to <80
80 to <90

Patients admitted to hospital or visited ED
Total Patients
AKI
No AKI
924,533
25084 (3%)
899449 (97%)
192,678
382,989
274,842

2522 (1.3%)
7946 (2.1%)
10370 (3.8%)

190156 (98.7%)
375043 (97.9%)
264472 (96.2%)
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>=90
Women
Year of cohort entry (index date)
2014-2015
2015-2016
Rural residence
Long-term care
Income Quintile
1
2
3
4
5
Comorbid conditions
Hypertension
Diabetes
Heart failure
Coronary artery disease
Chronic liver disease
Cancer
Chronic kidney disease
Kidney stones
Peripheral vascular disease
Cerebrovascular disease

4.2.9

74,024
516,175

4246 (5.7%)
12139 (2.4%)

69778 (94.3%)
504036 (97.6%)

605,244
319,289
151,323
43,351

16689 (2.8%)
8395 (2.6%)
2097 (1.4%)
3118 (7.2%)

588555 (97.2%)
310894 (97.4%)
149226 (98.6%)
40233 (92.8%)

180,227
192,686
182,957
186,407
182,256

5466 (3%)
5515 (2.9%)
4909 (2.7%)
4829 (2.6%)
4365 (2.4%)

5466 (3%)
5515 (2.9%)
4909 (2.7%)
4829 (2.6%)
4365 (2.4%)

814,604
358,472
125,136
239,437
33,359
145,286
86,442
12,457
13,197
25,835

24209 (3%)
13837 (3.9%)
7623 (6.1%)
8392 (3.5%)
1245 (3.7%)
4253 (2.9%)
7759 (9%)
391 (3.1%)
660 (5%)
1180 (4.6%)

790395 (97%)
344635 (96.1%)
117513 (93.9%)
231045 (96.5%)
32114 (96.3%)
141033 (97.1%)
78683 (91%)
12066 (96.9%)
12537 (95%)
24655 (95.4%)

Individual Medication Analysis

We identified a total of 595 unique medications prescribed to about 1 million patients in
the Ontario Drug Benefit Program database. The database includes medication name,
medication dose, date filled, and route-of-administration of the prescriptions. We
generated 595 binary features to record the use data for each medication and each patient.
We set the value of a specific medication feature for a patient when the medication was
administered to that patient in the 120 days prior to hospital presentation. When patients
take a drug, it affects them differently based on body composition and metabolism.
However, most physicians are not able to consider all of these factors when prescribing a
medication. Thus, to investigate the association between medications and AKI, we
intended to identify signals that affect a large population. If a particular signal is common
in a large number of people (i.e., a population of one million patients), then the
possibility of the existence of an association is very high. Our goal was to identify
potential interactions that are not yet understood or perhaps known. We considered this as
an information retrieval problem, such that our models were designed to discover the
possible relationships between each medication and AKI. We developed a multivariable
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logistic regression model to predict AKI based on the demographic, comorbidity, and
medication data and observed the attribute representing medication to understand the
relationships between a particular medication and AKI. Logistic regression is a special
type of regression technique used to predict the outcome of a binary dependent feature
from one or several predictors. We developed separate regression models for each
individual medication (i.e., 595 models). For each model, the regression coefficient and
p-value of the medication attribute were analyzed to identify potential associations. It is
important to mention that formal clinical studies are required to confirm such
interactions. The study was designed to assist healthcare experts at the ICES-KDT
program in choosing potential candidates for their future drug-safety studies.
The "glm" function in R packages was employed to implement multivariable logistic
regression models (Williams et al., 1984). Model covariates included demographic
features and baseline comorbidities. Thus, the formula in R included AKI as the response
and comorbidities, demographics, and medication as predictor variables. The value for
the "family" argument in the "glm" function was set to "binomial." We used the
"summary" function to get the estimate, p-value, z-score, and standard error for each
coefficient in the model. In addition, the "confit" function was used to compute the
confidence interval and odds ratio.
In order to avoid type I error in comparing multiple independent regression models, we
lowered the alpha value based on the Bonferroni correction to account for the number of
comparisons being performed. We considered a Bonferroni-corrected p-value less than
8.4e-5 (divided 0.05 by the number of individual medications) as statistically significant
for regression models with each medication.

4.2.10

Medication Combination Analysis

In order to identify the medication combinations that are associated with AKI, we first
prepared the medication combinations data. Since the number of individual medications
is 595, the total number of combinations is a large number. Hence, we used a data mining
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technique named Eclat (Agrawal et al., 1993) to select the frequent combinations that
included prescription data of at least 0.07% of the total number of prescriptions. Eclat is a
frequent itemset mining algorithm that uses a depth-first search to discover groups of
items that frequently occur in a transaction database. An itemset that appears in at least a
pre-defined number of transactions is called a frequent itemset. Each frequent
medication combination was annotated with its support. The support of a medication
combination was how many times it appeared in the medication database
We only included combinations of two medications in this analysis and identified 7,748
unique medication combinations. Then, we created binary features to record the presence
of these combinations. We set the value of a specific combination feature for a patient
when that patient had been dispensed all medications within the combination in the 120day period before the index date. Similar to the individual medication analysis, we
applied a multivariable logistic regression on each medication combination. The baseline
covariates, such as demographics and comorbidities, and medication combination
features were included as potential covariates in the models. We developed separate
regression models for each medication combinations identified using frequent itemset
mining analysis (i.e., 7,748 models). The regression coefficient and p-value of the
medication combination attribute were analyzed to identify combinations that are
associated with AKI. We then performed a stratified analysis to examine potential
medication-medications interactions further. We created a subset of medication
combinations based on their significance in the regression models. Statistically
significant combinations were detected by filtering the regression models based on a
Bonferroni-corrected alpha value, 6.5e-6 (divided 0.05 by the number of medication
combinations).
Stratified analyses were conducted on each medication available in one or more
combinations in the above subset. To do this, we created a list of unique medications (i.e.,
base medications) from the chosen subset of medication combinations. Then for each
medication in the list, we identified the other medication that holds a combination with
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the base medication. In the next stage, we prepared two sub-cohorts. The first one
includes both medications in the combination (base and other), and the second one
excludes the other medication in the combination. Finally, we applied multivariable
logistic regression on each sub-cohort that included the combination and/or base
medication feature along with the baseline covariates. The same process was followed for
each medication available on the list.
In this analysis, for each unique medication combination, we obtained two models for the
sub-cohorts. In order to help us to assess how the other medication affects the outcome of
the base medication, we compared the odds ratio of the combination attribute in the first
model with the odds ratio of the base medication attribute in the second model. We tested
the significance of all models in the stratified analysis using a Bonferroni-corrected alpha
value. We calculated the percentage change in odds ratios to report the result of this
analysis.

4.2.11

Tools and Technologies

SAS was used to cut and prepare the dataset because ICES administrative databases were
stored in the SAS server (“SAS Enterprise BI Server,” n.d.). In addition, we used R
packages (“RStudio | Open source & professional software for data science teams,” n.d.)
to conduct the necessary statistical and machine learning analyses in this study. R was
chosen because it 1) provides widespread support for carrying out data mining operations
such as frequent itemset mining and multivariable regression, 2) is available on the ICES
workstations, 3) has a rich array of libraries, 4) is platform-independent and open-source,
and 5) is continuously growing and providing updates with new features.

4.3 Results
This section describes the results of the study. The results are divided into two
subsections. The results of the individual medication analysis and medication
combination analysis are discussed in Subsection 3.1 and 3.2, respectively.
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4.3.1

Individual Medication and AKI

Some of the commonly prescribed medications in the 120 days before the ED visit were
Atorvastatin Calcium (24%), Rosuvastatin Calcium (22%), Hydrochlorothiazide (20%),
Amlodipine Besylate (19%), and Metformin Hcl (16%). A binary logistic regression
model was fit to each medication, where demographic and comorbidity features were
included as potential risk factors in the model to test the research hypothesis regarding
the relationship between the likelihood of developing AKI and specific medications.
Table 2 shows the full list of medications with their p-values, odds ratios, confidence
intervals, and standard errors. The medication classes are shown in brackets with
medication names. We sorted medications based on the odds ratio of the medication
feature in each model. Out of 595 medications, 55 of them were found to be strongly
associated with AKI (i.e., statistically significant after Bonferroni correction). Among
these 55 medications, six of them were Diuretics, four were Beta-blockers, three of them
belonged to Oral Anti-Glycemic, three of them were Prostatic Hyperplasia medications,
and the rest of them belonged to 33 other medication classes.
Among demographics, age, sex, residency status, and long-term care attributes have
shown statistically significant relationships with the probability of AKI. The fitted
models revealed that keeping all other attributes constant, the odds of getting diagnosed
with AKI for males over females varied between 1.35 to 1.38. The odds for older age
groups (i.e., 80 to <90 and >=90) was higher. The odds for rural residents were 24-28%
lower than the odds for urban residents. Similarly, the odds for patients in long term care
were 41-45% higher. By analyzing the comorbidity attributes in the models, we identified
that AKI was more likely to be associated with chronic kidney disease, hypertension,
diabetes, and heart failure, and chronic liver disease. Among these attributes, chronic
kidney disease, hypertension, and diabetes have shown very strong associations. The
average odds ratios for chronic kidney disease, hypertension, and diabetes patients were
1.81, 1.64 and,1.41, respectively.
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4.3.2

Medication Combinations and AKI

A medication combination was chosen for this analysis if it has been used by at least 700
patients during the study period using the eclat algorithm. The most frequent medication
combinations were Amlodipine Besylate-and-Atorvastatin Calcium (7%), Atorvastatin
Calcium-and-Metformin Hcl (6%), Atorvastatin Calcium-and-Ramipril (5%),
Amlodipine Besylate-and-Hydrochlorothiazide (5%), Atorvastatin Calcium-andHydrochlorothiazide (5%), Metformin Hcl-and-Rosuvastatin Calcium (5%), and
Hydrochlorothiazide-and-Rosuvastatin Calcium (4%).
In the next stage, we applied multivariable logistic regression on each selected
combination. We filtered the combinations based on the p-value of the medication feature
in each model. We found 78 combinations that were found to be strongly associated with
AKI among 7,748 combinations. Then, we performed a stratified analysis on the strongly
associated combinations and reported the percentage change in the odds ratio. We
identified 37 cases where a second medication is associated with increasing the risk of
developing AKI when used with another medication. Table 3 contains a filtered list of
combinations with a percentage change of more than 40%.
Table 3 shows the medication names with classes, odds ratios of models with and without
the second medication, and percentage change in odds ratios. In the stratified analysis, we
found 16 and 27 distinct classes representing the first (Base Medication column) and
second (Other Medication in Combination column) medications, respectively. The
percentage change in odds ratio had increased by 80% when Indapamide was used with
Clavulanic acid potassium or Amoxicillin. The combination of Allopurinol with
Venlafaxine Hcl or Morphine Sulfate was associated with a possible increase in the odds
of 55%. The odds of getting diagnosed with AKI increases if Alprazolam, Trandolapril,
Metformin, Clonidine Hcl, Acetaminophen & Oxycodone Hcl, or Cefuroxime Axetil is
used in combination with Furosemide. When Celecoxib, Pregabalin, or Atenolol was
used with one of the Antipsychotic medications (Quetiapine), the average change in odds
ratio was about 65%. It is interesting to note that Celecoxib (Anti-Inflammatory) was not

101

found to be associated with AKI (Table 2) when used individually but appeared to be
AKI-associated when used with Mirtazapine (Antipsychotic) or Quetiapine Fumarate
(Antidepressants).
The relationship between AKI and potential covariates (i.e., demographics and
comorbidities) in the combination models resembled the relationship of individual
models. By analyzing the regression coefficients of the combination models, we
identified patients with AKI were more likely to be men, resided in urban areas, lived in
long-term care, had chronic kidney disease, hypertension, diabetes, and heart failure. AKI
was less likely to be associated with income quintile, peripheral vascular disease, chronic
liver disease, and cerebrovascular disease.
Table 4-6: List of the individual medications sorted based on their odds
ratios.
Medication
Sunitinib Malate (Antineoplastic Miscellaneous)
Lenalidomide (Immunosuppressive Agents)
Abiraterone Acetate (Not Identified)
Metolazone (Diuretics)
Cyclosporine (Immunosuppressive Agents)
Megestrol Acetate (Progesteron Analogues)
Lithium Carbonate (Antimanic Agents)
Atropine Sulfate & Diphenoxylate Hcl (Antidiarrhea)
Furosemide (Diuretics)
Prochlorperazine Maleate (Antiemetics And Antinauseants)
Spironolactone (Diuretics (Potassium-Sparing))
Methyldopa (Centrally Acting Antiadrenergic)
Hydralazine Hcl (Vasodilator Antihypertensive Drugs)
Dexamethasone (Corticosteroids, Plain)
Ondansetron Hcl (Antiemetics And Antinauseants)
Clonidine Hcl (Centrally Acting Antiadrenergic)
Allopurinol (Xanthine Oxidase Inhibitor)
Linagliptin (Unclassified Therapeutic Agents)
Loperamide (Antidiarrhea)
Glyburide (Oral Anti-Glycemic)
Chlorthalidone (Diuretics)
Atenolol (Beta Blockers)
Acetylsalicylic Acid & Dipyridamole (Adenosine Diphosphate Inhibitors)
Olmesartan Medoxomil (Angiotensin Ii Antagonist)
Iron Ferrous Fumarate (Iron Preparations)
Quetiapine Fumarate (Antipsychotic Agents)
Nortriptyline Hcl (Tricyclic Antidepressant)
Mirtazapine (Antidepressants: Miscellaneous)
Iron Ferrous Gluconate (Iron Preparations)
Terazosin (Alpha Adrenergic Blocking Agents)
Olanzapine (Antipsychotic Agents)
Fenofibrate (Antilipemic: Fibrates)
Carvedilol (Beta-Blockers)
Doxazosin Mesylate (Alpha Adrenergic Blocking Agents)
Folic Acid (Vitamin B Complex)
Trimethoprim (Sulfonamides, Trimetroprim And Combination)
Indapamide (Diuretics)
Sulfamethoxazole (Anti-Bacterial Sulfonamide)
Moxifloxacin Hcl (Fluoroquinolones)

P-value
1.6e-09
9.4e-17
1.7e-10
1.3e-60
4.0e-06
2.6e-07
4.7e-12
3.4e-10
2.6e-133
9.1e-26
2.6e-112
4.9e-06
1.5e-26
2.4e-19
9.1e-13
3.9e-06
1.2e-81
4.1e-24
1.4e-09
1.3e-12
1.2e-18
1.23e-08
2.9e-07
7.9e-13
1.9e-39
4.4e-06
7.2e-19
2.1e-15
8.2e-16
1.5e-07
8.5e-07
3.6e-08
5.1e-09
6.6e-07
6.9e-09
8.5e-12
3.9e-08
2.1e-14
1.8e-10

Odds ratio (OR)
4.59
3.58
2.61
2.38
2.18
2.08
2.04
2
1.93
1.93
1.87
1.84
1.76
1.74
1.69
1.69
1.51
1.5
1.47
1.46
1.42
1.4
1.36
1.35
1.34
1.34
1.34
1.33
1.33
1.33
1.33
1.32
1.31
1.3
1.28
1.27
1.26
1.26
1.24

Std. error
0.25
0.15
0.15
0.05
0.17
0.14
0.1
0.11
0.02
0.06
0.03
0.13
0.05
0.06
0.07
0.09
0.02
0.04
0.06
0.04
0.06
0.02
0.06
0.04
0.02
0.03
0.06
0.04
0.04
0.05
0.06
0.05
0.05
0.05
0.04
0.03
0.03
0.03
0.04

OR’s 95% CI
2.72 - 7.37
2.62 - 4.79
1.92 - 3.48
2.14 - 2.63
1.54 - 3
1.56 - 2.72
1.66 - 2.48
1.6 - 2.46
1.87 - 2
1.7 - 2.17
1.77 - 1.97
1.4 - 2.37
1.58 - 1.95
1.54 - 1.96
1.46 - 1.94
1.4 - 2.02
1.45 - 1.57
1.38 - 1.62
1.29 - 1.66
1.34 - 1.58
1.25 - 1.59
1.06 - 1.47
1.21 - 1.53
1.24 - 1.46
1.29 - 1.4
1.26 - 1.43
1.18 - 1.51
1.24 - 1.43
1.24 - 1.43
1.19 - 1.48
1.18 - 1.48
1.19 - 1.46
1.19 - 1.43
1.17 - 1.43
1.18 - 1.39
1.19 - 1.36
1.19 - 1.33
1.18 - 1.35
1.15 - 1.34
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Nifedipine (Calcium Blockers)
Lisinopril (Ace Inhibitors)
Gabapentin (Gamma-Aminobutyric Acid (Gaba) Derivatives)
Oseltamivir Phosphate (Antiviral Agents - Influenza Virus Specific)
Metoprolol (Beta-Blockers)
Donepezil Hcl (Cholinesterase Inhibitors)
Gliclazide (Oral Anti-Glycemic)
Hydrochlorothiazide (Diuretics)
Metoprolol Tartrate (Beta-Blockers)
Amlodipine Besylate (Calcium Blockers)
Valsartan (Angiotensin Ii Antagonist)
Digoxin (Digitalis Preparations)
Bisoprolol Fumarate (Beta-Blockers)
Senna (Cathartics and Laxatives)
Ramipril (Ace Inhibitors)
Metformin Hcl (Oral Anti-Glycemic)

3.3e-06
5.1e-06
7.6e-09
1.1e-10
6.4e-11
1.9e-08
3.7e-11
1.9e-18
1.7e-21
2.4e-06
3.1e-11
1.85e-06
9.9e-08
1.7e-09
9.7e-15
1.8e-11

1.21
1.21
1.2
1.2
1.19
1.18
1.17
1.16
1.16
1.15
1.15
1.15
1.14
1.14
1.13
1.1

0.03
0.04
0.03
0.04
0.03
0.03
0.03
0.02
0.02
0.02
0.03
0.03
0.02
0.02
0.02
0.02

1.14 - 1.28
1.12 - 1.31
1.13 - 1.27
1.11 - 1.3
1.12 - 1.25
1.11 - 1.25
1.12 - 1.23
1.12 - 1.2
1.11 - 1.21
1.12 - 1.19
1.09 - 1.21
1.09 - 1.22
1.1 - 1.18
1.08 - 1.19
1.09 - 1.17
1.06 - 1.14

Table 4-7: List of the medication combinations sorted based on their
percentage change in odds ratios.
Clavulanic Acid Potassium (Penicillins)
Amoxicillin (Penicillins)
Alprazolam (Benzodiazepine Derivatives)

Base Odds
Ratio
1.24
1.24
1.86

Comb Odds
Ratio
2.22
2.21
3.27

%Chg in
Odds Ratio
79.00
78.27
75.86

Indapamide (Diuretics)

1.16

2.00

72.77

1.31

2.27

72.41

1.32

2.26

70.79

1.27

2.13

67.49

Perindopril Tert.Butylamine (Ace Inhibitors)

1.22

2.02

66.03

Amitriptyline Hcl (Tricyclic Antidepressant)

1.15

1.90

65.96

Bupropion Hcl (Antidepressants)

1.33

2.21

65.63

Lorazepam (Benzodiazepine Derivatives)

1.25

2.06

64.85

Trandolapril (Ace Inhibitors)
Donepezil Hcl (Cholinesterase Inhibitors)
Venlafaxine Hcl (Selective Serotonin Reuptake
Inhibitors - Other)

1.86
1.24

3.01
2.00

61.77
61.77

1.49

2.41

61.65

Base Medication

Other Medication in Comb.

Indapamide (Diuretics)
Indapamide (Diuretics)
Furosemide (Diuretics)
Donepezil Hcl (Cholinesterase
Inhibitors)
Mirtazapine (Antidepressants:
Miscellaneous)
Quetiapine Fumarate (Antipsychotic
Agents)
Nortriptyline Hcl (Tricyclic
Antidepressant)
Doxazosin Mesylate (Alpha
Adrenergic Blocking Agents)
Metoprolol Tartrate (Beta-Blockers)
Iron Ferrous Fumarate (Iron
Preparations)
Nortriptyline Hcl (Tricyclic
Antidepressant)
Furosemide (Diuretics)
Indapamide (Diuretics)
Allopurinol (Xanthine Oxidase
Inhibitor)
Terazosin (Alpha Adrenergic Blocking
Agents)
Fenofibrate (Antilipemic: Fibrates)
Terazosin (Alpha Adrenergic Blocking
Agents)
Lithium Carbonate (Antimanic
Agents)
Spironolactone (Diuretics (PotassiumSparing))
Allopurinol (Xanthine Oxidase
Inhibitor)
Iron Ferrous Fumarate (Iron
Preparations)
Folic Acid (Vitamin B Complex)
Dexamethasone (Corticosteroids,
Plain)
Quetiapine Fumarate (Antipsychotic
Agents)
Dexamethasone (Corticosteroids,
Plain)
Metoprolol (Beta-Blockers)
Ondansetron Hcl (Antiemetics And
Antinauseants)
Furosemide (Diuretics)
Quetiapine Fumarate (Antipsychotic
Agents)

Celecoxib (Non-Steroidal Anti-Inflammatory: NonAsa Base)
Celecoxib (Non-Steroidal Anti-Inflammatory: NonAsa Base)
Acetaminophen & Oxycodone Hcl (Analgesics And
Antipyretics: Miscellaneous)

Irbesartan (Angiotensin Ii Antagonist)

1.27

2.03

59.84

Candesartan Cilexetil (Angiotensin Ii Antagonist)

1.27

2.02

58.17

Pantoprazole Sodium (Proton Pump Inhibitors)

1.25

1.97

57.23

Atorvastatin Calcium (Antilipemic: Statins)

1.84

2.86

55.79

Clonazepam (Benzodiazepine Derivatives)

1.85

2.81

52.26

Morphine Sulfate (Narcotics: Opiate Agonists)

1.50

2.26

50.77

1.33

2.01

50.75

1.22

1.82

49.59

1.67

2.49

49.42

Pregabalin (Anticonvulsants: Miscellaneous)

1.32

1.95

47.67

Meloxicam (Non-Steroidal Anti-Inflammatory: NonAsa Base)
Hydrochlorothiazide (Diuretics)
Gabapentin (Gamma-Aminobutyric Acid (Gaba)
Derivatives)

Ramipril (Ace Inhibitors)

1.69

2.48

46.97

Omeprazole (Proton Pump Inhibitors)

1.17

1.71

46.70

Ranitidine Hcl (Histamine H2 Receptor Antagonist)

1.62

2.37

46.49

Metformin (Oral Anti-Glycemics)

1.86

2.69

44.56

Atenolol (Beta-Blockers)

1.32

1.90

43.70

103

Iron Ferrous Fumarate (Iron
Preparations)
Spironolactone (Diuretics (PotassiumSparing))
Spironolactone (Diuretics (PotassiumSparing))

Metformin (Oral Anti-Glycemics)

1.34

1.91

43.05

Candesartan Cilexetil (Angiotensin Ii Antagonist)

1.84

2.62

42.47

Enalapril Sodium (Ace Inhibitors)

1.86

2.61

40.83

Furosemide (Diuretics)

Acetaminophen & Oxycodone Hcl (Analgesics and
Antipyretics: Miscellaneous)

1.85

2.60

40.35

Dabigatran Etexilate (Anticoagulants Miscellaneous)

1.85

2.60

40.22

Clonidine Hcl (Centrally Acting Antiadrenergic)
Cefuroxime Axetil (Cephalosporin)

1.86
1.86

2.61
2.61

40.11
40.02

Spironolactone (Diuretics (PotassiumSparing))
Furosemide (Diuretics)
Furosemide (Diuretics)

4.4 Discussion
In this study, we demonstrated how machine learning techniques could help with the
identification of potentially nephrotoxic medications using administrative health
databases housed in ICES. Nephrotoxic medications are responsible for about 20% of
episodes of AKI, and the rate of medication-induced nephrotoxicity leading to AKI
among older patients is approximately 66% (Kohli et al., 2000; Peres and da Cunha,
2013). We have presented methods for identifying medications and medication
combinations that are associated with AKI using regression and frequent itemset mining
algorithms. We found that 9% of all the prescribed medications were possibly associated
with AKI by analyzing the medication data of one million older patients included in our
study. Our analysis identified Angiotensin II Receptor Blockers, Antibacterial Agents,
Diuretics, Iron Preparations, Nonsteroidal Anti-inflammatory Drugs, and Xanthine
Oxidase Inhibitors as medication classes that were significantly associated with AKI. In a
recent study of the French national pharmacovigilance database, Pierson-Marchandise et
al. (2017) found that the majority of cases of medication-induced AKI were related to
Antibacterial Agents, Antineoplastic Agents, Diuretics, Anti-inflammatory Drugs, and
agents acting on the Renin-angiotensin system (Pierson-Marchandise et al., 2017). A
similar conclusion was reached by a study of nursing home residents where Ace
Inhibitors, Angiotensin II receptor Blockers, Antibiotics, and Diuretics were identified as
the primary medication classes responsible for developing AKI.
Our study aimed to investigate how individual medication analysis results were
consistent with what has been found in previous studies. We first reviewed the results
with a nephrologist and learned that most of the statistically significant medications
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(Table 2) were already known to be associated with AKI, which confirmed the accuracy
of our findings. We also conducted an electronic literature search to find the research
papers that studied the relationships between these medications and AKI. To ensure that
relevant papers were not missed in our search, we used a relatively large set of keywords.
We used two sets of keywords. The first set represented the medication, and the second
was concerned with AKI. For the second set, we used the following terms: "AKI", "acute
kidney injury", " acute renal failure", "acute phosphate nephropathy", "acute prerenal
failure", and "anuria". All the studies included in this literature search were published
from 1995 till 2019. We found evidence through the literature search that confirmed the
association between 38 individual medications (among 55 statistically significant
medications) and AKI, which more comprehensively proved the efficacy of our study.
To explain the results of individual medication analysis, we divided the identified
medications into two main groups— known and likely-confounded. The medications that
belong to the first group were already known to be associated with AKI. The
relationships between AKI and these medications have previously been studied in the
literature. The likely-confounded group contained medications that were not yet proven
to be AKI-inducing. They were used to treat conditions that are associated with AKI,
included in studies with kidney function, or not studied before. There is a lack of
evidence regarding the association between AKI and some of these medications, such as
Prochlorperazine Maleate and Terazosin. The complete list of medications that are
divided into these groups is shown in Table 4. Out of 55 medications, there were 38
medications in the known group and 17 medications in the likely-confounded group. The
key finding of the individual medication analysis was the list of medications included in
the likely-confounded group. These medications can be suitable candidates for clinical
drug-safety studies to investigate this potential association.
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Table 4-8: The list of statistically significant medications from individual analysis
divided into three groups.
Known
Furosemide(Bove et al., 2018; K. M. Ho and Power, 2010)
Allopurinol (Alirezaei et al., 2017; Perez-Ruiz, 2017)
Amlodipine(Pierson-Marchandise et al., 2017; Saruta et al., 1995)
Hydrochlorothiazide (Pierson-Marchandise et al., 2017).
Iron Ferrous Fumarate (Leaf and Swinkels, 2016)
Spironolactone(Juncos and Juncos, 2016)
Bisoprolol(Pierson-Marchandise et al., 2017)
Atenolol(Fleet et al., 2014)
Metoprolol (Fleet et al., 2014)
Valsartan(Lopau et al., 2001)
Indapamide(Pierson-Marchandise et al., 2017).
Nifedipine(Mishima et al., 2017)
Iron Ferrous Gluconate(Leaf and Swinkels, 2016)
Quetiapine(Yamada et al., 2018)
Gabapentin (Miller and Price, 2009)
Linagliptin(Nandikanti et al., 2016)
Glyburide (McCoy et al., 2010)
Lenalidomide(Lipson et al., 2010)
Trimethoprim(Pierson-Marchandise et al., 2017).
Olmesartan Medoxomil(Georgaki-Angelaki et al., 2009)
Ramipril(Pierson-Marchandise et al., 2017).
Gliclazide(Pierson-Marchandise et al., 2017).
Atropine Sulfate (Pierson-Marchandise et al., 2017).
Folic Acid(Gupta et al., 2012)
Chlorthalidone(Peskoe et al., 1978)
Clonidine Hcl(Allison, 2015)
Fenofibrate(Pierson-Marchandise et al., 2017).
Dipyridamole(Puri et al., 2016)
Olanzapine(Hwang et al., 2014)
Digoxin(Pierson-Marchandise et al., 2017).
Lisinopril(Pierson-Marchandise et al., 2017).
Methyldopa(Perazella, 2015)
Oseltamivir Phosphate(Watanabe et al., 2014)
Metolazone(Sean M. Bagshaw et al., 2007; Rp, 2019; Shulenberger et al.,
2016)
Cyclosporine(Bennett, 2013)
Dexamethasone(Jacob et al., 2015; Kumar et al., 2009)
Moxifloxacin Hcl(Bird et al., 2013)
Sulfamethoxazole(Pierson-Marchandise et al., 2017)

Likely-confounded
Hydralazine Hcl(Sari, 2019)
Ondansetron Hcl(Aamdal, 1992)
Lithium Carbonate(Sari, 2019)
Bisoprolol Fumarate(J. Liu et al., 2019)
Abiraterone Acetate(Neyra et al., 2015)
Sunitinib Malate(Jha et al., 2013)
Carvedilol(Dupont, 1992)
Donepezil Hcl(Erbayraktar et al., 2017)
Acetylsalicylic Acid (Sari, 2019)
Mirtazapine(Dev et al., 2014)
Loperamide(Mackowski et al., 2015)
Doxazosin Mesylate(Mori et al., 2001)
Senna(Vanderperren et al., 2005)
Megestrol Acetate(Boccanfuso et al.,
2000; Rammohan et al., 2005)
Nortriptyline(Dawlilng et al., 1981)
Terazosin
Prochlorperazine Maleate

Through the medication combination analysis, we found that out of 25 thousand patients
with AKI in our dataset, about 85% were prescribed multiple medications within 120
days prior to the index date. The incidence rate of developing AKI is usually higher
among patients who are prescribed multiple medications. For instance, in a study of
38,782 adverse drug reaction events, out of 1,254 reported AKI cases, about 66%
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included two or more concomitantly prescribed medications (Pierson-Marchandise et al.,
2017). Another study suggested that there were statistically significant associations
between the duration of simultaneous medication use and the development of AKI
(Chang et al., 2012). Similarly, a study of Taiwan's National Health Insurance system
showed that the concurrent use of certain medication classes (such as Diuretics, Beta
Blockers, Calcium Channel Blockers, Alpha Blockers, Ace Inhibitors, Digoxin, and
Platelet Aggregation Inhibitors) was strongly associated with the development of AKI
(Chao et al., 2015). In order to compare our findings with the existing literature, we
discussed the results of medication combination analysis using medication classes since
most of the previous studies presented their results this way. As shown in Table 3, some
of the AKI-associated combinations are Alpha Adrenergic Blocking Agents-and-Ace
Inhibitors, Corticosteroids-and-Ace Inhibitors, Diuretics-and-Ace Inhibitors, PotassiumSparing Diuretics -and-Ace Inhibitors, Diuretics-and-Analgesics and Antipyretics,
Tricyclic Antidepressant-and-Analgesics and Antipyretics, Alpha Adrenergic Blocking
Agents-and-Angiotensin II Antagonist, and Antilipemic: Fibrates-and-Angiotensin II
Antagonist. We have identified that using a combination of Diuretics with some specific
medication classes are associated with increasing the risk of developing AKI. In line with
our findings, the effect of using Diuretics with Renin Angiotensin Aldosterone System
Agents, Ace inhibitors, or Penicillin on AKI has been investigated in several research
studies (Adhiyaman et al., 2001; Audia et al., 2008; Fournier et al., 2014, 2012; Loboz
and Shenfield, 2005; Steinhäuslin et al., 1993; Wu et al., 2014).
In order to verify the results of the medication combination analysis, we compared our
findings with a recent study (Rivosecchi et al., 2016). In their study, Rivosecchi et al.
identified 76 unique combinations of medication classes that were associated with AKI
by assessing 2,139 citations. Overall, 73.7% of selected medication classes were
categorized as very low quality, 15.8% were of low quality, and 10.5% were considered
medium quality. We found that our results are consistent with the studies included in this
literature review. It is important to note that there were 19 medications in our study that
were not statistically significant individually but were found to be strongly associated
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with AKI when used with another medication (Table 2 and Table 3). There are also a few
combinations of medication classes in our study, such as Antipsychotic Agents and Antiinflammatory, Diuretics and Xanthine Oxidase Inhibitor, to name a few, which have been
studied individually but there is a lack of evidence in the literature on how these
combinations are associated with AKI (Dixit et al., 2010; Gois et al., 2016; Jiang et al.,
2017; Karajala et al., 2009; Zhang et al., 2017). Clinical drug-safety studies need to be
conducted to confirm these medication-medication interactions.
The main strength of the study presented in this paper was its exhaustive analysis of
medication usage patterns of the one million hospitalized patients within a 120-day lookback window. It is noteworthy that all the patients were elderly (65 years or older),
suffering from multiple diseases and taking several potentially nephrotoxic medications.
We included most of the frequently prescribed medications and investigated all possible
combinations among these medications in our study. Next, to assess the true impact of
medications on AKI, we incorporated the patients' demographic and comorbidity features
as covariates in the regression analysis. In addition, we performed a stratified analysis to
investigate the synergistic effect of medication combinations on AKI, which made our
study more comprehensive and unique in comparison to other studies. To our knowledge,
this study introduced a novel analysis technique by integrating frequent itemset mining,
regression, and stratification to identify medications and combinations that can
potentially be associated with AKI.
This research also demonstrates how machine learning can be used to address a wellknown problem in the medical domain. It highlights what needs to be considered when
designing studies that are intended to incorporate machine learning techniques to support
data-driven tasks using health administrative datasets.

4.5 Limitations
Our study has some limitations. First, our results can only be generalized to the elderly,
as we only had complete medication data on those aged 65 and older. Second, our study

108

population might have included clinically unstable patients who were admitted to the
hospital or emergency department. This could be a confounding factor as clinically
unstable patients are more likely to take multiple concomitant medications, increasing
their chances of developing AKI. Third, our findings can only be generalized to the
population of Ontario since the models were derived and validated in cohorts from
hospitals in Ontario. Lastly, there could be multiple reasons for which a patient is
prescribed with medication, and these reasons may lead to the development of AKI rather
than the medication itself. The study was designed to assist healthcare researchers at the
ICES-KDT program in identifying potential candidates for their future medication-safety
studies. This is not a confirmatory analysis, and proper clinical studies are required to
confirm the findings.

4.6 Conclusion
Medication-induced nephrotoxicity is one of the major causes of AKI worldwide. In the
present study of the ICES database, we identify the individual medications and
medication combinations that are potentially associated with AKI by applying a
combination of regression and frequent itemset mining techniques to this field for the
first time. We have shown that our results are consistent with previous studies throughout
this paper. Although most of the medications that we identify are already known to be
associated with AKI, some of them have not been thoroughly studied yet. Our findings
would raise awareness to conduct clinical research on these potentially nephrotoxic
medications. Attention should be directed at avoiding nephrotoxic treatments when an atrisk situation is identified to reduce the chance of patients developing AKI. This requires
not only careful monitoring by prescribers but also comprehensive studies on these
medications. Ongoing research in this field might provide us with more reliable methods
in the detection of potentially nephrotoxic medications and their combinations, thus
allowing timely intervention to prevent AKI. This research will help machine learning
researchers to understand what needs to be considered when designing studies that are
intended to incorporate machine learning methods to accomplish various data-driven
tasks using healthcare datasets.
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Chapter 5

5

Visual Analytics for Dimension Reduction and Cluster
Analysis of High Dimensional Electronic Health
Records

This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, A.X. Garg,
and E. McArthur, “Visual Analytics for Dimension Reduction and Cluster Analysis of
High Dimensional Electronic Health Records” in the Health Section of the Informatics
Journal, Volume 7; May 2020. We changed the format to match the general format of the
dissertation. Figure, Table, and Section numbers specified herein are relative to the
chapter number. For example, “Table 1” corresponds to Table 5-1; “Figure 1”
corresponds to Figure 5-1; and “Section 1.1” corresponds to Section 5.1.1. Moreover,
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter.

5.1 Introduction
The increasing use of EHR-based (Electronic Health Record) systems in healthcare has
resulted in generating data at an unprecedented rate in recent years (Caban and Gotz,
2015; Murdoch and Detsky, 2013). EHR data includes, but is not limited to, medical and
demographic records, healthcare administrative records, and results of laboratory tests
(Cowie et al., 2017). The complex, diverse, and growing information available in EHRs
creates promising opportunities for the healthcare providers to drastically improve the
healthcare system (Kamal, 2014; Murdoch and Detsky, 2013). It is often challenging for
healthcare providers to keep pace with the large volumes of heterogeneous data stored in
EHRs (Rind et al., 2019). Automated data analysis techniques based on data mining and
machine learning hold great promise to fulfill the computational requirements of EHRs
(Marlin et al., 2012; Wetzel, 2001). There are currently a variety of efforts underway to
organize, analyze, and interpret EHRs using unsupervised machine learning techniques
such as clustering (Estiri et al., 2019; Foguet-Boreu et al., 2015; Haraty et al., 2015;
Khalid et al., 2018; Liao et al., 2016; Marlin et al., 2012).
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Cluster analysis (CA) can be used to discover hidden patterns in EHRs by grouping
entities (e.g., patients, medications) with similar features into homogenous groups (i.e.,
clusters) while increasing heterogeneity across different groups (Dilts et al., 1995;
McLachlan, 1992). It divides data into meaningful, useful, and natural groups without
prior knowledge of the labels or nature of the groupings. With the large amount of
unlabeled data stored in EHRs, CA has the potential to characterize medical records into
meaningful groupings. Several studies have been conducted that employ different
clustering techniques to identify multimorbidity patterns (Foguet-Boreu et al., 2015),
implausible clinical observations (Estiri et al., 2019), and risk factors for a disease (Doust
and Walsh, 2011). Despite the effectiveness of using CA in analyzing EHRs, it suffers
from a problem which has been referred to as the “curse of dimensionality”. This
problem arises when the dataset is high-dimensional (i.e., has more than 1000 features), a
very common occurance in EHRs (Ruan et al., 2019). In such situations, the output of CA
is not reproducible and meaningful since variances among data elements become sparse
and large (Adachi, 2017; Ronan et al., 2016). One solution is to employ dimensionality
reduction (DR) techniques that can potentially reduce the number of features to a
manageable size before using CA (Mitsuhiro and Yadohisa, 2015).
DR refers to the transformation of the original high-dimensional dataset into a new
dataset with reduced dimensionality without loss of much information (Siwek et al.,
2013). DR techniques are developed based on the idea that most high-dimensional
datasets contain overlapping information (Wilke, 2019). DR techniques can be used to
improve the performance of CA by removing multicollinearity and creating a smallvolume dataset. Many recent studies have combined techniques from both CA and DR to
find similarity among data elements and form meaningful groups (Wenskovitch et al.,
2018). Despite the fact that a combination of DR and CA can result in efficient
processing time and better interpretability, a number of complicated decisions need to be
made when using techniques from both families (i.e., CA and DR) (Sembiring et al.,
2011). For instance, when applying CA, it is important to consider which technique and
distance measure to use, which features and samples to include, and what granularity to
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seek (Demiralp, 2017). Similarly, one needs to determine the optimal values for the
configuration parameters when using a DR technique (Halpern et al., 2012).
Consequently, combining these techniques results in more complicated problems. Given
a wide range of techniques for DR and CA, determining which combination of techniques
of CA and DR techniques leads to the desired results is not straightforward (Wenskovitch
et al., 2018). Moreover, the intermediary steps of the analysis processes of CA and DR
are often hidden from users, making it difficult to choose optimal values for the
configuration parameters (Yoo et al., 2012). Therefore, one of the challenges of using
these techniques lies with their lack of transparency and interpretability, hence limiting
their application in EHR-based systems.
In order to address this issue, analysis processes can be made accessible to users through
interactive visualizations. Interactive visualizations provide users with an overview of the
data while at the same time enabling them to access, restructure, and modify the amount
and form of displayed information (D. A. Keim et al., 2010; Thomas and Cook, 2005).
They allow exploration of the visualized data to answer user-initiated queries (Sedig and
Parsons, 2013). In recent years, several EHR-based visualization systems have been
developed to support healthcare providers in performing various user-driven activities
(Rind et al., 2011b). Although users are often good at visually perceiving the overall
structure of the data, it is difficult for them to extract meaningful patterns from
visualization systems when the data is large and high-dimensional. Most of these systems
can only represent a limited number of features within the data due to the limited real
estate space on display devices (Aimone et al., 2013; Faisal et al., 2013; Kosara and
Miksch, 2002; Lavado et al., 2018). Another issue with visualization systems is that they
do not incorporate analytical processes, hence falling short in fulfilling the computational
demands of EHRs. Thus, an integrated approach may be needed in which automated
analysis techniques (i.e., DR and CA) and user interfaces that facilitate interaction with
visualizations of data (i.e., interactive visualizations) are coupled together.
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Visual analytics fuses the strengths of analysis techniques and interactive visualizations
to allow users to explore data interactively, identify patterns, apply filters, and manipulate
data as required to achieve their goals (Parsons et al., 2015; Saffer et al., 2004; A. F.
Simpao et al., 2014). This process is more complicated than an automated internal
analysis coupled with an external visual representation to show the results of the analysis.
It is both data-driven and user-driven and requires re-computation when users manipulate
the data through the visual interface (Ola and Sedig, 2014).
The purpose of this study is to demonstrate how visual analytics systems can be designed
in a systematic way to analyze the large-scale high-dimensional data in EHRs. To this
end, we present a novel system that we have developed, called VALENCIA—Visual
Analytics for Cluster Analysis and Dimension Reduction of High Dimensional Electronic
Health Records. VALENCIA is intended to assist healthcare providers at ICES-KDT
(ICES - an independent, non-profit, world-leading research organization that uses
population-based health and social data to produce knowledge on a broad range of
healthcare issues; KDT - Kidney Dialysis and Transplantation program), located in
London, Ontario, Canada. This visual analytics system allows users to choose from
multiple DR and CA techniques with different configuration parameters, combine these
techniques, and compare analysis results through interactive visualizations. We
demonstrate the usefulness of this system by investigating the process of analyzing the
health administrative data housed at ICES to gain novel and deep insights into the data
and tasks at hand while at the same time identifying the most appropriate combination of
analysis techniques. While few visual analytics systems have been developed for
different areas in healthcare (Choo et al., 2013; Demiralp, 2017; Klimov et al., 2015;
Ninkov and Sedig, 2019; Stasko et al., 2008; Wise, 1999), VALENCIA is novel in that it
integrates a number of DR and CA techniques, real-time analytics, data visualization, and
human-data interaction mechanisms in a systematic way. As such, the design concepts of
VALENCIA can be generalized for the development of other visual analytics systems
that deal with high-dimensional datasets in other domains (e.g., insurance, finance, and
bioinformatics, to name a few).
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The rest of this paper is organized as follows. Section 2 provides an overview of the
conceptual and terminological background to understand the design of VALENCIA.
Section 3 briefly describes other visual analytics systems that are related to VALENCIA.
Section 4 explains the methodology employed for the design of the proposed system by
describing its structure and components. Section 5 presents a usage scenario of
VALENCIA to illustrate the usefulness of the system. Finally, Section 6 discusses
conclusions and some future areas of application.

5.2 Background
This section presents the necessary terminology and concepts for understanding the
design of VALENCIA. First, we describe the components of visual analytics. Afterwards,
we briefly describe the processes of DR and CA. Finally, the healthcare stakeholders
subsection introduces intended users of the system.

5.2.1

Visual Analytics

Visual analytics combines advanced analytics techniques with visual representations to
analyze, synthesize, and facilitate high-level cognitive activities while allowing users to
get more involved in discourse with the data (D. A. Keim et al., 2010; Thomas and Cook,
2006). The information processing load of visual analytics is distributed between users
and the main components of the system—namely, the analytics and interactive
visualization engines (Cui, 2019; Jeong et al., 2015; D. Keim et al., 2010b; Ola and
Sedig, 2014; Parsons and Sedig, 2014; Sedig and Parsons, 2013). The analytics engine
deals with the analysis of the data and carries out most of the computational load. The
interactive visualization engine incorporates visual representations to amplify human
cognition when working with the data (Sears and Jacko, 2007; Sedig and Parsons, 2016).
Human cognition is limited when confronted with data-intensive tasks, especially when
the data is high-dimensional and complex (Green and Maciejewski, 2013; Ola and Sedig,
2014). The analytics engine of the system incorporates techniques from different fields
such as statistics, machine learning, and data mining to support human cognition in such
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situations. Although the analytics engine carries out the majority of the computational
load of the system, users are responsible for controlling the configuration parameters and
internal steps of the analysis. The main responsibility of the analytics engine is to store,
pre-process, transform, and analyze the data. This process can be divided into three
stages: data pre-processing, data transformation, and data analysis (Ola and Sedig, 2014).
The pre-processing stage is responsible for preparing raw data from different sources,
which includes procedures such as cleaning, integration, and reduction (Han et al., 2011).
Next, in the transformation stage, the pre-processed data is transformed into forms
suitable for analysis (Kusiak, 2001). The transformation stage includes procedures such
as smoothing, aggregation, feature generation, discretization, and normalization (Han and
Kamber, 2011). Finally, in the data analysis stage, various statistical and machine
learning techniques are applied to the transformed data to discover hidden patterns among
data items and extract implicit, novel, and useful information (Agrawal et al., 1993; Sahu
et al., 2008). Most of these techniques are intended for users with significant experience
and do not allow proper exploration of the intermediary steps and computed results.
Visual analytics addresses these issues by incorporating interactive visualization in the
human-in-the-loop process.
The interactive visualization engine provides users with the ability to change the
displayed data, filter the subset of the information displayed, tune the configuration
parameters of the analysis techniques, and control the intermediary steps of the analytics
engine. This, in turn, sets off a chain of reactions that will result in the execution of
additional data analysis processes. Despite the benefits of interactive visualizations in
enhancing the cognitive needs of users, they prove inadequate when faced with problems
requiring heavy computations (Ola and Sedig, 2014). Another challenge is to determine
how to organize a large number of data items in visual representations, especially when
the data is high-dimensional. Therefore, an integrated approach that combines data
analysis with interactive visualizations through visual analytics is more suitable for a
comprehensive exploration of high-dimensional EHR data (Kehrer and Hauser, 2013;
Keim et al., 2008).
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5.2.2

Dimension Reduction

Most of the high-dimensional EHR datasets consist of multiple correlated features that
offer overlapping data (e.g., most of the diabetes patients use similar medications). DR
techniques can be used on such datasets to reduce dimensions without losing much
information. This has long been one of the leading research topics in statistics, data
mining, and machine learning (Sorzano et al., 2014). In addition to data analysis, DR
techniques have been widely used in visualization research due to their ability to
represent high-dimensional datasets in a low-dimensional space (Cook et al., 2007, p. 1;
Fujiwara et al., 2020; Hege et al., 2009; Xin Geng et al., 2005). For instance, it is possible
to transform a high-dimensional comorbidity dataset into a dataset with reduced
dimensions to represent it in a scatter plot where relative positions among coordinates
indicate the pairwise relationships among the transformed dimensions.
There are many DR techniques in the literature. Each DR technique has its own set of
parameters, optimization criteria, and behaviours, which in turn affects data types and
tasks that the technique supports. Different DR techniques should be represented using
different types of visual representations because the internal mechanisms of these
techniques are dissimilar. DR techniques can be broadly categorized into two groups:
supervised and unsupervised (Cunningham, 2008). Most of the unsupervised DR
techniques only consider the pairwise relationships among data items. Thus, the
generated lower-dimensional projection can be represented in a cartesian-coordinatebased visualization. On the other hand, supervised techniques take into account additional
information about the cluster structure of the data items. Therefore, supervised DR
techniques require the class labels associated with cluster structure to obtain a lowdimensional projection of the original data.
In many existing visual analytics systems, DR techniques have been used as a
preprocessing step to prepare the data for traditional machine learning methods that work
well with a lower number of features (Mitsuhiro and Yadohisa, 2015; Obaid et al., 2019;
Yan et al., 2006). A number of DR techniques are incorporated in our proposed system to
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help users understand the high-dimensional EHR data better and prepare the data for CA.
Since the cluster structure and/or class labels are not available at the initial stage, we only
incorporate unsupervised DR techniques in VALENCIA.

5.2.3

Cluster Analysis

CA can be instrumental in retrieving the cluster structure information from the
transformed dimensions. It is a machine learning method that partitions data items with
similar characteristics into groups called clusters. When CA is applied on a dataset
containing comorbidities data, it creates different patient groups/clusters each having
similar comorbid conditions. The groups formed by CA offer valuable insights into the
data. In the above example, if a patient with an unknown comorbidity profile belongs to a
cluster where diabetes and hypertension are common, there is a high chance for that
patient to have those conditions. Moreover, CA results can be used to create an additional
categorical feature to improve the performance of the data mining methods. Furthermore,
CA has the potential to add significant value to visual analytics systems by offering a
visual understanding of natural groupings of data items in the dataset (Choo et al., 2013;
Demiralp, 2017).
The overall goal of CA is to determine the similarity between data items. There are
different ways to measure similarity. Accordingly, CA techniques can be divided into
four categories: connectivity, centroid, distribution, and density techniques
(Kameshwaran and Malarvizhi, 2014). When data items are placed in a data space,
connectivity techniques assume that items closer to each other exhibit more similarity
than items that are farther away. Centroid techniques determine the similarity of data
items by measuring closeness to the centroids using an iterative approach. Distribution
techniques are based on the assumption that all data items in the same cluster share a
common distribution (e.g., normal, gaussian, to name a few). Finally, density-based
techniques analyze the density of the data items in a data space and group different
density regions into clusters.
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Each CA technique has its own set of configuration parameters, optimization criteria, and
behaviours, which affects its performance for different datasets. Our goal in the design of
VALENCIA is to assist users explore high-dimensional EHR data from different
perspectives and identify the best CA technique that fits their needs. Thus, we incorporate
at least one CA technique from each category (i.e., connectivity, centroid, distribution,
and density) in our proposed system.

5.2.4

Healthcare Stakeholders

For the purposes of this study, we characterize stakeholders as those people who are
integrally involved in the healthcare system to provide different services, such as medical
practitioners, clinical researchers, and so on. With the growth of healthcare organizations,
the interrelationship among healthcare stakeholders is getting complex (Davis, 2019).
Irrespective of their field of expertise, stakeholders interact with EHRs at some level to
perform numerous tasks to achieve novel healthcare solutions. For instance, medical
practitioners use the historic treatment plan data to forecast the progress of treatments
(Soyiri and Reidpath, 2013), or clinical researchers develop frameworks to discover
temporal knowledge from healthcare administrative data (Klimov et al., 2015). To
support complex, data-driven tasks, EHR data require some initial analysis to allow
healthcare stakeholders to get insight into the distribution of the data and understand
relationships among data items. The initial analysis may include preprocessing and
compression of high-dimensional data to make it ready for other machine learning and
statistical methods. Because of their lack of support for interactive visualizations,
particularly when dealing with high-dimensional data, it is often difficult to do the abovementioned task with conventional data analysis systems (i.e., R, SAS, Weka, to name a
few). VALENCIA is designed to assist healthcare stakeholders at the ICES-KDT
program (i.e., clinicians, scientists, epidemiologists, and analysts) to be able to explore
and analyze healthcare administrative data housed at ICES.
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5.3 Related work
In this section, we discuss some of the available visual analytics systems. There are not
too many EHR-based systems that adopt DR and/or CA techniques. Thus, we include any
visual analytics systems that incorporate DR and/or CA techniques in this section. In
addition, we provide a brief overview of visual analytics systems that are designed for
EHRs, whether they are tied to DR/CA or not. This section is divided into four parts:
ones using DR, CA, both DR and CA, and EHR.

5.3.1

DR-Based Visual Analytics Systems

GGobi19 (Cook et al., 2007) is a visual analytics system that uses a DR technique called
grand tour (Asimov, 1985) to represent encoded high-dimensional data. The advantage of
this technique in comparison with other DR techniques is that it supports exploration of
the high-dimensional space by allowing users to continuously modify the basis vectors
into which data items are mapped. However, the grand tour technique can only be used
when the data is not very high-dimensional. Because of this limitation, the application of
GGobi19 is restricted when dealing with a very large number of dimensions which is
often the case in EHRs. Another visual analytics system that uses a DR technique
(specifically, PCA) to represent high-dimensional data is iPCA (Hege et al., 2009). The
use of DR on high-dimensional data often results in significant information loss. iPCA
offers a solution to this problem by introducing the idea of reducing the dimensions to an
intermediary size and visualizing them using parallel coordinates plot. Thus, iPCA allows
exploration of reduced dimensional data without loss of much information from the
original dataset. It can also help users get a better understanding of the role of the reduced
dimensions by visualizing the PCA basis vectors. Praxis (Cavallo and Demiralp, 2018) is
another system that allows users to change the input and output of DR techniques
dynamically and observe these changes through interactive visualizations. Praxis
implements PCA and a number of autoencoder-based DR techniques. TimeCluster (Ali et
al., 2019) is another system that incorporates DR, deep convolutional auto-encoder,
scatter plot, and time-series graph to analyze large time-series data. It allows users to
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compare the results of multiple DR techniques visually. Although most of these systems
are designed to assist users in exploring high-dimensional data using DR, they only
include a limited number of DR techniques. Moreover, some of these systems, such as
GGobi19 and iPCA do not support exploration of very high-dimensional data because
they visualize the features of the original data along with the results of DR.

5.3.2

CA-Based Visual Analytics Systems

The Hierarchical Clustering Explorer (HCE) (Seo and Shneiderman, 2003) allows users
to explore the results of CA of gene expression data using dendrograms and heatmaps.
Although it enables users to visually compare the results of CA, it only supports
hierarchical clustering techniques. Similar to the HCE, Matchmaker (Lex et al., 2010)
allows users to arrange and compare multiple clusters simultaneously using heatmaps and
parallel coordinates. It shows raw data along with the clustering results. ClusterSculptor
(Nam et al., 2007) is a visual analytics system that uses k-means as the clustering engine
to aid users in the derivation of classification hierarchies. Although it allows users to tune
the configuration parameters through an interactive visual interface, it does not support
any other clustering techniques. iGPSe (Ding et al., 2014) is another system that is
designed to visually compare the results of clustering of different expression data types
using parallel sets. It allows users to investigate which features are shared between
multiple clusters from two different CA techniques. Both iGPSe and HCE have
interpretability problems for large datasets because of having too many crossing lines.
CComViz (Zhou et al., 2009) resolves this issue by rearranging clusters and their items to
minimize visual clutter between features. XCluSim (L’Yi et al., 2015) also supports the
comparison of several CA results of gene expression datasets using a force-directed
layout, dendrogram, and parallel sets. XCluSim offers a better understanding of the
characteristics of each CA technique and its parameters along with results. Although
most of the abovementioned visual analytics systems are designed to compare multiple
CA results, they often suffer from lack of interpretability when dealing with large
datasets. A combination of the CA with DR can resolve this issue, especially when the
data is high-dimensional.
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5.3.3

DR and CA-Based Visual Analytics Systems

IN-SPIRE (Wise, 1999) is a visual analytics system for processing text documents; it
incorporates both CA, DR, and interactive visualizations. It uses a bag-of-words model to
encode the documents as high-dimensional vectors and then applies k-means with a
specific number of clusters. Although it is equipped to deal with a large amount of data, it
offers only a limited number of interactions to alter the analysis techniques and their
configurations. Another system that utilizes both CA and DR for analyzing documents
and their entities is Jigsaw (Stasko et al., 2008). To reduce the number of keywords in the
vocabulary, Jigsaw implements an automatic named-entity extraction technique. It then
uses k-means to display related documents and their keywords through visualization.
Similar to IN-SPIRE, Jigsaw supports a limited number of interactions and does not
allow users to change the CA technique. Testbed (Choo et al., 2013) is another system
that addresses these limitations by incorporating seventeen DR and four CA techniques to
analyze large-scale high-dimensional datasets. It allows users to apply any combinations
of these techniques to visually compare their results. Another system for interactive
exploration of high-dimensional data is Clustrophile (Demiralp, 2017); this system
incorporates six DR and two CA techniques. It allows users to tune different
configuration parameters and observe the changes through several interactive
visualizations such as a heatmap and a scatter plot. Despite the advantages, both Testbed
and Clustrophile allow users to apply clustering on the original dataset, which can be
very high-dimensional. Some CA and visualization techniques may not perform well in
those situations due to the “curse of dimensionality”.

5.3.4

EHR-Based Visual Analytics Systems

MatrixFlow (Perer and Sun, 2012) is a visual analytics system that assists users in
discovering subtle temporal patterns across patient cohorts stored in EHRs. It integrates
an advanced network modeling framework (i.e., Orion (Heer and Perer, 2014)) with
interactive visualizations to represent networks of clinical events as a temporal flow of
matrices. Another visual analytics system is VisualDecisionLinc (Mane et al., 2012) that
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facilitates the interpretation of large amounts of clinical data by providing overviews of
treatment options and patient outcomes in an interactive dashboard. It enables clinicians
to identify patient subpopulations that share similar medical characteristics to help them
in the decision-making process. Simpao et al. (Simpao et al., 2015) developed a
dashboard to facilitate the monitoring of medication alerts in EHRs to reduce irrelevant
alerts and improve medication safety. It assists clinicians in exploring not only
medication alerts but also alert types and patient characteristics. Visual Temporal
Analysis Laboratory (ViTA-Lab) (Klimov et al., 2015) is an interactive and data-driven
framework that is designed for the investigation of temporal clinical data. It combines
query-driven visualizations with longitudinal data mining techniques to assist users in
discovering temporal patterns within time-oriented clinical data. Another visual analytics
system is Care Pathway Explorer (Perer et al., 2015) that enables users to discover
common clinical event sequences and helps them to study how these event sequences are
associated with patient outcomes. In order to achieve this, it integrates a frequent
sequence mining technique with an interactive user interface. PHENOTREE (Baytas et
al., 2016) allows interactive exploration of patient cohorts and interpretation of
hierarchical phenotypes by integrating sparse principal component analysis with an
interactive visual interface. VISA_M3R3 (Abdullah et al., 2020) is a recent visual
analytics system that incorporates multiple regression, frequent itemset mining, and
interactive visualization to assist users in the identification of nephrotoxic medications
using EHRs. Although most of these systems incorporate complex visualization and
enable users to interactively explore EHR data, they only include a limited number of
analytics techniques. Moreover, some of these systems do not allow users to access and
modify the analytics engine through visualization, which is an essential aspect of visual
analytics.

5.4 Methods
This section describes the methodology we have employed to design the proposed visual
analytics system, namely VALENCIA. In Section 4.1, we provide an overview of the
design process and participants. We then describe task analysis and design criteria in
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Sections 4.2. Then, in Section 4.3, we introduce the components of VALENCIA and
briefly describe how the overall system works, also discussed more extensively in
Section 4.4, 4.5, and 4.6. Finally, Section 4.7 outlines the implementation details of
VALENCIA.

5.4.1

Design Process and Participants

Healthcare stakeholders usually deal with both well- and ill-defined tasks to solve various
research problems. The well-defined tasks have clear expected solutions, specific goals,
and, oftentimes, a single solution path. Unlike well-defined tasks, ill-defined tasks do not
have a solution path (Varga and Varga, 2016). To help us understand how healthcare
stakeholders perform real-world tasks, and to help us conceptualize and design
VALENCIA, we adopted a participatory design approach. It is a co-operative approach
that involves all stakeholders in the design process to ensure the output meets their
requirements (Leighton, 2004). The system was primarily designed to assist the
healthcare experts at the ICES-KDT program located in London, Ontario, Canada. A
clinician-scientist, an epidemiologist, a data scientist, and two computer scientists were
involved in the conceptualization, design, and evaluation process. They were from the
computer science and epidemiology department of Western University. Participants were
identified and contacted through the ICES-KDT. During the primary stage of the design
process, we discerned that exploring EHR through DR, CA, and interactive visualization
is not a straightforward task. It is often difficult to understand which analytics technique
produces the desired result for a given dataset, which visualization technique is more
suitable for the analysis results, or which interaction techniques are more appropriate to
meet the requirements of the user. It becomes an ill-defined problem when analytics and
interactive visualizations are combined in a VA system. In order to make appropriate
design decisions, we interviewed healthcare experts in our team (i.e., a clinician-scientist
and epidemiologist) to understand 1) data-driven tasks they perform with EHRs 2)
analytics techniques they rely on to accomplish those tasks, and 3) visualizations with
which they are familiar. We negotiated with healthcare experts the possibility of using
several semi-structured interviews, which allowed new concepts to be brought up during
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the process. We conducted these interviews in person at the ICES-KDT center. Typical
stakeholders of the system are involved in assessing and suggesting features towards
similar systems regularly. In our collaboration with experts, we first finalized the
analytics techniques that could allow them to accomplish data-driven tasks they would
like to perform with the system. We then created several horizontal prototypes to narrow
down the visualization design possibilities and selected appropriate visualization
techniques for the data, analytics, and users. We performed formative evaluations
continuously at every stage of the design and development process. This process was
essential to build trust between the proposed system and its end-users.

5.4.2

Task Analysis and Design Criteria

In our collaboration with the healthcare stakeholders, we recognized four high-level tasks
to consider in designing VALENCIA.

5.4.2.1

Displaying an Overview of the Data

Users would like to explore the features of the dataset so that they can decide which
features to incorporate in the analysis. For instance, they would like to see frequencies of
distinct categories for the categorical variables. Since some analysis techniques work best
with specific data types, it is important to understand the characteristics of the features
and their distributions.

5.4.2.2

Allowing Iteration Over DR Techniques

Choosing the appropriate DR technique is not a straightforward task. Users have to make
several decisions such as which technique to use, which values for the configuration
parameters are appropriate, and how many transformed dimensions to retain, to name a
few. After the initial selection, users would like to refine their decisions in an iterative
manner.

124

5.4.2.3

Allowing Iteration Over CA Techniques

Users would like to explore the data using different CA techniques with various
parameter settings. They want to investigate how the clusters are formed and verify the
results. Users would like to refine their decisions by going through the CA process
iteratively.

5.4.2.4

Facilitating Reasoning about DR and CA

Users often would like to understand which features of the dataset are affecting the
transformed dimensions, which dimensions are essential in identifying a given cluster,
and how different selections of features, dimensions, techniques, and/or parameters
influence the results. Since clustering is performed on the transformed data, users would
like to know the summary statistics of different features and identify which feature
groups or features are more important within each cluster.

5.4.3

Workflow

As shown in Figure 1, VALENCIA has two modules: the analytics engine and the
interactive visualization engine. The analytics engine is composed of two components: 1)
DR engine and 2) CA engine. The interactive visualization engine is composed of two
views: 1) DR view, and 2) CA view. The DR view has four subviews: 1) raw-data
subview, 2) projected-features subview, 3) association subview, and 4) variance subview;
it supports eight interactions: selecting, drilling, filtering, annotating, arranging,
searching, and transforming. The CA view is composed of three subviews: 1) hierarchical
subview, 2) frequency subview, and 3) projected-observation subview; it supports six
interactions: selecting, drilling, filtering, arranging, searching, and transforming.
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Figure 5-29: Basic workflow of VALENCIA. The backgrounds of the components
are color-coded to show the similarity between processes.
The basic workflow of VALENCIA is as follows. Once the data is loaded, it gets
preprocessed and encoded via the default encoding scheme. Users can then interactively
explore the dataset through the raw-data subview to choose their features of interest.
Next, upon selection of the DR technique and configuration parameters, the subset of the
data containing the chosen features is analyzed in the DR engine. The system updates the
projected-features, association, and variance subviews when the data items are generated
in the DR engine. Users can observe representation of the categories of different features
in proximity to each other based on their values in the projected dimensions through the
projected-features subview. The association subview allows users to understand which
features are most significantly associated with different dimensions. Users can observe
the amount of variation retained by each projected dimension from the variance subview.
This subview also allows users to select the dimensions to be analyzed through the CA
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engine. Users can observe the hierarchical structure of the CA result through the
hierarchical subview. After selecting the dimensions, when users click the submit button,
they get to the CA view. Upon selection of the CA technique and configuration
parameters, the CA engine generates data items to be represented in the hierarchical,
frequency, and projected-observation subviews. The frequency subview displays the
distribution of features in each subset of the data selected through the hierarchical
subview. The projected observation subview allows users to explore the positions of the
observations in the dataset with respect to the projected dimensions. The association
subview is shared between both the DR and CA views; however, the data in this subview
gets filtered in the CA view based on the selection through the variance subview. Finally,
users can export the output of the analysis using the export button in the CA view.

5.4.4

Encoding and Preprocessing

VALENCIA accepts input files in the JSON (JavaScript Object Notation) format and
enables output to be exported in the same format. It has a built-in preprocessing
procedure to encode the categorical features. The system enables users to select multiple
features within a group (e.g., diabetes and hypertension in comorbidities group), all
features of a group (e.g., all comorbidities or medications) or all features in all groups. A
collapsible tree structure is implemented to support this operation in VALENCIA. The
subset of the data containing selected features are then transferred to the analytics engine
for further processing.

5.4.5

Analytics Engine

The analytics engine of VALENCIA has two main components: 1) the DR engine (a subengine of the analytics engine) that transforms the EHR data from the high-dimensional
space to a space of lower dimensions, and 2) the CA engine (a sub-engine of the analytics
engine) that organizes objects in low-dimensional space into meaningful groups whose
members share similar characteristics in some way. Several techniques belonging to both
families are incorporated in VALENCIA. Users are able to analyze the inputted dataset
using DR, CA, or a combination of both techniques. Some studies in the literature have
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identified several limitations of combining some specific DR and CA techniques (e.g.,
(Arabie, 1994; De Soete and Carroll, 1994; Mitsuhiro and Yadohisa, 2015; Rocci et al.,
2011; Timmerman et al., 2010; Vichi and Kiers, 2001)). For instance, DR techniques that
rely on probability distribution (e.g., t-distributed stochastic neighbour embeddings) are
not suitable for distance or density-based CA techniques. VALENCIA overcomes these
limitations by providing users with the ability to choose a combination from a number of
DR and CA techniques and verify the results of the analysis with both original and lowdimensional data through interactive visualizations. This analysis process is iterative,
which allows users to go through any number of combinations until an optimal solution is
found.

5.4.5.1

DR Engine

In analytical activities, it is often challenging for users to choose a DR technique among
an abundance of available algorithms. There is no single solution to the problem of
recognizing which technique is appropriate for a particular dataset. The choice of a DR
technique primarily depends on the nature of the data. It also depends on the domain
knowledge of users and the problem at hand. Linear DR techniques such as
correspondence analysis (Hirschfeld, 1935), classical multidimensional scaling (CMDS)
(Torgerson, 1958), principal component analysis (PCA) (F.R.S, 1901; Hotelling, 1933),
multiple correspondence analysis (MCA) (Greenacre and Blasius, 2006), and multiple
factor analysis (MFA) (Escofier and Pagès, 1994) are better at representing the global
structure of the data. On the other hand, nonlinear techniques such as t-Stochastic
neighbour embedding techniques (t-SNE) (Maaten and Hinton, 2008) and nonmetric
multidimensional scaling (NMDS) (Kruskal, 1964; Shepard, 1962) are better at
representing and preserving local interactions. VALENCIA incorporates eight linear and
nonlinear DR techniques to allow users to analyze high-dimensional EHR data. Some of
the well-known DR techniques that are implemented in VALENCIA include PCA, MCA,
MFA, and t-SNE.
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PCA uses variance to obtain principal components (i.e., orthogonal vectors) in the feature
space that accounts for the maximum variance in the data. Although PCA is originally
designed for continuous features, a special version of PCA, categorical principal
component analysis (princals), can be used for categorical features (De Leeuw, 2005;
Gifi, 1990). VALENCIA uses R libraries "PCA" and "princals" to implement PCA. On
the other hand, MCA is a correspondence analysis technique for compressing and
visualizing datasets with multiple categorical features. It is a generalization of PCA when
the features to be analyzed are categorical instead of continuous (Abdi and Williams,
2010). To implement MCA, VALENCIA uses the "MCA" function from the
"FactoMineR" package in R. In addition, MFA is a multivariate analysis technique to
summarize or visualize complex datasets where observations are described by multiple
sets of features structured into different groups. The distance between observations is
defined based on the contribution of all active groups. To implement this technique, we
use the "MFA" function in the "FactoMineR" package in R.
Unlike PCA, t-SNE is a nonlinear dimensionality reduction technique that can deal with
more complex patterns in multidimensional space (Maaten and Hinton, 2008). It relies on
the probability distribution of observations in the high-dimensional space to calculate the
probability in the corresponding low-dimensional space. This technique is implemented
using the "Rtsne'' package in VALENCIA. NMDS is another nonlinear dimensionality
reduction technique that uses rank-orders to collapse data from high-dimensional space
into a limited number of dimensions. VALENCIA uses the "vegan" package to
implement NMDS.
Determining the suitable number of new dimensions in the lower-dimensional space is a
challenging task. The optimal number of dimensions to keep for CA mainly depends on
the dataset. Users are often interested in particular signals in the dataset, and the choice of
dimensions also depends on whether the signal of interest is captured within the
dimensions in the reduced space. Thus, choosing the appropriate dimensions is crucial in
VALENCIA because the DR engine is used to prepare the data for CA. It is also
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important to reduce the number of dimensions to an appropriate size because of the
limitation of the screen space, especially when users want to visually explore the highdimensional data. For instance, in the case of principal component analysis with a highdimensional dataset, the first two or three principal components may describe a small
fraction of variance of the dataset and/or may not capture the variation of interest (i.e., the
signal of interest can be a confounding factor). In those situations, users may need to
explore higher-order components through visualization and select a combination of lowand higher-order components to preserve the desired variance. VALENCIA allows users
to explore the projected dimensions produced through different DR techniques using
interactive visualizations. Users have the ability to adjust not only the number of
dimensions but also different configuration parameters of a particular DR technique. It is
important for users to find the optimal values of configuration parameters to get their
desired results from the DR engine. Some arguments are adjusted automatically by the
system based on the type of features in the dataset. The data items for the visual
representations are produced based on the values of different arguments in the DR
engine.

5.4.5.2

CA Engine

It is often difficult to interpret and visualize the results of CA when the data is highdimensional. To address this issue, VALENCIA employs DR techniques to lower the
dimension from possibly thousands to a manageable size, making it possible not only to
apply different CA techniques on the projected data but also to incorporate different
visualization techniques. It also offers the flexibility of analyzing a dataset containing
mixed features because some CA techniques might not work well in such situations
(Mitsuhiro and Yadohisa, 2015). Similar to DR, there is no single CA technique that suits
every dataset and/or problem. Moreover, the configuration parameters of CA techniques
need to be adjusted for different problems to find an optimal solution. There are several
CA algorithms in the literature, and new algorithms are often introduced to solve
different problems. Many of these algorithms are problem- and data-specific. Since there
is no globally optimal CA technique, VALENCIA incorporates a number of CA
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techniques from different methods (i.e., connectivity, centroid, distribution, and density)
that work together with a number of DR techniques. Through the integration of DR and
CA, it allows users to identify patterns and groups in low-dimensional space and discover
knowledge in multidimensional data.
One of the widely used CA techniques is k-means (Hartigan and Wong, 1979; Jain,
2010), a centroid-based method that partitions the data into clusters. It defines clusters in
such a way that the total within-cluster (i.e., intra-cluster) variation is minimized. In
general, this algorithm first selects k observations as initial centers or centroids from the
dataset. Then, all remaining observations are assigned to their closest centroid using a
distance function. Next, the new mean value of each cluster and its centroid are
calculated. All the observations are reassigned based on the updated cluster means. These
steps are repeated until convergence is achieved. To implement this technique in
VALENCIA, we use the "kmeans" function in the "stats" package in R.
Unlike k-means, hierarchical clustering (Nielsen, 2016) does not require users to specify
the number of clusters initially. It comes in two forms: agglomerative and divisive
(Rokach and Maimon, 2005). Agglomerative clustering works in a "bottom-up" manner.
Observations are initially considered as single clusters, and similar clusters are then
combined to create new clusters with multiple observations. This process is repeated until
all observations are grouped in a single cluster. On the contrary, divisive clustering works
in a "top-down" manner where observations are combined or divided based on a
similarity measure. We use the "dist()" function in R to compute distances between
observations. Agglomerative and divisive techniques are implemented using "hclust()” in
“stats" and “diana()” in “cluster” packages, respectively, to generate hierarchical trees in
VALENCIA.
The density-based clustering (Ester et al., 1996) can be used to identify clusters of
different sizes and shapes from the data. Each cluster must contain a minimum number of
observations. It seeks the regions in the data space that have a high density of
observations, which are separated by low-density regions. VALENCIA uses the "dbscan"
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function in the "fpc" package in R to provide support for density-based clustering. Users
can define the radius of the neighbourhood around an observation by choosing "eps"
argument and the minimum number of observations within a specified radius using
"MinPts" argument.
Model-based clustering (Fraley and Raftery, 2002) assumes that the data is generated by
an original model and tries to recover that model based on certain criteria. The recovered
model is then used to define the clusters. Unlike other techniques mentioned above,
model-based techniques implement a soft assignment, where each observation is assigned
with a probability of belonging to a cluster. One of the well-known criteria to determine
the model parameters is maximum likelihood. VALENCIA uses the "mclust" package in
R to provide support for model-based clustering. This package uses maximum likelihood
to fit different models, which can be compared based on their Bayesian information
criterion score.
There are several ways to assess the quality of CA, each of which has limitations relating
to the subjective quality of individual evaluations (Feldman and Sanger, 2007).
VALENCIA allows users to develop a feedback loop with the system through a series of
interactions. Users adjust different configuration parameters to observe their effects on
features of interest to evaluate the performance of a particular CA technique. In order to
find the optimal CA technique for a dataset, users can try several configuration settings.
For example, when working with k-means, the "centers" argument can be modified to
control the number of initial cluster centroids, and "iter.max" can be tuned to regulate the
maximum number of iterations. While users have the flexibility to adjust some
arguments, many arguments are adjusted automatically by the system. Despite the
ubiquitous use of DR and CA techniques in the literature, their combination can be
difﬁcult to interpret, especially in relation to the features of the original dataset. To
overcome this issue, the data items produced through the CA engine are made available
to users through a number of visualizations. These visualizations represent the
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distribution of clustered observations in both high- and low-dimensional space, allowing
users to verify the results and avoid misinterpretation.

5.4.6

Interactive Visualization Engine

VALENCIA is composed of two main views: DR and CA. The DR view is composed of
4 subviews: raw-data, projected-features, association, and variance. The CA view is
composed of 3 subviews: hierarchical, frequency, and projected-observations. These
views are supported by several selection controls, such as collapsible tree structure, dropdown menu, search bar, and checkbox. Each of these views represents an important
aspect of the analytics engine. In this section, we describe how data items generated in
the analytics engine are mapped onto visual representations to allow healthcare
stakeholders to achieve the tasks mentioned in Section 4.2.

5.4.6.1

DR View

The components in the DR view allow healthcare stakeholders to import raw data,
explore features, select features of interest, apply DR techniques, adjust configuration
parameters, analyze DR results, and generate data items for the CA engine. This section
describes four main subviews of the DR view (Figure 2).

5.4.6.1.1

Raw-data Subview

The raw-data subview is composed of a collapsible tree structure, bar chart, and data
table. Upon selection of an input file, VALENCIA maps the hierarchical features of the
preprocessed data into a collapsible tree structure. Users can expand the tree structure
multiple times by clicking on the “+” icon in each level; this reveals groupings of the
features in that level. The lowest level of the tree contains the actual feature names.
The grouping or feature name at each level of the tree structure has a checkbox, allowing
users to select not only a specific feature but also a group of features. The list of selected
features and relevant information is shown in a data table. Moreover, users can hover the
mouse over any feature in the tree structure to see the distribution of that feature through
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a bar chart. The data table and bar chart are on the right side of the tree structure, as seen
in the top-middle section of Figure 2.

Figure 5-30: The DR view containing (A) raw-data subview, (B) projected-features
subview, (C) association subview, and (D) variance subview.

5.4.6.1.2

Projected-Features Subview

The projected-features subview includes a scatter plot, collapsible tree structure, search
bar, and several drop-down menus. Initially, users select a DR technique, relevant
configuration parameters, and the number of projected dimensions to engage with the DR
engine. Upon these selections, the coordinates of the chosen features (selected through
the raw-data subview) are mapped onto a scatter plot. The scatter plot displays glyphs
representing categories of each feature in proximity to each other based on their values in
the projected dimensions. All the categories of a specific feature are encoded with the
same color and all the features belonging to the same group are represented by a specific
shape (e.g., triangle, rectangle, star, to name a few). Each category can also be
represented by its corresponding label. Both the glyph and label can be turned on/off via
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two separate checkboxes. In the scatter plot, a linear scale is used for both horizontal and
vertical axes to represent the selected dimensions. Users can interactively adjust the
dimensions corresponding to the axes via two drop-down menus. The displayed
information in the scatter plot can be filtered using a collapsible tree structure. This tree
structure shows the list of chosen features through the raw-data subview. It allows users
to select features of interest to observe their positions in the scatter plot. The tree
structure is accompanied by a search bar that enables users to look for a specific group
and/or feature.
Users can click on a glyph representing a category of a specific feature to observe the
position of other glyphs and labels belonging to that feature. This interaction filters out
all other glyphs to make it easy for users to investigate the feature of interest. Users can
drill the glyphs for additional information by hovering the mouse over them. It is
sometimes difficult for users to distinguish between glyphs when they are densely
clustered in the scatter plot. In order to address this issue, VALENCIA provides scrolling
to allow users to zoom in/out on the scatter plot. While zooming, users may wish to see
glyphs that are not visible in the visual representation of the scatter plot. In such
situations, users can navigate through the scatter plot by selecting any region within the
representation (with the mouse) and dragging it to the desired location. These interactions
are useful for exploring high-dimensional and heavily-categorized datasets.

5.4.6.1.3

Association Subview

Once the DR technique is applied, the correlation coefficient between each feature and
projected dimension is shown in a heatmap in the association subview. The heatmap
visualizes the magnitude and direction of the correlations through variations in coloring.
It allows users to cross-examine multivariate data, through placing features in the
columns and projected dimensions in the rows. Users can identify patterns by examining
variance across multiple features and dimensions through this subview. They can also
detect similarities between both features and dimensions and observe if any correlations
exist between them. Only the significantly correlated (i.e., filtered by p-value)
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coefficients are included in the heatmap, leaving the unassociated cells empty. Each cell
in the heatmap contains a color-coded numerical value representing the relationship
between the feature and dimension in the connecting row and column. The color-coding
is based on a color scale that blends from one particular color to another, to show the
difference between low and high values. In order to assist users in interpreting the
heatmap, a legend is included in the association subview. The legend contains a gradient
scale, which is created by blending dark brown and navy blue.
Users can sort the heatmap based on either a feature or dimension by clicking on the
corresponding row or column header. This allows users to observe which dimensions best
represent each feature and how different features affect each dimension. Users can drill to
obtain the actual value of the coefficient by hovering the mouse over the corresponding
cell. Users may face difficulty while exploring this subview because of the limited screen
space, especially when the dataset is high-dimensional. To address this issue,
VALENCIA supports selecting any region of the subview with the mouse (left-click) and
dragging it to the desired position. It also allows users to zoom in/out on the heatmap by
scrolling the mouse within the region specified for this subview. These interactions make
it possible for users to observe all the elements of the heatmap and investigate features of
interest more closely.

5.4.6.1.4

Variance Subview

The variance subview includes a line-column chart and checkboxes that correspond to
each projected dimension. The line-column chart combines a line graph and column chart
by using a common x-axis. The column chart encodes each projected dimension in a
vertical bar, allowing users to compare the proportion of variance retained by that
dimension using the eigenvalues measure. The line chart encodes the cumulative
percentage, obtained by adding the successive variances to calculate the running total.
This subview supports drilling (mouse over) by displaying both actual and cumulative
variance. Users can select a dimension by clicking on its corresponding checkbox. This
allows users to choose a subset of projected dimensions so that it can be analyzed with
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the CA engine. In practice, users tend to look for a minimum number of projected
dimensions that cover maximum variance in the dataset.

5.4.6.2

CA View

The components in this view allow users to apply different CA techniques, adjust
configuration parameters, analyze the output, and export the final result (Figure 3). This
view shares a common subview (i.e., association subview) with the DR view. The three
main subviews of the CA view are described in this section.

Figure 5-31: The CA view containing (A) association subview, (B) projectedobservations subview (C) hierarchical subview, and (D) frequency subview.

5.4.6.2.1

Hierarchical Subview

Upon selection of a CA technique and relevant configuration parameters, the hierarchical
structure of the clustered data is displayed in a zoomable treemap in the hierarchical
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subview. The space in the visual representation of the treemap is divided into nested
rectangles. The set of rectangles in the first, second, and third levels represents clusters,
groups within a particular cluster, and features within a particular group, respectively.
There are several algorithms in the literature that can be used to determine the size of the
rectangles in a treemap. VALENCIA determines the size of the rectangles based on the
impact of each feature on a particular cluster. The algorithm to compute the size is
presented in Procedure 1. For hierarchies, the size of a rectangle that contains other
rectangles is determined by the sum of areas of the contained rectangles. All the
rectangles representing groups and features within a cluster are encoded with the same
color. VALENCIA automatically assigns colors to different clusters. The sets of
rectangles in the first and second levels are transparent, showing the contained rectangles
in the background. The varying sizes, colors, and nested structures of the rectangles allow
users to identify patterns that would be difficult to detect otherwise.
Procedure 5-1: Compute the size of the rectangles

(1)

Require: Raw dataset with cluster labels

(2)

compute the number of features in each group in number_of_groupfeatures []

(3)

compute max_groupfeatures = maximum value in number_of_groupfeatures []

(4)

compute frequency of each feature in the dataset

(5)

divide the dataset based on each cluster

(6)

for each cluster C in the dataset

(7)

for each feature F in the dataset

(8)

compute relative frequencies of feature F in cluster C

(9)

feature_weight = (relative frequencies / frequency [F]) * 100

(10)

adjusted_feature_weight [C,F] = (max_groupfeatures / number_of_groupfeatures [F]) *
feature_weight

(11)

return adjusted_feature_weight [][]

(12)

Initially, the set of rectangles belonging to the first level (i.e., clusters) is visible in the
representation of the treemap. Users can navigate through the rectangles in different

138

levels by clicking on a rectangle representing a cluster or group. The top-left corner of
the treemap contains a button and navigation links. The button allows users to get back to
the previous level from particular levels (i.e., second or third). The navigation links get
updated dynamically as users navigate through the treemap. These links allow users to
jump into any level by clicking on them. Users can hover the mouse over a rectangle to
bring out the label of the corresponding rectangle. When a rectangle is hovered, it
becomes highlighted (black) to help users understand which rectangle will be selected if
they click on it.

5.4.6.2.2

Frequency Subview

The frequency subview includes a parallel set, collapsible tree structure, search bar, and
checkbox. Parallel Sets (Kosara, 2010) is a visualization technique that is developed
mainly for interpreting categorical data. For each feature or cluster, horizontal bars are
displayed for possible categories in the frequency subview. The width of the bar encodes
the frequency (i.e., number of matches) of that category. Starting with the first feature,
each of its corresponding categories is connected to the categories of the next feature,
which reveals how that category is subdivided. This subdivision process gets repeated
recursively, which creates a tree of “ribbons”. The relationship between horizontal bars
and ribbons helps users understand the distribution of combinations of categories. The
horizontal bars and ribbons are color-coded based on the categories of the first feature.
VALENCIA assigns colors to different categories automatically to make sure they are
visually distinguishable.
The data items displayed in the parallel sets can be controlled through a collapsible tree
structure and an interaction with the treemap in the hierarchical subview. Users can select
checkboxes of features in the collapsible tree structure to include them in the parallel sets.
Features are organized into groups to make them easy to find. A search bar is also
included to find a specific feature. The interaction with the tree structure helps users to
investigate the distribution of features of interest in different clusters. The displayed
information in the parallel sets can also be controlled by selecting a rectangle
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representing a cluster, group, or feature in the treemap. Initially, a common set of features
along with clusters are shown in the parallel sets for the entire dataset. As users interact
with the treemap, the subset of data belonging to the contained rectangles in the treemap
is shown in the parallel sets. For instance, if users click on a rectangle representing a
cluster in the treemap, only the data items belonging to that cluster are displayed in the
parallel sets. This process continues until users reach the last level in the treemap.
Whenever users interact with either the tree structure or the treemap, the parallel sets gets
updated based on the latest interaction.
To get additional information, users can move their mouse over the components of the
parallel sets to highlight them and bring out tooltips. The tooltip of each horizontal bar
displays the frequency and percentage (as a fraction of the entire dataset) of its
corresponding category. When users move their mouse over a horizontal bar, all the bars
and ribbons connected to that particular bar get highlighted. The tooltip of a ribbon
displays the combination of criteria (categories) that the ribbon represents along with the
frequency and relative percentage. When users hover over a ribbon, all other connected
ribbons get highlighted. Users can drag any features and categories to reorder them. The
mouse pointer changes to help users understand which components are draggable. The
features and categories can be dragged vertically and horizontally, respectively. This
helps users to rearrange components of the parallel set and choose which feature should
be used to color the ribbons.

5.4.6.2.3

Projected-Observations Subview

Projected-observations subview includes a scatter plot matrix and histograms. The
scatterplot matrix is used to show the projected observation from the DR and CA
analyses. It can be seen as a collection of scatterplots organized into a matrix where each
scatterplot displays the relationship between a pair of projected dimensions. While each
off-diagonal cell in the matrix maps a pair of distinct dimensions, there is no logical
mapping for the diagonal cells. Therefore, VALENCIA incorporates histograms in the
diagonal cells of the matrix. Histograms plot the frequency of observations in each
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projected dimension. The observations are color-coded based on their corresponding
cluster. The same color scheme is used for both the treemap, scatter plot matrix, and
parallel sets. The scatter plot matrix helps users determine the linear correlation between
multiple dimensions and detect patterns in the distribution of the clustered observations
using projected dimensions. Users can observe each histogram to visually detect the
median, outlier, and distribution (e.g., normal, skewed, to name a few) of the
observations.
When users apply brushing to select a region in any scatter plot, all observations outside
the brushed region get grayed out in the scatter plot matrix. This interaction helps users
investigate a set of observations in the region of interest. The mouse pointer changes
when users move the mouse over any region that can be brushed. Several buttons are
generated to filter observations displayed in the scatter plots and histograms. The number
of buttons depends on the number of clusters. Each button and its corresponding cluster
share the same color to help users understand the mapping. These buttons can be turned
on/off by clicking on them. Each button can be used to filter observations of its
corresponding cluster.

5.4.7

Implementation Details

The VALENCIA system is implemented using standard PHP programming language, R
packages, JavaScript library D3, Ajax, JavaScript library jQuery, SAS, and standard
HTML. D3, jQuery and HTML were used to develop the front end of the system, which
includes all the external representations (i.e., interactive visualization engine). A number
of packages in R were used to develop the analytics engine of the system. Since ICES
data is stored in the SAS server, we used SAS to cut the data and integrate data from
different sources. The communication between analytics and visualization engines is
implemented using AJAX and PHP.
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We used R to develop the components of the analytics engine because it 1) offers various
packages to perform DR and CA, 2) is a platform-independent open-source tool, and 3) is
available in the ICES working environment.
We chose D3 to develop various external representations mainly because it 1) offers a
data-driven approach to attach data to the Document Object Model elements. 2) provides
users with the ability to get access to the full capabilities of modern web-browsers, 3) is
an open-source library, and 4) is compatible with other programming languages that have
been used in our system.

5.5 Usage Scenario
In this section, we demonstrate how VALENCIA can assist healthcare stakeholders at the
ICES-KDT program in the investigation and exploration of high-dimensional EHR data.
The datasets include demographics, comorbidities, hospital admission codes, medication
profiles, and procedures, all linked using unique identifiers derived from health card
numbers. We describe multiple scenarios to demonstrate how intended users perform
numerous tasks to achieve their goals in finding appropriate DR and/or CA techniques
and optimal configuration settings. Throughout this process, users get an overall
understanding of relationships among data items in the EHRs.

5.5.1

Data Sources

We ascertained patient characteristics, drug prescription, and healthcare utilization data
from 5 health administrative databases housed at ICES. We obtained vital statistics from
the Ontario Registered Persons Database that contains demographic data on all residents
of the Province of Ontario who have a valid health card. We used the Ontario Drug
Benefit program database to get the prescription drug use data. This database records all
outpatient prescriptions dispensed to patients aged 65 years or older, with a very low
error rate (Levy et al., 2003). We ascertained hospital admission, procedure, baseline
comorbidity, and emergency department visit data from the National Ambulatory Care
Reporting System (i.e., ED visits) and the Canadian Institute for Health Information
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Discharge Abstract Database (i.e., hospitalizations). Baseline comorbidity data were also
obtained from the Ontario Health Insurance Plan database, containing claims data for
physician services.

5.5.2

Cohort Creation

For this analysis, we created a cohort of patients who visited an ED or hospital between
April 1st, 2014 and March 31st, 2016. The hospital admission date or ED visit date
served as the cohort entry date (i.e., index date). If a patient had multiple hospital
admissions or ED visits, we chose the first incident. Patient records with invalid data
regarding age, sex, and health-care number were excluded from the cohort. We captured
the hospital admission diagnosis and procedural information on the index date. We
applied a 5-year look-back window to obtain relevant baseline comorbidity data and 120
days look-back window to obtain prescription data. We used the International
Classification of Diseases, tenth revision (post-2002) codes to identify baseline
comorbidities.

5.5.3

Cohort Description

There were a total of 47 unique features and about 1 million patients in the cohort. The
results of the analysis are suppressed to comply with the privacy regulations for reducing
the possibility of patient reidentification. Therefore, the data points shown in the
projected-observation subview are suppressed in cells with five or fewer patients. The
cohort includes eleven comorbidities—namely, acute kidney injury, cerebrovascular
disease, chronic kidney disease, chronic liver disease, coronary artery disease, diabetes
mellitus, heart failure, hypertension, kidney stones, major cancers, and peripheral
vascular disease. It contains four demographics features, including age, sex, income
quintile, and location. There are thirteen features representing drug classes of ACEinhibitors, alpha-adrenergic blocking agents, angiotensin II receptor blockers, betablockers, calcium blockers, potassium-sparing diuretics, other diuretics, antipsychotic
agents, fluoroquinolones, macrolides, immunosuppressive agents, nonsteroidal antiinflammatory agents, and oral anti-glymetics. The cohort contains three features to

143

represent the procedures—namely, angiograms, angioplasty stent, and transluminal
angioplasty. Finally, it contains sixteen hospital admission diagnosis codes, including
fluid disorders, delirium, atrial fibrillation, mycoplasma, anemia, valve disorders, femur
fracture, chronic ischemia, volume depletion, paralytic ileus, chronic pulmonary,
septicemia, abnormal function, hyperplasia of prostate, dementia, and glomerular
disorders.
All the patients in the cohort are aged over 64 years, and the mean age is 70 years. About
56% of the patients are female, and 16% are from rural locations. The pre-existing
comorbidities are hypertension (88%), diabetes (38%), coronary artery disease (25%),
heart failure (14%), major cancer (16%), chronic kidney disease (9%), cerebrovascular
disease (3%), peripheral vascular disease (2%), and kidney stones (1%). Some of the
commonly prescribed drug classes are ace-inhibitors or angiotensin II receptor blockers
(60%) and diuretics (57%). The most frequent diagnosis codes associated with AKI were
chronic pulmonary (3%), atrial fibrillation (3%), chronic anaemia (2%), and ischaemic
(2%).

5.5.4

Case Study

VALENCIA can be used in an iterative manner. This allows users to move freely among
different stages, skipping some stages if needed, especially after going through the
process of choosing a DR or CA technique once. In this study, we explain the process of
using the system in a sequential manner to make it easier for readers to follow.
First, users import the data file by clicking on the “Browse Files” button in the DR view.
The data file gets preprocessed by the system automatically.
Intended users can be interested in selecting a number of features from different feature
groups. The imported dataset has five feature groups (i.e., demographics, comorbidities,
hospital admission codes, procedures, and medications). Let us assume that a user
analyzes the features using the raw-data subview and chooses fifteen features from
hospital admission codes, twelve features from medications, and all features from
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procedures, demographics, and comorbidities through the collapsible tree structure
(Figure 4-A). As shown in Figure 4-B, the user has the option to observe the description
of each feature while choosing them. The selected features are displayed in a scrollable
data table for verification as shown in Figure 4-C.

Figure 5-32: The raw-data subview containing (A) collapsible tree structure, (B) bar
chart, and (C) data table.
The user has the option to choose the DR technique and set the configuration parameters
for that technique. Let us assume that the user selects “MCA” as the DR technique and
sets the method and number of dimensions to “indicator” and “6”, respectively. The DR
engine then automatically sets indices for quantitative and categorical supplementary
features. Upon these selections, the DR engine applies the selected technique with the
specified configurations on the chosen features.

(A)

(B)

(C)

Figure 5-33: Showing an overview of the projected-features subview, which includes
(A) all glyphs with respect to dimensions one and two, (B) some selected glyphs and
labels with regard to dimensions three and four, and (C) all the glyphs and labels
representing age upon drilling.
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Then, VALENCIA updates the projected-features, association, and variance subviews
when the data items are generated. As shown in Figure 5-A, the projected-features
subview displays the coordinates of features relative to the dimensions. The first two
dimensions (i.e., dimension one and two) are shown by default as axes of the scatter plot.
In Figure 5-B, the user can change the X- and Y-axes from default to dimensions three
and four. Initially, the scatter plot displays all the glyphs corresponding to all feature
categories. As shown in Table 1, the shapes of the glyphs are chosen automatically by the
system based on different groups of features such as comorbidities, demographics, and so
on. The user is interested in investigating a few specific features, and thus they select age
from demographics, diabetes mellitus and hypertension from comorbidities, and anemia
from the hospital admission codes using the collapsible tree structure in the projectedfeatures subview (Figure 5-B). Since the glyphs displayed in the scatter plot belong to
different groups (i.e., demographics, comorbidities, and admission codes), they are
encoded by different shapes and colors. However, all the categories belonging to a
feature (e.g., male and female categories for feature sex) are represented by the same
shape and color. The user selects the checkbox to observe the label of each glyph in
Figure 5-B. They click on the glyph representing age to observe the position of other
glyphs and labels (i.e., different categories of age) belonging to that feature (Figure 5-C).
Table 5-9: Showing the shapes of the glyphs based on different groups of features.
Group

Demographics

Shape

(Plus)

Comorbidities

★ (Star)

Hospital admission codes

▲ (Triangle)

Procedures

■ (Rectangle)

Medications

♦ (Diamond)

Although the chosen features in Figure 5-B contribute to the definition of dimension four,
they are not well represented in dimension three. This makes the user interested in
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investigating which features contribute most to dimension three using the heatmap in the
association subview. As shown in Figure 6-A, the heatmap displays the correlation
between features and dimensions. There are six columns to represent six dimensions and
44 rows to represent the features. The positive relationships between features and
dimensions are encoded with colors ranging from light blue to dark blue, whereas
negative ones range from light brown to dark brown. The cells are empty when the
correlation between a specific row and column is not significant (e.g., between income
and dimension two). In order to find the features that are related to dimension three, the
user can click on “Dim3” column header once to sort the features in a descending order.
This reveals that “income”, “volume depletion”, “delirium”, “mycoplasma”, and
“dementia” are positively correlated to dimension three (Figure 6-B). Then the user can
select these features in the projected-features subview to investigate these correlations
more closely.
After going through the above-mentioned process iteratively, the user finalizes the
number of features, DR technique, and configuration parameters. At the final stage of the
DR view, the user chooses the dimensions to be included in the CA engine by observing
the line-column chart in the variance subview. This helps the user to understand the
amount of variation retained by each dimension. Let us assume that the user selects
checkboxes for dimension one, two, and three after analyzing them thoroughly, as shown
in the bottom-left corner of Figure 2. Upon clicking the “submit” button, the system takes
the user to the CA view.
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(A)

(B)

Figure 5-34: Showing an overview of the association subview, which includes (A) a
heatmap representing the association between six dimensions and 44 features and
(B) a heatmap where all the features are sorted in a descending order based on
dimension three.
Once the CA view is loaded, the user chooses a CA technique and relevant configuration
parameters to activate the CA engine. Let us assume that the user selects “kmeans” as
their desired CA technique and sets the number of clusters and maximum number of
iterations to “3” and “100”, respectively. Upon these selections, when the data items are
generated based on the results of CA, VALENCIA updates the hierarchical, frequency,
and projected-observations subviews. As shown in Figure 7-A, the projectedobservations subview displays the clustered observations in the low-dimensional space.
The user can verify the output of the chosen CA technique by observing the distribution
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of observations that are color-coded based on different clusters. For instance, the user can
observe that the clusters are more distinguishable from each other in the scatter plots
between dimensions one and two (Figure 7-A). In order to understand the distribution of
the observations better and detect outliers, the user applies brushing on a region in a
scatter plot (between dimensions one & two). This helps the user to investigate how the
observations in the selected region are distributed in other scatter plots (Figure 7-B). As
shown in Figure 7-C, when the user clicks on button “C-3”, the system removes all the
observations belonging to cluster three.

(A)

(B)

(C)

Figure 5-35: Showing the overview of the projected-observation subview, which
displays (A) all the observations color-coded based on clusters, (B) the brushing
interaction, and (C) observations in cluster-1 and cluster-2 because cluster-3 is
filtered out.
This allows the user to compare the remaining clusters more easily. If the user becomes
interested in getting additional information about the dimensions (e.g., which features are
associated with these dimensions), they can use the association subview. Although this
subview is also available in the DR view, it is included in the CA view to allow the user
to retrieve such information without switching between views. As shown in the left
corner of Figure 3, the association subview within the CA view contains information of
the first three dimensions based on the user’s selection in the DR view. Next, if the user
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is interested in exploring the hierarchical structure of the clustered data in highdimensional space (raw data), they can refer to the hierarchical subview.

(A)

(B)

(D)

(C)

(E)

Figure 5-36: Showing the overview of the hierarchical subview, which displays (A)
all the clusters, (B) feature groups within cluster-1, (C) feature groups within
cluster-2, (D) feature groups within cluster-3, and (E) features within the
comorbidity group in cluster-3.
The hierarchical subview allows the user to detect which clusters cover the maximum
amount of variation of the data (Figure 8-A). The user clicks on a rectangle representing a
cluster (i.e., cluster-1, cluster-2, and cluster-3) in this subview to observe how different
feature groups contribute to the variance of a particular cluster. For instance,
demographics, medications, and comorbidities have the highest contributions to cluster-1,
cluster-2, and cluster-3, respectively (as shown in Figure 8-B, 8-C, and 8-D). Then, the
user can click on the rectangle representing comorbidities within cluster-3, which reveals
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that diabetes mellitus (DIAB) and hypertension (HYP) are the dominating features in this
group (Figure 8-E).
The user can consult the frequency subview to get the frequency distribution of clusters
and features. As shown in Figure 9-A, 32%, 59%, and 9% of the patients are assigned to
cluster one, two, and three, respectively. About 82% of these patients are aged between
65 and 85, and most of them are assigned to the first two clusters. Upon interacting with
the hierarchical subview, the frequency subview gets updated dynamically to allow the
user to get additional information at every level. For instance, Figure 9-B displays the
frequencies of the comorbidities when the user selects the “cluster-3”->“comorbidities”
rectangles (Figure 8-E) in the hierarchical subview. The user can observe that 93% of the
patients in cluster-3 have hypertension. In order to change the color of the ribbons based
on the outcome of the heart failure feature (HF), they can reorder the horizontal bars by
dragging hypertension (HYP) to the top.
The user can also observe the distribution of all other comorbidity features within cluster3. Next, let us assume the user becomes interested in checking how the patients who have
heart failure, diabetes mellitus, anemia, and delirium are subdivided into different
clusters. The user can activate the collapsible tree structure by clicking on particular
checkboxes corresponding to these features to filter the displayed information. Figure 9-C
shows how patients in different clusters are subdivided into these features and vice versa.
It is possible to explore the interrelationship between not only the clusters and features
but also different features in this manner. For example, the user can observe that most of
the patients belonging to cluster-1 have diabetes. In order to investigate this relationship
more closely, the user can change (i.e., from clusters to feature) the ordering and colorcoding by moving diabetes mellitus (DIAB) to the top. The color scheme for clusters in
the frequency, hierarchical, and projected-observations subviews are identical; this makes
it easy for the user to visually perceive the connection between these subviews (Figure
3).
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(A)

(B)

(C)

Figure 5-37: Showing the overview of the frequency subview, which shows the
distribution of (A) different clusters and demographics, (B) all the comorbidities
within a particular cluster, and (C) clusters and some user-selected features.
At any stage of the analysis in the CA view, the user can click the “Back” button to
navigate back to the DR view. They can switch between the DR and CA views as many
times as is required. After going through this iterative process of applying different CA
techniques, tuning configuration parameters, and analyzing results with different
subviews, the user exports the resulting dataset by clicking on the “Export” button. The
output dataset contains all the data elements along with cluster labels for each patient.
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5.6 Conclusion
In this study, we have shown how visual analytics systems can be designed to address the
challenges of high-dimensional data stored in EHRs in a systematic way. To achieve this,
we have reported the development of VALENCIA, a visual analytics system designed to
assist healthcare stakeholders at the ICES-KDT program. VALENCIA incorporates two
main components: an analytics engine, made up of two sub-engines: the DR engine and
the CA engine; and an interactive visualization engine, made up of the DR view and the
CA view. The main contribution of VALENCIA is to bring a wide range of state-of-theart and traditional analysis techniques, integrate them seamlessly, and make them
accessible through interactive visualizations. VALENCIA offers a balanced distribution
of processing load between users and the system through a proper integration of analytics
techniques (i.e., the DR and CA engines) with visual representations (i.e., different
interactive views in the interactive visualization engine) to facilitate the performance of
high-level cognitive tasks. Through a real case study, we have demonstrated how
VALENCIA can be used to analyze the healthcare administrative dataset of older patients
who visited the hospital or emergency department in Ontario between 2014 to 2016.
Through the formative evaluations conducted during the participatory design process, we
have seen that VALENCIA assists healthcare experts in 1) exploring datasets using
different DR and CA techniques, 2) generating hypotheses, 3) identifying relationships
among data items, 4) evaluating results of the analysis, and 5) recognizing patterns and
trends that would be otherwise difficult to identify without such a system. A number of
training materials have been prepared to assist new users in getting familiar with the
system. Users at the ICES-KDT program were able to identify suitable analysis
techniques and configuration settings for their health administrative datasets. They got
familiar with different analytics techniques quickly while exploring them through
VALENCIA, although they never worked with those techniques before. They also have
reported that the interactive visual interface makes it easy for them to explore the analysis
results.
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In terms of the scalability and extensibility of VALENCIA, we designed it in a modular
way so that it can easily accept new data sources and analysis techniques (both DR and
CA). VALENCIA can be used to analyze high-dimensional datasets in many other
domains, such as insurance, biotechnology, finance, and image processing.
The study should be evaluated with respect to four limitations. The first one is that, as the
size of the dataset grows, its computational time for the DR and CA techniques increases;
this limits the real-time functionality of the interactive visualizations. The second
limitation is that, even though we have had a participatory design and healthcare experts
have evaluated VALENCIA and have found it helpful and usable, we have not conducted
any formal studies to assess its performance, nor the efficiency of its human-data
discourse mechanisms. Third, since the system has been designed for a healthcare
organization, we have not tested the performance of the system on any other domain
except healthcare. Fourth, some subviews of the system may not function properly if the
number of features in the dataset gets too large due to limitations of screen space and
computational resources.
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Chapter 6

6

Predicting Acute Kidney Injury: A Machine Learning
Approach using Electronic Health Records

This chapter is accepted for publication as S.S. Abdullah, N. Rostamzadeh, K. Sedig,
A.X. Garg, and E. McArthur, “Predicting Acute Kidney Injury: A Machine Learning
Approach using Electronic Health Records” in the Information Journal, July 2020. We
changed the format to match the general format of the dissertation. The Figure, Table,
and Section numbers specified herein are relative to the chapter number. For example,
“Table 1” corresponds to Table 6-1; “Figure 1” corresponds to Figure 6-1; and “Section
1.1” corresponds to Section 6.1.1. Moreover, when the term “paper”, “research”, or
"work" is used, it refers to this specific chapter.

6.1 Introduction
Acute kidney injury (AKI) is common among patients admitted to hospitals, affecting
approximately 10% of hospitalized patients and more than 25% of patients in the
intensive care unit (Porter et al., 2014; Selby et al., 2012). AKI is defined as an abrupt
loss of kidney function over a short period of time [2]. AKI may lead to prolonged
hospital stays, lower chance of survival, and a higher risk of developing chronic kidney
disease. Over the last 10-15 years, the incidence rate of AKI has increased in the United
States (Nadkarni et al., 2016; Wu et al., 2014), the United Kingdom (Kolhe et al., 2016),
and Canada (Liu et al., 2010; Mehrabadi et al., 2014). The growing incidence rate of AKI
is associated with the changing spectrum of diseases. There is an increasing body of
evidence proving that patients with extrarenal complications and multiple comorbidities
are at a greater risk of developing AKI (Mehta et al., 2004; Siddiqui et al., 2012). Aikar et
al. (Waikar et al., 2006) have shown that the high comorbidity rate, measured by the
Deyo-Charlson comorbidity index, is associated with AKI. As a patient's number of
comorbid conditions grows, there is a rise in associated physician visits, healthcare
utilization, medication intake, and hospitalizations (Zulman et al., 2014), ultimately
leading to an increase in healthcare expenditure. Given the associated risk and expense, a
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promising strategy is required to improve the care for AKI patients. However, a UKbased report published in 2009 demonstrated significant under-recognition of AKI,
leading to delayed recognition, inadequate treatment, and ineffective monitoring (Ali et
al., 2007; Bagshaw et al., 2007).
Thus, there is a rising demand for techniques that can be used for the detection of AKI.
However, the complex pathophysiology and etiology of AKI make the diagnosis and
management of this disease challenging. There are different guidelines such as RIFLE
(Eriksen et al., 2003), AKIN (Palevsky et al., 2013), WRF (Gottlieb et al., 2002) and
KDIGO (Clinical Practice Guideline, 2012) for AKI diagnosis. Most of these guidelines
rely on a rise in serum creatinine (i.e., a laboratory test) alone as the gold standard.
However, serum creatinine-based guidelines are often not ideal for the diagnosis of AKI
among older patients because the age-related deteriorations in glomerular filtration rates
affect the baseline measure (Kate et al., 2016). Another limitation of this measurement is
due to the fact that serum creatinine may vary with muscle mass since it is a product of
muscle catabolism (Delanaye et al., 2017). In addition, serum creatinine-based guidelines
require a premorbid serum creatinine value to be used as a baseline creatinine, which may
not be available for all patients (Mohamadlou et al., 2018). Although some guidelines
also rely on urine output to diagnose AKI, it is only monitored for patients with reduced
kidney function (Kate et al., 2016). Despite these challenges, even if AKI can be
diagnosed properly, the clinicians often fail to intervene due to a lack of time and
treatment options. The treatments of AKI are primarily focused on avoiding nephrotoxic
medications and administering supportive care (Clinical Practice Guideline, 2012).
Although more advanced treatments are identified in recent years, their effectiveness has
not been proven in clinical trials yet (Pozzoli et al., 2018). Thus, interventions often have
poor performance if a patient has developed AKI already (Lieske et al., 2014; Mehta,
2011). So, it is more effective to predict AKI prior to its diagnosis. A number of recent
studies have shown that AKI is predictable and avoidable if early risk factors can be
identified using Electronic Health Records (EHRs). For instance, Kate et al. (2016) have
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revealed that it is possible to predict up to 30 percent of AKI cases in the hospital settings
using the patient data stored in EHRs (Kate et al., 2016).
EHR contains patient medical records, such as comorbid conditions, medications,
laboratory test results, diagnosis codes, demographics, and discharge summaries, which
can be used for the risk profiling of patients (Mohamadlou et al., 2018; Rostamzadeh et
al., 2020). With the evolution of EHRs and the widespread use of information technology
systems, these medical records are available nowadays for subsequent reuses (Abdullah
et al., 2020a, 2020b; Abramson et al., 2011; Delamarre et al., 2015). EHRs offer an
opportunity to employ machine learning techniques to recognize risk factors associated
with AKI and identify patients at risk of developing AKI. Several clinical decision
support systems have been developed in recent years for earlier detection of AKI using
machine learning techniques (Abdullah et al., 2020c; Cheng et al., 2017; Davis et al.,
2017; Gameiro et al., 2020; Ibrahim et al., 2019; Rashidi et al., 2020; Tran et al., 2019).
However, many of these systems suffer from various performance and design related
issues such as lack of predictive power, substantial trade-offs between sensitivity and
specificity, a limited number of machine learning techniques, small population size, lack
of predictors, and limited patient populations (Gameiro et al., 2020; Mohamadlou et al.,
2018).
This study is designed to predict AKI among hospitalized and emergency department
patients using machine learning techniques. We incorporate ICES' healthcare
administrative datasets containing one million older patients' medical records who visited
the hospital or emergency department between 2014 and 2016. We developed 31
prediction models based on different combinations of two sampling techniques, three
ensemble methods, and eight classifiers. Our study differs from other studies in several
ways: (1) we developed prediction models for patients who are at risk of developing AKI
within 90 days timeframe after being discharged from hospital or emergency department;
(2) we included a large number of predictors to train the models; and (3) we validated the
important features of each model with healthcare experts through formative evaluations
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to improve the performance and reliability of the models. The rest of this study is
organized as follows. Section 2 describes the methodology employed for the design of the
study. Section 3 presents the experimental results. Finally, Section 4 includes the
discussion, and Section 5 describes the limitations of the study.

6.2 Materials and Methods
We discuss the data sources and methodology in this section that includes the design
process, settings, design flow, data integration, cohort entry criteria, input features,
outcomes, and proposed machine learning techniques.

6.2.1

Design Process and Participants

As a part of continuing clinical research, medical experts usually conduct clinical trials
and case studies in their areas of expertise. In many situations, the result of these clinical
studies is not reproducible due to limited and specific population size. Machine learning
can help healthcare experts evaluate the relevance of such studies and explore more
complicated relationships among data elements. Despite the advantages, one significant
drawback of the machine learning approach is a general lack of interpretability. Thus, it is
underexplored in clinical studies as most of the healthcare experts often find it difficult to
understand these models and results (Spasic and Nenadic, 2020). On the other hand,
although computer science experts are more experienced in working with machine
learning techniques, they are not familiar with clinical terms. It becomes difficult for
them to interpret and validate the analysis results without the help of domain experts. To
address this issue, we adopted a participatory design approach to conceptualize and
design our study. It is a co-operative approach that includes all stakeholders (e.g., users,
designers, and evaluators) in the process to make sure the result of the analysis meets
their needs (Muller, 2007). A clinician, a statistician, an epidemiologist, and several data
scientists participated in the conceptualization, design and evaluation process of this
study. During the primary stage of the design process, we came to know that healthcare
experts perform studies to predict diseases in many different ways. There is no single
correct analysis technique because different techniques have their strengths and
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weaknesses, and the selection of an appropriate technique for a task is not
straightforward. As such, we invited healthcare experts in our team to provide us with a
list of analysis techniques, which they usually practice. We decided to employ both
traditional and state-of-art analysis techniques to build trust with end-users and, at the
same time, allow them to explore complex relationships in the dataset.

6.2.2

Study Design and Setting

We conducted a population-based retrospective cohort study in older patients who visited
a hospital or emergency department between April 1st, 2014 and March 31st, 2016, using
health administrative databases stored at ICES. These datasets were connected using
unique encoded identifiers and analyzed at ICES.
Ontario has a population of about 13 million residents with universal access to physician
services and hospital care, which includes 1.9 million people aged 65 years or older. We
suppressed the results of this study in cells with five or fewer patients to comply with
ICES privacy regulations and minimize the possibility of reidentification of patients.

6.2.3

Workflow

Figure 1 shows the basic workflow of the study described in this paper. In the first step,
we created an integrated dataset from five different health administrative databases. The
data sources are discussed in Section 2.4. Next, we describe the inclusion and exclusion
criteria in Section 2.5. The features in the comorbidity, prescription, demographic, and
hospital admission codes data were encoded and transformed into suitable forms for the
analysis in the preprocessing stage, which is discussed in Section 2.8. The analysis
techniques and results are presented in Section 2.9 and 3, respectively.
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Figure 6-38: Workflow diagram of the presented study where different colours are
used to represent three main parts (data integration and preprocessing, analysis and
validation). The figure shows how different combinations are formed using two
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sampling techniques (i.e., under sampling and SMOTE), three ensemble methods
(i.e., boosting, bagging, and XGBoost), and eight machine learning classifiers.

6.2.4

Data Sources

We ascertained patient characteristics, drug prescriptions, outcome and medical history
data from 5 administrative databases (as shown in Appendix A). These datasets are linked
using a unique identifier, which is derived from health card numbers. We collected vital
statistics from the Ontario Registered Persons Database, which includes demographic
data of all residents in Ontario who have a valid health card. We utilized the Ontario
Drug Benefit Program database to get prescription medication use data. Ontario Drug
Benefit Program holds all the outpatient prescription records dispensed to older patients,
which has an error rate of less than 1% (Levy et al., 2003). We ascertained baseline
comorbidity, emergency department visit, and hospital admission data from the National
Ambulatory Care Reporting System (i.e., for the emergency department) and the
Canadian Institute for Health Information Discharge Abstract Database (i.e., for hospital
admissions). We applied the ICD-10 (i.e., International Classification of Diseases, post2002) codes to identify baseline comorbidities within the look-back window. In addition,
Baseline comorbidity data were acquired from the Ontario Health Insurance Plan
database, which holds claim records for physician services. ICES Physician Database was
used to obtain the demographic, education, practice, and specialty information on all
physicians. All the coding definitions for the comorbidity databases are provided in
Appendix B.

6.2.5

Cohort Entry Criteria

We identified a cohort of individuals aged 65 years or older who visited the emergency
department or were admitted to hospital between 2014 and 2016 (Figure 2). The hospital
admission or emergency department discharge dates were taken as the cohort entry or
index date. If a patient had multiple hospital admissions and emergency department
visits, we chose the first incident. We excluded patients with invalid or missing age, sex,
and health card number. In addition, we excluded patients who: (1) previously underwent
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a kidney transplant or dialysis treatment as AKI is usually no longer relevant once
patients develop end-stage kidney disease; (2) left the emergency department or hospital
without being seen by a physician or against medical advice; and (3) developed AKI
during emergency department visit or hospital admission as they are already under
observation. The diagnosis codes for the exclusion criteria are presented in Appendix C.

Figure 6-39: Provides an overview of data creation plan and how we prepared the
final cohort.

6.2.6

Input Features

We used the Chi-Square test for feature selection and then filtered the selected features
with a healthcare expert. The final cohort included about one million patients and a total
of 86 unique features. The cohort contained eleven comorbidity features—namely,
chronic kidney disease, diabetes mellitus, cerebrovascular disease, coronary artery
disease, hypertension, chronic liver disease, major cancers, peripheral vascular disease,
heart failure, and kidney stones. We applied a 5-year look-back window to detect these
baseline comorbidities. There were four demographics features—namely, sex, age,
region, and income quintile. We included 55 medications that were prescribed to the
patients within 120 days before the first hospital admission or emergency department
visit. These medications belonged to thirteen distinct drug classes—namely, ACEinhibitors (blood pressure and heart failure), beta-blockers (blood pressure), alphaadrenergic blocking agents (blood pressure), angiotensin-receptor blockers (blood
pressure), calcium blockers (blood pressure), macrolides (antibiotics), fluoroquinolones
(antibiotics), potassium-sparing diuretics (weak diuretic), other diuretics, nonsteroidal
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anti-inflammatory agents (pain relievers), oral hypoglycemic (diabetes mellitus), and
immunosuppressive agents (immune system activity).
The cohort also included sixteen ICD-10 diagnosis codes that were identified during the
index hospitalization or emergency department visit. The codes were related to delirium,
mycoplasma pneumoniae, disorders of fluid, electrolyte and acid-base balance (e.g.,
hyperosmolality and hypernatraemia, hypo-osmolality and hyponatraemia, acidosis,
alkalosis, mixed disorder of acid-base balance, hyperkalaemia, hypokalaemia, fluid
overload, and other disorders of electrolyte and fluid balance), atrial fibrillation, anemia,
femur fracture, valve disorders, atherosclerotic cardiovascular disease, diseases of the
digestive system (e.g., paralytic ileus, intussusception, volvulus, gallstone ileus, other
impaction of intestine, intestinal adhesions with obstruction, and other and unspecified
intestinal obstruction ileus), Certain infectious and parasitic diseases (e.g., sepsis due to
Staphylococcus aureus, other specified Staphylococcus, Haemophilus influenzae,
Escherichia coli, Pseudomonas, Serratia marcescens, other gram-negative organisms,
gram-negative Septicaemia, and Enterococcus), dehydration and other volume depletion,
abnormal function (e.g., abnormal results of function tests of central nervous system,
peripheral nervous system and special senses, pulmonary function tests, cardiovascular
function tests, kidney function tests, liver function tests, thyroid function tests, other
endocrine function tests, and electrocardiogram suggestive of ST-segment elevation
myocardial infarction , abnormal cardiovascular function tests, and other abnormal results
of cardiovascular function tests), chronic pulmonary (e.g., chronic obstructive pulmonary
disease with acute lower respiratory infection and acute exacerbation and other specified
chronic obstructive pulmonary disease), dementia, glomerular disorders (e.g., glomerular
disorders in infectious and parasitic diseases, neoplastic diseases, blood diseases and
disorders involving the immune mechanism, diabetes mellitus, other endocrine,
nutritional and metabolic diseases, and systemic connective tissue disorders), and
hyperplasia of prostate.
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6.2.7

Outcome: Identification of AKI

Machine learning models were built to predict AKI within 90 days after being discharged
from the hospital or emergency department. Positive cases were those in which patients
revisited hospital or emergency department with AKI within 90 days after being
discharged, and negative cases were the ones when hospitalizations or emergency
department visits with AKI never took place. There was a total of 899,449 negative and
5,993 positive cases in the dataset. There were no recurrent AKI examples (i.e., excluded
25,084 patients) in the data because we excluded the cases where AKI or dialysis was
acquired during the index hospital stay or emergency department visit.
The incidence of AKI was detected using the Canadian Institute for Health Information
Discharge Abstract Database and National Ambulatory Care Reporting System based on
the ICD-10 (International Classification of Diseases - Tenth Revision) diagnostic codes
(i.e., ICD-10 code of AKI is "N17").

6.2.8

Data Preprocessing

For each feature described in Section 2.5, the last recorded value before the first hospital
admission or emergency department visit was captured. Medication, diagnosis code, and
comorbidity features were set to either "Y" or "N." If a patient had a certain comorbid
condition or was prescribed a medication, then its corresponding value was taken as "Y."
Instead of reporting individual ages, we calculated age group features for the patients. If a
patient's age laid within the specified range of an age group, we set the value to "1" for
that corresponding feature. The sex feature took either "M" or "F" if the information is
available in the dataset. Patients with invalid age or sex were removed from the cohort.
The region feature took either "R" or "U" to represent rural and urban, respectively. The
income feature took an integer value ranged between 1 to 5 to represent the income
quintile of a particular patient.
All these features from different data sources were integrated using the encoded
identifiers derived by ICES using patient health card numbers. The features in the cohort
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were transformed into a format and scale that was suitable for the machine learning
techniques. For each patient, we aggregated multiple values (rows) of a single feature
into one by considering the latest values of that feature.

6.2.9

Analysis using Machine Learning Techniques

We employed both traditional and state-of-art analysis techniques to build trust with endusers and, at the same time, allow them to explore complex relationships in the dataset.
We developed 31 AKI prediction models based on combinations of eight classifiers—
namely, classification and regression tree (CART) (Wilkinson, 2015), C5.0 (Quinlan,
2014), naïve Bayes (NB) (Lewis, 1998), logistic regression (Bahnsen et al., 2014), and
support vector machine (SVM) with four different kernels (linear, polynomial, sigmoid,
and radial) (Cristianini and Shawe-Taylor, 2000), two sampling techniques—namely,
under sampling and SMOTE, and three ensemble methods—namely, Boosting, Bagging,
and XGBoost. These techniques are chosen for several reasons: 1) They each represent
different types of machine learning methods. For example, the decision tree is a rulebased, regression is a statistical, and naïve Bayes is a probability-based method. 2) Each
of these methods has its own set of advantages and limitations. For instance, decision tree
models are more human-interpretable but often fail to represent complex relationships
among data elements. On the contrary, SVM is equipped to model complex non-linear
relationships using different kernels but difficult to interpret. 3) Medical experts are more
familiar with regression than other machine learning algorithms, which convinced us to
include regression in this analysis.

6.2.9.1

Ensemble-Based Methods

Since the number of negative cases was significantly higher than the number of positive
cases, we considered the dataset as highly imbalanced. Traditional machine learning
techniques that are designed to optimize the overall accuracy tend to achieve poor
performance in this class imbalanced learning scenario. An ensemble method offers a
solution to this problem by combining several classification models to obtain better
performance than the base classifiers (Dietterich, 2000). To deal with the class imbalance
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issue in this study, we incorporated four different combinations of ensemble and
sampling methods—namely, SMOTEBoost, SMOTE-Bagging, UnderBagging, and
RUSBoost that are available in the "embc" package of R (Barandela et al., 2003; Freund
and Schapire, 1997; Wang and Yao, 2009). The RUSBoost was implemented using the
"rus" function in the "ebmc" package. The weak learners in RUSBoost are trained on
random under-sampled datasets (Seiffert et al., 2010). Those learners are then combined
to generate the final ensemble model. We used the "sbo" function to implement
SMOTEBoost. SMOTE (Synthetic Minority Oversampling Technique) is a sampling
technique that synthesizes new instances for the minority class using the k-nearestneighbours algorithm (Chawla et al., 2002). SMOTEBoost returns several weak learners
that are trained on SMOTE-generated datasets along with their error estimations (Galar et
al., 2012). The "sbag" function was used to implement SMOTEBagging, which combines
SMOTE and random over-sampling to rebalance the dataset [44]. We used the "ub"
function to implement the UnderBagging method. Unlike other ensemble methods
discussed above, UnderBagging only incorporates random under-sampling to reduce the
instances of the majority class in each bag to rebalance the class distribution. We
configured this function in such a way that the amount of majority instances became
equal compared to the minority instances (i.e., imbalance ratio = 1). We used NB, SVM,
CART, and C50 as weak learners for the ensemble methods, which are discussed in the
following subsections.

6.2.9.1.1

Support Vector Machine

The objective of the SVM is to find an optimal separating hyperplane in a multidimensional space (i.e., depending on the number of features) that distinctly divides the
instances of different classes. Although SVM models are often not human-interpretable,
it has been proven to work well on prediction tasks involving a large number of features
[18]. It has become popular in healthcare research recently because it is more effective in
analyzing high dimensional EHRs. In addition, the regularisation parameters of SVM
kernels help users avoid over-fitting. Since the performance of the models widely varies
depending on the selection of the kernel (Tomar and Agarwal, 2013) and kernels are
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quite sensitive to over-fitting (Cawley and Talbot, 2010), one of the main challenges is to
select an appropriate kernel. Thus, we tested the performance of four well-known kernel
functions in this study—namely, linear, polynomial, sigmoid, and radial.

6.2.9.1.2

Decision Tree

A decision tree is the representation of possible outcomes of a decision depending on
certain conditions (Quinlan, 2014). It is similar to a flowchart where every non-leaf node
represents a test for a specific feature, and the leaf node represents a particular outcome.
Decision tree reduces the ambiguity of complicated clinical decisions and requires
reduced effort for data preparation compared to other techniques. It can be an effective
technique to analyze datasets with missing values because the tree-building process is not
affected by the missing data (Niuniu and Yuxun, 2010). We choose the decision tree
mainly because it is easy to interpret and understand. Despite the advantages, decision
tree models are often volatile, meaning that a minor alteration in the training data may
cause a massive change in the structure of the tree. To overcome this issue, we included
other types of base classifiers along with decision tree and verified the structure of the
generated tree with a healthcare expert. We incorporated two different algorithms to
develop decision tree models in this study. The classification and regression tree (CART)
were implemented using “rpart” package (Wilkinson, 2015), and the C5.0 classifier was
implemented using the “C50” package in R (Quinlan, 2014).

6.2.9.1.3

Naïve Bayes

NB is a simple probabilistic classifier established on Bayes theorem (Lewis, 1998), which
is exceptionally fast to train compared to other complex techniques (Tomar and Agarwal,
2013). Classification of the new data using this technique only requires mathematical
operations based on the feature probability. We choose NB mainly because it is less
sensitive to missing data. However, since this technique is designed based on the
assumption of feature independence, the performance may deteriorate when features in
the training data are related. We used the "naive Bayes" package to implement the NB
algorithm in this study (McCallum and Nigam, 1998).
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6.2.9.2

Logistic Regression

Logistic regression draws a separating line among the classes using the training dataset
and then applies that line to classify the unknown data points. It is used to analyze the
relationships between one dependent feature and one or more independent features.
Logistic regression models are informative as they reveal the association among features
in terms of odds ratios. Over the last decades, logistic regression techniques have become
very popular in healthcare studies (Ismail and Anil, 2014). Although logistic regression
models are not designed to support imbalanced classification directly, they can be
modified to work with skewed distributions. In order to adjust the regression coefficients
while training with the imbalance data, we implemented a cost-sensitive regression
model. We adjusted the weight of the minority class based on the cost of its
misclassification compared to the cost of misclassifying the majority class. We used
internal 10-fold cross-validation during training to determine the appropriate weight for
the minority class.

6.2.9.3

XGBoost

XGBoost (i.e., eXtreme Gradient Boosting) is an advanced implementation of gradient
boosted decision trees that can be used for ranking, regression, and classification
problems (Chen and Guestrin, 2016). One of the main advantages of XGBoost is that it
supports parallel computation, which makes it faster than other implementations of
gradient boosting. Because of its time complexity and performance superiority, it has
been widely used in healthcare research, such as analysis of EHRs (C. Wang et al., 2018)
and cancer diagnosis (C.-W. Wang et al., 2018). We used the "xgboost" package to
implement XGBoost in R. Since this implementation of XGBoost only works with
numeric data, we converted the categorical features in our dataset into numerical vectors.
The "xgboost" package includes both a tree learning algorithm and linear model solver.
We implemented both algorithms to compare their performance. This package has a
built-in mechanism to control the balance of positive and negative weights as well. To
train the models with unbalanced data, we adjusted the "scale_pos_weight" parameter
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based on the ratio of the negative class to the positive class (Wang et al., 2019). We
performed a grid search on the parameters of XGBoost and tuned the regularization
parameters using the best parameters from the grid search.

6.2.10

Tools and Technologies

We primarily used two different data analysis software: SAS and R. SAS was used to cut
and process the cohort because ICES health administrative databases were stored in a
SAS server (“SAS Enterprise BI Server,” n.d.). We used SAS programming, SQL, and
predefined macros to prepare data for analysis. Then we loaded the preprocessed dataset
in R packages (“RStudio | Open source & professional software for data science teams,”
n.d.) for additional analysis using machine learning techniques. We chose R mainly
because it 1) is installed on the ICES workstations already, 2) has a rich array of machine
learning libraries, 3) is open-source and platform-independent, and 4) is continuously
providing updates with new libraries.

6.3 Results
This section presents the results of this study. We divided the results into two
subsections. First, we provide an overview of the dataset in Subsection 3.1. The results of
predictive models are presented in Subsection 3.2.

6.3.1

Cohort Characteristics

A total of 905,442 participants were included in the derivation cohort, of which 5,993 had
AKI during their hospital admission or emergency department visit after being
discharged from the index encounter. We excluded 25,084 patients who developed AKI
during the index hospitalization or emergency department visit. Selected characteristics
of the derivation cohort are presented in Table 1.
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Table 6-10: Baseline characteristics of patients in the cohort who were admitted to
the hospital or visited the emergency department between 2014 and 2016.
Characteristics

Cohort size
Age, yr, mean (SD)
65 to <70
70 to <80
80 to <90
>=90
Sex
Women
Year of cohort entry (index date)
2014-2015
2015-2016
Location
Rural residence
LTC
Long-term care
Income Quintile
1 (lowest)
2
3
4
5 (highest)
Comorbid conditions (by codes)
Hypertension
Diabetes
Heart failure
Coronary artery disease
Chronic liver disease
Cancer
Chronic kidney disease
Kidney stones
Peripheral vascular disease
Cerebrovascular disease
Hospital Diagnosis Codes
Disorders of fluid, electrolyte and
acid-base balance (E87)
Delirium (F05)
Atrial fibrillation (I48.91)
Mycoplasma pneumoniae (B96)
Anaemia (D64.9)
Valve disorders (I35)
Fracture of femur (S72)
Atherosclerotic cardiovascular
disease (I25.10)
Volume depletion (E86.9)
Diseases of the digestive system
(K00-K95)
Abnormal functions of organs and
systems (R94.8)
Chronic pulmonary (J81.1)

Patients admitted to hospital or visited ED
Total Patients

AKI

No AKI

905,442

5993

899,449

181,088 (20%)
371,231 (41%)
269,147 (30%)
81,489 (9%)

589
1911
2485
1008

180,499
369,320
269,147
80,481

507,047 (56%)

2901

504,146

588,537 (65%)
316,904 (34%)

3987
2006

584,550
314,898

144,870 (16%)

501

144,369

36,217 (4%)

745

35,472

172,035 (19%)
189,143 (21%)
182,588 (20%)
181,086 (20%)
180,590 (20%)

1,306
1,318
1,173
1,154
1,043

170,729
187,825
181,415
179,932
179,547

814,604 (88%)
358,472 (38%)
125,136 (14%)
239,437 (26%)
33,359 (4%)
145,286 (16%)
86,442 (9%)
12,457 (1%)
13,197 (2%)
25,835 (3%)

5784
3306
1821
2005
297
1016
1854
93
158
282

808,820
355,166
123,315
237,432
33,062
144,270
84,588
12,364
13,039
25,553

13563 (1%)

962

12601

4996 (1%)
34120 (4%)
6197 (1%)
11814 (1%)
1261 (1%)
7263 (1%)

342
1978
434
791
186
231

4654
32142
5763
11023
1075
7032

21472 (2%)

1256

20216

3739 (1%)

240

3499

4552 (1%)

264

4288

11348 (2%)

725

10623

24217 (3%)

971

23246
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Hyperplasia of prostate (N40.1)
Certain infectious and parasitic
diseases (A00-B99)
Dementia (F03. 90)
Glomerular disorders (N08)

5047 (1%)

153

4894

1191 (1%)

105

1086

8714 (1%)
3988 (1%)

390
569

8324
3419

All the patients in the cohort were aged 65 years or older, where the mean age was 70
years. Among the participants, about 56% were women. About six percent of patients
were in long term care, and sixteen percent were from rural areas. The pre-existing
comorbidities were diabetes (38%), hypertension (88%), major cancer (16%), coronary
artery disease (25%), cerebrovascular disease (3%), heart failure (14%), chronic kidney
disease (9%), kidney stones (1%), and peripheral vascular disease (2%). Some of the
commonly prescribed medications were rosuvastatin calcium (22%), atorvastatin calcium
(24%), amlodipine besylate (19%), metformin hcl (16%), and hydrochlorothiazide (20%).

6.3.2

Classification Results

We evaluated all of the machine learning models using 10-fold cross-validation
(Japkowicz and Shah, 2011). The cohort was divided into ten equal groups, where nine
groups were used for training, and the tenth group was used for testing. We repeated this
process ten times, using different parts for training and testing, and assessed the
performance of the models for each fold. We then combined the results of these folds to
calculate the evaluation scores. We measured the validity of the tests in terms of
sensitivity and specificity. Sensitivity is the capacity of a test to classify an individual as
“at-risk” correctly. It represents the probability of a test being positive when “AKI” is
present. On the contrary, specificity refers to the ability to classify an individual as “riskfree” correctly. Since predicting AKI was a binary classification problem (i.e., AKI or
Non-AKI), all of the machine learning techniques were capable of providing a confidence
score along with the output. The trade-off between sensitivity and 1-specificity was
achieved by altering the threshold on the confidence scores, generating the receiver
operating characteristic (ROC) curve. We used the ROC space to compare the
performances of alternative tests in terms of 1-specificity and sensitivity. Thus, we
computed and reported sensitivity, specificity, and area under the receiver operating
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characteristic curve (AUROC). The AUROC ranged from 0.61 to 0.88 for predicting AKI
among 31 machine learning models. The average AUROC values of ensemble methods
were higher than the cost-sensitive logistic regression model. Among the sampling-based
ensemble methods, the performances of the UnderBagging and RUSBoost methods were
better than the SMOTE. We achieved the best result of AUROC 0.88 with 1) a
combination of RUSBoost and SVM using a sigmoid kernel and 2) XGBoost using a tree
learning algorithm. The AUROC of the linear boosting algorithm (XGBoost) was 0.84,
which was higher than the cost-sensitive logistic regression but lower than the tree
learning algorithm (XGBoost). Since it is a disease prediction problem, high sensitivity
was more useful than specificity. The highest sensitivity was 0.90, which was achieved
using SVM-sigmoid and SVM-radial kernels with RUSBoost and SMOTE-Bagging,
respectively. The complete list of performance measures is presented in Table 2.
Table 6-11: Performances of the machine learning techniques grouped by four
ensemble-based methods and results of XGBoost and cost-sensitive regression
analysis.
Ensemble-Based Methods
NA

SMOTEBoost

SMOTE-Bagging

UnderBagging

RUSBoost

Machine Learning Techniques
Logistic Regression
CART
C5.0
NB
SVM (linear)
SVM (polynomial)
SVM (sigmoid)
SVM (radial)
CART
C5.0
NB
SVM (linear)
SVM (polynomial)
SVM (sigmoid)
SVM (radial)
CART
C5.0
NB
SVM (linear)
SVM (polynomial)
SVM (sigmoid)
SVM (radial)
CART
C5.0
NB

Sensitivity
0.79
0.77
0.84
0.61
0.84
0.78
0.76
0.70
0.60
0.62
0.69
0.76
0.82
0.84
0.90
0.71
0.88
0.58
0.77
0.85
0.89
0.79
0.78
0.84
0.68

Specificity
0.72
0.69
0.78
0.89
0.74
0.82
0.85
0.83
0.71
0.84
0.73
0.84
0.73
0.71
0.74
0.83
0.76
0.72
0.84
0.71
0.71
0.90
0.74
0.77
0.72

AUROC
0.77
0.74
0.83
0.75
0.79
0.81
0.84
0.82
0.68
0.79
0.72
0.81
0.80
0.81
0.86
0.79
0.85
0.61
0.83
0.84
0.85
0.86
0.76
0.82
0.71
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XGBoost

SVM (linear)
SVM (polynomial)
SVM (sigmoid)
SVM (radial)
Tree boosting
Linear boosting

0.84
0.74
0.90
0.71
0.89
0.86

0.78
0.85
0.79
0.87
0.81
0.77

0.83
0.82
0.88
0.85
0.88
0.84

6.4 Discussion
In this study, we demonstrated how machine learning techniques could help with the
prediction of AKI using administrative health databases stored at ICES. Several machine
learning-based models have been developed in recent studies to predict AKI among
patients in ICU and post-operative (Abdullah et al., 2020c; Cheng et al., 2017; Davis et
al., 2017; Gameiro et al., 2020; Ibrahim et al., 2019; Rashidi et al., 2020; Tran et al.,
2019). However, most of these models only focus on a specific medical condition and
consider the risk factors associated with that condition. For instance, Go et al. (2010)
examined how AKI affects the risk of chronic kidney disease, cardiovascular events, and
other patient-related outcomes in hospital settings (Go et al., 2010). The earlier AKI can
be predicted, the better the chances are to prevent AKI and its associated cost. The
features that have been used in most of the existing studies work better in predicting AKI
if their values are recorded closer to the timing of AKI onset. However, it may not be
beneficial to detect AKI close to its onset because clinicians will not have enough time to
intervene. Thus, there is a trade-off between accuracy and usefulness, which can be
optimized using information available in EHRs. Although some studies have developed
risk stratification models for AKI using EHRs (Kane-Gill et al., 2015; Matheny et al.,
2010), they can only predict hospital-acquired AKI and do not consider patients who are
at risk of developing AKI after being discharged. To our best knowledge, there are no
previous studies in the literature that predict the risk of AKI after being discharged from
the hospital using both the historical and healthcare utilization data. Thus, this study is
not only novel but also clinically relevant because it provides clinicians with the ability to
intervene and treat patients before AKI cause irreversible damage.
We analyzed all AKI events that took place within 90 days after being discharged from
the hospital or emergency department and developed prediction models to identify high-
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risk patients. We decided to choose 90 days timeframe for following up because 1) out of
all AKI cases within six months after discharge, about 85 percent were acquired within
this timeframe; and 2) it was a reasonable timeframe considering the trade-off between
the models’ usefulness (from a clinical point of view) and predictive power (from a
machine learning point of view). Table 3 shows how many AKI acquired cases were
identified within different time intervals. The machine learning models presented in this
study can be adapted to make predictions at any other timeframes if needed.
We incorporated eight different machine learning classifiers and three ensemble methods,
and two sampling techniques to develop 31 prediction models. Although each
combination of machine learning techniques and ensemble-based methods performed
reasonably well, the performance of SVM with sigmoid kernel and tree-based XGBoost
produced better results than other techniques in general. The performance of all of the
ensemble-based methods were consistent and produced similar results for different base
classifiers. The results shown in Table 2 indicate that the models agreed with each other.
Table 6-12: The number of AKI cases are grouped into six time periods.
Intervals
1-3 days
4-7 days
8-14 days
15-30 days
31-60 days
61-90 days

Readmission with AKI
415
534
888
1517
3579
1499

To understand the models better, we explored the features that are important in each
prediction model. We analyzed this information with a nephrologist to confirm the
correctness of the models. We observed the odds ratio and p-value of the features in the
regression model, feature importance in decision tree and XGBoost models, and
coefficients in the SVM-linear models to understand the association between different
features and AKI. The features included in this study can be divided into four
categories—namely, demographics, comorbidities, medications, and diagnosis codes.
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In general, features from comorbidities and hospital diagnosis codes were more
associated with AKI. Although the importance of the features varied based on the
machine learning techniques, most of the features that stood out were common among
these models. For instance, diabetes mellitus, hypertension, coronary artery disease, heart
failure, major cancers, chronic liver disease, peripheral vascular disease, and chronic
kidney disease were the comorbidity features that were important in most of the
prediction models. These comorbid conditions are already known to be associated with
AKI in the literature (Dylewska et al., 2019; Girman et al., 2012; Hsu and Hsu, 2016;
Olsson et al., 2013; Rydén et al., 2014). The medication features that contributed to the
higher risk of AKI include furosemide, allopurinol, hydrochlorothiazide, atorvastatin,
metolazone, sunitinib malate, spironolactone, dexamethasone, chlorthalidone, atenolol,
dexamethasone and oseltamivir phosphate. These medications are known to be
nephrotoxic (Chao et al., 2015; Ho and Power, 2010; Perez-Ruiz, 2017; PiersonMarchandise et al., 2017; Verdoodt et al., 2018; Wu et al., 2014). Delirium, anaemia,
mycoplasma, fluid disorders, atrial fibrillation, atherosclerotic cardiovascular disease,
mycoplasma pneumoniae, hyperplasia of prostate, glomerular disorders, and valve
disorders were the features belonging to the diagnosis codes that were associated with
increasing the risk of AKI in the prediction models. Several studies in the literature
associate these medical conditions with AKI (Carrara et al., 2017; Godin et al., 2013; Ng
et al., 2016; Siew et al., 2017; Zaleska-Kociecka et al., 2019). Among the demographic
features, age, sex, location (i.e., urban or rural residence), and long-term care were found
to be associated with AKI in most of the prediction models. Similar to comorbidity,
medication, and diagnosis code, these demographic features are already known to be
associated with AKI (Evans et al., 2017; Neugarten and Golestaneh, 2018; Yokota et al.,
2018) in the literature, which more conclusively proves the correctness of the prediction
models. Through a comprehensive analysis of ICES' healthcare administrative datasets,
this study shows that AKI is predictable using EHRs. Successful implementation of these
prediction models in a healthcare setting can potentially reduce the risk of AKI among
older patients.

175

6.5 Limitations and Future Work
The study should be evaluated with respect to several limitations. First, our models were
trained and tested on a cohort of older patients (65 years or older), which limits the
generalizability of the models. Second, we excluded patients with missing or invalid
demographics information. This may affect the performance of the models if the
excluded data includes any interesting or rare cases. Third, the models are based on a
cohort containing Ontario patients only, which limits this study to a specific geographic
location. Fourth, the proposed prediction models are trained and tested on a specific
patient cohort. It is essential to test the models' performance with real-time medical data
before applying them in a clinical setting. Fifth, since we developed 31 prediction
models, and many of them have different mechanisms to identify feature importance, the
interrelationships produced by these models are very complex. This study only identifies
the most significant predictors but does not incorporate any rankling system for
predictors. Finally, we identified the episode of AKI using ICD-10 codes, which may not
include undetected cases in hospital settings. Moreover, since AKI was identified using
the diagnosis code, this study does not consider the severity of AKI. Our future work
concerns a deeper analysis of severe AKI that requires dialysis.

6.6 Conclusion
AKI is characterized by a sharp decline in renal function and associated with increased
health-related costs and mortality. AKI is avoidable and may be preventable through an
earlier prediction using risk factors available in EHRs. This study is designed to identify
older patients who are discharged from the hospital or emergency department and at risk
of developing AKI within 90 days after discharge. We employ eight traditional and stateof-art machine learning classifiers along with two sampling techniques, and three
ensemble methods to build AKI prediction models. The performances of these models
were consistent, and a maximum AUROC of 0.88 was achieved through 10-fold crossvalidation. We analyzed the models with a healthcare expert and identified features that
are most relevant in predicting AKI. Most of these features are already known to be AKI-
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associated, which proves the correctness and feasibility of the prediction models. This
study predicts the risk of AKI for a patient after being discharged from the hospital or
emergency department, which provides healthcare providers enough time to intervene,
monitor them more carefully, and avoid prescribing nephrotoxic medications for such
patients.
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Chapter 7

7

Conclusion

This dissertation has discussed several aspects relating to the design of VA for EHRs.
First, a systematic literature survey has been conducted to analyze the design and
implementation of existing EHR-based systems. We then presented a framework to
evaluate EHR-data-driven tasks and activities in the existing systems. The gaps that we
identified during the analysis with the framework motivated us to design new EHR-based
VA systems. Therefore, we designed and developed two novel VA systems—namely,
VISA_M3R3 (VISual Analytics, VISA for Multiple Regression analyses and fRequent
itemset Mining of electronic Medical Records, M3R3) and VALENCIA (Visual
Analytics for Cluster Analysis and Dimension Reduction of High Dimensional Electronic
Health Records). We also conducted two independent population-based retrospective
cohort study to test the hypothesis and ideas generated from the VA systems. These
systems and studies are designed to assist the healthcare researchers at the ICES-KDT
program. We demonstrated the effectiveness of the proposed systems by investigating the
process of analyzing the health administrative data housed at ICES to solve different
AKI-related problems.
This chapter, which serves as a conclusion of the dissertation, is divided into three
sections: 1) a review of the chapters and some of their contributions, 2) general
contribution of this dissertation to the scientific literature, and 3) some future research
areas.

7.1 Dissertation Summary
In Chapter 2, we have presented a framework to examine EHR-data-driven activities and
tasks in the context of interactive visualizations. Using a literature survey of 19 EHR-based
existing systems, we demonstrated how different combinations of sub-tasks, tasks, and subactivities work together to help users achieve their overall goals in the system. The
proposed framework can help 1) designers to conceptualize activities, sub-activities, tasks,
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and sub-tasks of new systems, 2) researchers to understand the design concepts in a
systematic way, and 3) evaluators to assess existing EHR-based interactive visualization
systems.
In Chapter 3, we described how VA systems could be designed systematically to support
EHR-driven tasks and investigate complex clinical problems. We developed VISA_M3R3
that integrates multiple statistical and machine learning techniques with interactive
visualization to identify potentially nephrotoxic medications. VISA_M3R3 has shown to
assist healthcare researchers in 1) comparing multiple logistic regression models, 2)
understanding the relationships among predictors and response variable, 3) identifying
frequent itemsets from items of interest, and 4) interpreting regression results.
VISA_M3R3 can also be used to develop an alert system to raise physicians’ awareness of
AKI-associated medications. This, in turn, will prompt healthcare providers to carry out
additional clinical investigations on these high-risk medications.
VISA_M3R3 only visualizes regression models of medication combinations but do not
investigate how individual medications within combinations are affecting AKI. In Chapter
4, we presented a population-based retrospective cohort to overcome this limitation and
understand the synergistic effect of AKI-inducing medication combinations more
comprehensively. Through an investigation of prescription records of one million adult
patients stored in the ICES datasets, we identified 55 AKI-inducing medications among a
total of 595 medications and 78 AKI-inducing medication combinations among a total of
7,748 frequent medication groups. We also identified 37 cases where a medication is
associated with increased risk of developing AKI when combined with another medication.
Finally, we performed an electronic literature search and consulted with a nephrologist to
verify the findings of this study. Although many of the medications and medication
combinations that we detected are already known to be nephrotoxic, some of them have
not been investigated before. This study will assist healthcare researchers in identifying
candidates for future drug-safety studies.
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In Chapter 5, we explained how VA systems could be designed to address the challenges
of high-dimensional EHRs. We introduced VALENCIA that integrates a wide range of
traditional and state-of-the-art analysis techniques with several interactive visualizations to
provide a deeper understanding of the structure of data, results, control parameters, and
analytical processes. We have demonstrated the utility of VALENCIA using a case study.
Through a number of formative evaluations, we have found that VALENCIA assists
healthcare providers in 1) exploring EHRs using different dimension reduction and
clustering techniques, 2) identifying relationships among different features, 3) generating
hypotheses, and 4) comparing results of different analysis techniques.
We identified multiple risk factors of AKI while performing a cluster analysis of the ICES
dataset using VALENCIA, which motivated us to design another study for predicting AKI.
In Chapter 6, we employed a number of machine learning techniques to develop prediction
models to identify patients who were at risk of developing AKI within 90 days after they
were discharged from the emergency department or hospital. We included demographics,
comorbid conditions, medications, and hospital diagnosis codes as predictor variables. A
total of sixteen prediction models based on combinations of four machine learning
techniques and four ensemble-based methods, along with a cost-sensitive logistic
regression model, were developed for this study. The performances of these models were
consistent, and we achieved an AUROC of 0.88 through ten-fold cross-validation.

7.2 General Contributions
As described in Chapter 1, the broad concern of this research surrounds the design of
visual analytics for EHRs. Currently, there is a scarcity of research in this field, and
therefore, we intended to bridge the gap through this work. This dissertation presents the
design process of human- and activity-centered computational systems for healthcare. It
is often challenging to fulfill the computational and cognitive demands of healthcare
providers when designing such systems. This dissertation also describes how different
EHR-related challenges can be addressed by combining statistical methods, data mining
algorithms, machine learning techniques, and information visualization. It demonstrates
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how VA systems can be designed systematically and how healthcare providers'
capabilities to interact with machine learning processes can be improved by VA. In
addition, this dissertation offers the healthcare domain with evidence of the effectiveness
of VA for managing EHRs. This research has suggestions for other domains that require
their data to be made accessible and analyzable through VA.
Through a systematic survey in Chapter 2, this dissertation provides a detailed analysis of
the EHR-data-driven tasks and activities supported by the existing interactive
visualization systems, which was lacking in the literature. Moreover, the proposed
activity and task analysis framework is helpful for the designer and evaluators of any
EHR-based visualization system. This framework will lead to the development of best
practices for designing related frameworks in other domains.
Another contribution of this dissertation is the VA systems, VISA_M3R3 and
VALENCIA, that are discussed in Chapters 3 and 5. To help us learn how healthcare
providers perform real-world tasks, and to help us design and develop these systems, we
adopted a participatory design approach. We performed formative evaluations at every
step of the design and development process with the stakeholders at the ICES-KDT
program. Through these evaluations, the healthcare experts found the systems useful and
sophisticated. The systems would benefit not only healthcare researchers across the globe
but also designers of EHR-based VA systems. These systems are also scalable and can be
reconfigured to work with other forms of data.
Other contributions emerge from the population-based studies presented in Chapters 4
and 6. Chapter 4 presented an automated approach to identify AKI-associated medication
and medication combinations. The drug-safety studies in clinical settings are usually
costly and time-consuming. The proposed approach can help healthcare researchers to
prepare a short list of suitable candidates for clinical studies, which not only saves money
and time but also supports the identification of potentially unknown nephrotoxic
medication combinations. In addition, the study in Chapter 6 demonstrates how machine
learning can be used to predict AKI using EHRs. Most of the existing AKI prediction
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models are designed for a specific medical condition and predict AKI close to its onset.
To the best of our knowledge, Chapter 6 presents the first study that predicts the risk of
AKI for patients who are discharged from the hospital or emergency department, which
provides enough time for clinicians to intervene.

7.3 Limitations and Future Work
The systems and studies presented in this dissertation lay a foundation for the usefulness
of VA tools in healthcare. Through the activity and task analysis framework, we
identified that there are a limited number of interactive visualization systems that support
higher-level activity, “predicting” and “monitoring.” The proposed systems are primarily
designed to support “interpreting” and “predicting.” More research is needed to explore
how EHR-based VA systems can be extended to support the activity, “monitoring.”
This dissertation reports the development of two VA systems—namely, VISA_M3R3
and VALENCIA. We described the data sources, input, output, stakeholders, interface,
design criteria, levels of abstraction and different subsystems of these systems in
Chapters 3 and 5. Although we included workflow diagrams to describe the systems'
design, the architectures of these systems are not described thoroughly. The description
was mainly focused on the conceptual challenges but did not consider the practical
difficulties of these complex systems. For instance, we did not investigate how many
users can be supported by the systems simultaneously or the systems’ capability of
interacting with other systems. Since both VISA_M3R3 and VALENCIA were
developed to process sensitive patient records in an access-restricted offline setting, it
was not required to create web services or implement any adapter (i.e., software that
connects two systems and reconciles the distinctions between them).
Another limitation of these systems lies in their ability to increase their functionalities
and capacity based on users’ demand. The description of these systems does not describe
the challenges regarding scalability and extensibility. Scalability refers to methods that
guarantee that the functionality and quality of a system are maintained as the number of
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users goes up or the complexity of the data increases. On the other hand, extensibility
refers to a system's ability to adapt to new interfaces, functionalities, data, and input. We
employed multiple programming languages, platforms, and servers for developing these
systems. The current VISA_M3R3 and VALENCIA systems were implemented using
HTML, JavaScript library D3, standard PHP programming language, SAS, and R
packages. The datasets were stored in the SAS server. R server was incorporated to
perform all the underlying processing. Web server (PHP) was used to host the HTML
files to maintain communication with the R server. Since different technologies are
combined to develop these systems, it is easy to incorporate new analysis algorithms
(e.g., using a new library or package in R), additional features in the interface (e.g.,
modifying D3 functions), and supplementary data (e.g., incorporating new datasets).
However, we were not able to determine the scalability of these systems. Since we
developed them in an access-restricted virtual machine, we did not get a chance to access
the systems' scalability. We will evaluate these systems more comprehensively in the
future.
Although healthcare experts have evaluated VISA_M3R3 and VALENCIA during the
design process and found it useful, we have not conducted formal studies to assess their
performances, nor the efficiency of their human-information discourse mechanisms.
Thus, additional studies can help ascertain the effectiveness of these systems for both
expert and non-expert users.
Both systems presented in this dissertation are implemented and tested using ICES-KDT
datasets. Studies that assess the effectiveness of these systems with different datasets and
settings will provide a better understanding of the efficacy of the systems.
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Appendices
Appendix A: List of databases held at ICES.
Data Source
Canadian Institute for Health
Information Discharge
Abstract Database and
National Ambulatory Care
Reporting System

Ontario Drug Benefits

Study Purpose

The Canadian Institute for Health Information Discharge Abstract
Database and National Ambulatory Care Reporting System collect
diagnostic and procedural variables for inpatient stays and ED visits,
respectively. Diagnostic and inpatient procedural coding use the 10th
version of the Canadian Modified International Classification of Disease
system 10th Revision (after 2002).

Cohort creation,
description, exposure,
and outcome
estimation

The Ontario Drug Benefits database includes a wide range of outpatient

Medication
prescriptions,

prescription medications available to all Ontario citizens over the age of
65. The error rate in the Ontario Drug Benefits database is less than 1%.

Registered Persons Database

Ontario Health Insurance
Plan

Description

description, and
exposure

The Registered Persons Database captures demographic (sex, date of
birth, postal code) and vital status information on all Ontario residents.
Relative to the Canadian Institute for Health Information Discharge
Abstract Database in-hospital death flag, the Registered Persons
Database has a sensitivity of 94% and a positive predictive value of
100%.

Cohort creation,
description, and
exposure

The Ontario Health Insurance Plan database contains information on
Ontario physician billing claims for medical services using fee and
diagnosis codes outlined in the Ontario Health Insurance Plan Schedule
of Benefits. These codes capture information on outpatient, inpatient,
and laboratory services rendered to a patient.

Cohort creation,
stratification,
description, exposure,
and outcome

Appendix B: Coding definitions for co-morbid conditions.
Variable

Major cancer

Chronic liver
disease

Database

Code

Set Code

International Classification of
Diseases 9th Revision

150, 154, 155, 157, 162, 174, 175, 185, 203,
204, 205, 206, 207, 208, 2303, 2304, 2307,
2330, 2312, 2334

International Classification of
Diseases 10th Revision

971, 980, 982, 984, 985, 986, 987, 988, 989,
990, 991, 993, C15, C18, C19, C20, C22, C25,
C34, C50, C56, C61, C82, C83, C85, C91, C92,
C93, C94, C95, D00, D010, D011, D012, D022,
D075, D05

Ontario Health Insurance
Plan

Diagnosis

203, 204, 205, 206, 207, 208, 150, 154, 155,
157, 162, 174, 175, 183, 185

Canadian Institute for
Health Information
Discharge Abstract
Database

International Classification of
Diseases 9th Revision

Canadian Institute for
Health Information
Discharge Abstract
Database

4561, 4562, 070, 5722, 5723, 5724, 5728, 573,
7824, V026, 571,
2750, 2751, 7891, 7895
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Ontario Health Insurance
Plan

Canadian Institute for
Health Information
Discharge Abstract
Database
Coronary artery
disease
(excluding
angina)

International Classification of
Diseases 10th Revision

B16, B17, B18, B19, I85, R17, R18, R160,
R162, B942, Z225, E831, E830, K70, K713,
K714, K715, K717, K721, K729, K73, K74,
K753, K754, K758, K759, K76, K77

Diagnosis

571, 573, 070

Fee code

Z551, Z554

Canadian Classification of
Diagnostic, Therapeutic and
Surgical Procedures

4801, 4802, 4803, 4804, 4805, 481, 482, 483

Canadian Classification of
Health Interventions

1IJ50, 1IJ76

International Classification of
Diseases 9th Revision

412, 410, 411

International Classification of
Diseases 10th Revision

I21, I22, Z955, T822

Diagnosis

410, 412

Ontario Health Insurance
Plan
Fee code

R741, R742, R743, G298, E646, E651, E652,
E654, E655, Z434,
Z448

Diabetes

Canadian Institute for
Health Information
Discharge Abstract
Database

Ontario Health Insurance
Plan

Canadian Institute for
Health Information
Discharge Abstract
Database
Heart failure

Ontario Health Insurance
Plan

Hypertension

Canadian Institute for
Health Information

International Classification of
Diseases 9th Revision

250

International Classification of
Diseases 10th Revision

E10, E11, E13, E14

Diagnosis

250

Fee code

Q040, K029, K030, K045, K046

Canadian Classification of
Diagnostic, Therapeutic and
Surgical Procedures

4961, 4962, 4963, 4964

Canadian Classification of
Health Interventions

1HP53, 1HP55, 1HZ53GRFR, 1HZ53LAFR,
1HZ53SYFR

International Classification of
Diseases 9th Revision

I500, I501, I509, I255, J81

International Classification of
Diseases 10th Revision

I21, I22, Z955, T822

Diagnosis

428

Fee code

R701, R702, Z429

International Classification of
Diseases 9th Revision

401, 402, 403, 404, 405
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Discharge Abstract
Database

International Classification of
Diseases 10th Revision

I10, I11, I12, I13, I15

Diagnosis

401, 402, 403

International Classification of
Diseases 9th Revision

5920, 5921, 5929, 5940, 5941, 5942, 5948,
5949, 27411

International Classification of
Diseases 10th Revision

N200 , N201 , N202 , N209 , N210 , N211 ,
N218 , N219 , N220 , N228

Canadian Classification of
Diagnostic, Therapeutic and
Surgical Procedures

5125, 5129, 5014, 5016, 5018, 5028, 5038,
5126, 5159

Canadian Classification of
Health Interventions

1KA76, 1KA50, 1KE76, 1KG50, 1KG57,
1KG76MI, 1KG87, 1IA87LA, 1IB87LA,
1IC87LA, 1ID87LA, 1KA87LA, 1KE57

International Classification of
Diseases 9th Revision

4402, 4408, 4409, 5571, 4439, 444

International Classification of
Diseases 10th Revision

I700, I702, I708, I709, I731, I738, I739, K551

Fee code

R787, R780, R797, R804, R809, R875, R815,
R936, R783, R784, R785, E626, R814, R786,
R937, R860, R861, R855, R856, R933, R934,
R791, E672, R794, R813, R867, E649

International Classification of
Diseases 9th Revision

430, 431, 432, 4340, 4341, 4349, 435, 436, 3623

International Classification of
Diseases 10th Revision

I62, I630, I631, I632, I633, I634, I635, I638,
I639, I64, H341, I600, I601, I602, I603, I604,
I605, I606, I607, I609, I61, G450, G451, G452,
G453, G458, G459, H340

International Classification of
Diseases 9th Revision

4030, 4031, 4039, 4040, 4041, 4049, 585, 586,
5888, 5889, 2504

International Classification of
Diseases 10th Revision

E102, E112, E132, E142, I12, I13, N08, N18,
N19

Diagnosis

403, 585

Ontario Health Insurance
Plan

Kidney stones

Peripheral
vascular disease

Canadian Institute for
Health Information
Discharge Abstract
Database

Canadian Institute for
Health Information
Discharge Abstract
Database

Ontario Health Insurance
Plan

Cerebrovascular
disease (stroke
or transient
ischemic attack)

Chronic kidney
disease

Canadian Institute for
Health Information
Discharge Abstract
Database

Canadian Institute for
Health Information
Discharge Abstract
Database

Ontario Health Insurance
Plan

Appendix C: Diagnostic codes for exclusion criteria.
Variable

Database

Code Set

Code

Dialysis

Canadian Institute
for Health
Information

Canadian
Classification of
Diagnostic,

5127, 5142, 5143, 5195, 6698
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Discharge Abstract
Database

Kidney
transplant

Therapeutic and
Surgical Procedures
Canadian
Classification of
Health Interventions

1PZ21, 1OT53DATS, 1OT53HATS, 1OT53LATS, 1SY55LAFT,
7SC59QD, 1KY76, 1KG76MZXXA, 1KG76MZXXN, 1JM76NC,
1JM76NCXXN

International
Classification of
Diseases 9th Revision

V451, V560, V568, 99673

International
Classification of
Diseases 10th
Revision

T824, Y602, Y612, Y622, Y841, Z49, Z992

Ontario Health
Insurance Plan

Fee code

R850, G324, G336, G327, G862, G865, G099, R825, R826, R827,
R833, R840, R841, R843, R848, R851, R946, R943, R944, R945,
R941, R942, Z450, Z451, Z452, G864, R852, R853, R854, R885,
G333, H540, H740, R849, G323, G325, G326, G860, G863, G866,
G330, G331, G332, G861, G082, G083, G085, G090, G091, G092,
G093, G094, G095, G096, G294, G295

Canadian Institute
for Health
Information
Discharge Abstract
Database

Canadian
Classification of
Health Interventions

1PC85

Ontario Health
Insurance Plan

Fee code

S435, S434
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